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Introduction and outline of the thesis 
 
Adapted from: Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw. 







































In 1982, Burgdorfer and colleagues cultured the causative agent of Lyme disease for the first 
time, the bacterium Borrelia burgdorferi (Figure 1A) (1). Borrelia is a thin (0.2-0.5 µm), 
elongated (20 µm), helically coiled Gram-negative bacterium that belongs to the phylum 
Spirochaetes (2). It has a protoplasmic cylinder surrounded by a fluid outer membrane and a 
peptidoglycan layer. The outer cell membrane contains many lipoproteins, including the 
outer surface proteins (Osps) A through F (3). In the periplasmic space, situated between the 
outer cell membrane and the peptidoglycan layer, seven to eleven flagella are attached to 
and winded around the protoplasmic cylinder. These flagella are responsible for the shape 
and motility of the pathogen (4). The flagella consist of a helical filament made of 41-kDa 
flagellin, a basal body and a hook that is attached to the protoplasmic cylinder (5).  
 
The corkscrew-shaped bacterium could be linked to the clinical signs that had developed in 
schoolchildren in a small town called Old Lyme, Connecticut, USA, who were all bitten by 
ticks (6). A couple of years later it could be demonstrated that interaction between the saliva 
of the tick and the blood of the host was the place of transmission of Borrelia spirochetes 
(7). In the past 20 years the knowledge but also the prevalence of Lyme disease has 
increased significantly. In 2009, 20% of all ticks were infected with the Borrelia bacterium in 
the Netherlands and 22,000 individuals were diagnosed with early signs of Borrelia infection, 
namely the typical erythema migrans (EM, Figure 1B).  








Figure 1. Borrelia morphology and characteristic skin inflammation after Borrelia infection. 
Microscopic detection of Borrelia bacteria using dark-field microscopy. Figure 1A shows clumping 





The Borrelia burgdorferi sensu lato family is a diverse group of worldwide occuuring 
pathogens, nowadays consisting of 18 spirochetal members. Within this group, B.burgdorferi 
sensu stricto is seen as the primary pathogenic genospieces that causes Lyme disease. The 
genome of B. burgdorferi sensu stricto (strain B31) has been sequenced and seems quite 
small with approximately 1.5 megabases. It consists of an unusual small linear chromosome 
of 950 kilobases and 21 plasmids, of which twelve are linear (lp) and nine circular (cp) (8;9). 
Borrelia distinguishes itself from other spirochetes by the fact that 40% of its genetic 
material, including genes encoding for certain outer-membrane proteins,  is encoded by 
these plasmids (8). Some of the plasmids can be lost during in vitro cultivation, indicating 
that they are not all stable and may not be essential (10). Other plasmids are crucial, since 
they encode for proteins that are essential for survival of Borrelia. These proteins include 
outer surface proteins (Osps) and other lipoproteins, which will be discussed extensively in 
the last part of this chapter.  
 
Borrelia spirochetes are transmitted by ticks of the Ixodes complex, with I. ricinus and I. 
persulcatus being the primary vectors in Europe and Asia. In general, I. scapularis (or I. 
dammini) is considered, in addition to I. pacificus, to be the most important vector in North 
America (11;12). However, some groups argue that I. scapularis is a vector to humans, 
although this tick is infected naturally with B.burgdorferi and is an efficient experimental 
vector (11). At any stage (larval, nymphal, adult) of their 2-year life, ticks can be infected 
with Borrelia. The percentage of ticks infected varies from 9% to 55% (13;14). Once infected, 
ticks transmit Borrelia by injection of Borrelia-containing saliva into the skin upon feeding 
(11). This is primarily done by nymphs since they are small and consequently less noticed, 
which is important since transmission of Borrelia to a mammalian host is dependent on the 
duration of attachment (15). Ticks feed on a large range of animals, and although many do 
not act as a reservoir, they are important for the survival of the tick since they supply 
nutrients. In Europe, rodents such as the Apodemus mice and voles, shrews, hares and 
several birds are significant reservoirs (16;17). In the USA, mostly rodents and deer are 
involved as reservoirs (18).  
 
In the USA most cases of Lyme disease are caused by Borrelia burgdorferi sensu stricto (1). 
This is in contrast to Europe, of which at least 3 Borrelia species have currently been 
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described to cause Lyme disease, namely B.burgdorferi, B. afzelii, and B.garinii (19). The 
clinical manifestations of Lyme disease can be divided into three stages: early infection, 
disseminated infection and persistent infection (20;21). In the first stage, a localized 
infection of the skin, so-called erythema migrans (EM), can be seen in approximately 70 to 
80% of the patients (22-24). If the pathogen disseminates through the blood and lymphatics, 
it can localize in places such as the heart, eyes, joints, and peripheral or central nervous 
system (CNS). This can lead to the second stage, the so-called early disseminated Lyme 
disease which can occur after several weeks to a few months post-infection. Lyme arthritis 
develops in approximately 50% of patients with untreated EM, being the most frequent 
symptom of disseminated Lyme disease in the USA. It is characterized by recurrent 
intermittent attacks of inflammation, usually in the large joints and most often the knee (18). 
In addition to arthritis, CNS involvement can develop at this stage with manifestations such 
as aseptic meningitis, radiculoneuritis, cranial neuritis and meningoradiculitis (also called 
Bannwarth syndrome) (25;26). The third stage, persistent infection or late stage Lyme 
disease, can be present months to years after the initial tick bite. It is characterized by 
acrodermatitis chronica atrophicans (ACA), which is frequently accompanied by sensory 
peripheral polyneuropathy and is almost exclusively caused by B. afzelii (27). Chronic Lyme 
disease can also include persistent neuroborreliosis and chronic arthritis (18;28). Some of 
these conditions develop despite long-term antibiotic treatment. There are two hypotheses 
for the pathogenesis of chronic arthritis: one hypothesizes that the joint inflammation is due 
to persistent infection, the other hypothesis claims that an infection-induced autoimmune 
process is involved (29). There are differences in clinical presentation of Lyme disease 
between Europe and the USA, which is partly due to a relation between the Borrelia species 
and the type of clinical manifestation. For example, B.burgdorferi sensu stricto is commonly 
associated with arthritis, while B. afzelii causes mainly skin manifestations and B. garinii 
often gives rise to neuroborreliosis (29). 
  
Mechanisms through which Borrelia promotes transmission and dissemination - Outer 
surface proteins OspA, OspB and OspC 
Borrelia utilizes different mechanisms to establish adequate transmission (figure 2). Outer 
surface proteins (Osps) play an important role. To be able to survive inside the tick, Borrelia 




attach to the tick midgut by binding to the tick receptor for OspA (TROSPA) (30-32). In this 
way, Borrelia can stay in the tick midgut as long as the tick is unfed. Upon feeding of the tick 
on a mammal, Borrelia travels to the salivary glands. At this time, OspA is downregulated 
and OspC is upregulated. Regulation of this expression is mediated by temperature and pH 
(33). OspC binds a tick salivary protein, Salp15, that contributes to transmission to mammals 
by its immunosuppressive properties, one of which is the inhibition of antibody-mediated 
killing and inhibition of CD4+ T-cell activation (10;34). Evidence that OspC is of key 
importance in the transmission was provided by OspC-deficient Borrelia that were unable to 
colonize ticks (35) and to establish infection in mice (36). Furthermore, OspC might be 
important for dissemination since disseminated disease is associated with only certain OspC 




Figure 2. Transmission and dissemination of Borrelia  
Borrelia bacteria are able to inhibit killing by host cells via several different mechanisms. This can be 
done  by inhibition of innate immune cells, such as macrophages and the complement system. Next to 
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binding to endothelial cells via p66, spirochetes are also able to enter the host tissues, form cysts to 
hide from attacking cells or change their outer surface antigens to protect themselves. 
 
Adhesins 
After Borrelia reaches the dermis, it expresses binding proteins on the surface (adhesins) to 
facilitate its dissemination (38). Adhesion to the extracellular matrix is one way to 
accomplish this, and particularly decorin-binding adhesins (DbpA and DbpB) seem to play an 
important role by binding to decorin, a collagen-associated proteoglycan (39;40) (figure 2). 
Decorin is usually linked to glycosaminoglycans (GAGs) and both glycoproteins seem to be 
needed for optimal binding (41). The binding protein BBK32 is also important for binding to 
the extracellular matrix since it binds to fibronectin, an extracellular matrix protein (42;43). 
Expression of BBK32 is dependent on the type of Borrelia strain, but also on the culture 
conditions in vitro. 
 
Another mechanism through which Borrelia promotes dissemination is by penetrating the 
matrix and the endothelial monolayers. This is mediated by binding of Borrelia to 
plasminogen, leading to plasmin formation and induction of proteolytic activity (44-46). 
Matrix metalloproteinase-1 (MMP-1) and MMP-9, whose expression and release is induced 
by Borrelia, enhance the penetration of tissue barriers as well (in vitro) (47;48).  
 
Spirochetes do not only use adhesins for binding to the extracellular matrix, but for binding 
to cells as well. This is accomplished by binding to non-decorin GAGs, which are produced by 
a wide variety of cells (49;50). The binding capacity is dependent on the cell type and the 
spirochete strain (51). One example is the Borrelia glycosaminoglycan protein (Bgp) that 
binds to heparin sulfate present on the surface of endothelial cells (50). The p66 outer-
surface protein also binds to endothelial cells (and macrophages) by binding the integrin 
αVβ3 that is present on their cell surface (52;53). Integrins are heterodimeric receptors, and 
are the most important metazoan receptors involved in adhesion of cells to the extracellular 
matrix and other cells (54). Next to binding endothelial cells, p66 also binds platelets through 
the integrin αIIbβ3 (55). Consequently, p66 seems very important for colonization of the 




Many aspects of Lyme disease’s pathophysiology remain unexplained, and the nature of the 
immune response to the pathogen is only partly understood. One important aspect of the 
spirochetal-host interaction is represented by the spirochetal recognition of the host. How 
spirochetes are recognized by the innate immune system and how they cause inflammation 
remains partially unclear. The activation of the innate immune system by Borrelia 
spirochetes will lead to the development of adaptive immune responses towards the 
microorganism. Therefore, the recognition of Borrelia and the initial triggering of innate 
immunity is important for understanding the immune-mediated late complications seen in 
Lyme disease. 
 
Immediately after invasion by Borrelia spp., host defense mechanisms that recognize the 
pathogens are activated and effective immune responses are induced. Innate immune cells, 
such as macrophages and NK(T) cells, are the first cells that recognize the pathogens. 
Pathogen-associated molecular patterns (PAMPs) play a very important role in activation of 
the innate immune system. PAMPs are conserved structures or components expressed on 
microorganisms that cannot be found in host cells. They are shared by groups of 
microorganisms and show little variation among a given class. Their expression can be 
essential for the survival of the microorganism (56). This last characteristic prevents 
extensive changes in structure and gives the innate immune system a chance to recognize 
the microorganism. Examples of PAMPs include hypomethylated DNA with CpG motifs, 
peptidoglycans, lipopeptides, flagellins and double-stranded RNA (57). Gram-negative 
bacteria cause a major inflammatory response through the stimulatory properties of 
lipopolysaccharide (LPS) (58;59). Borrelia does not contain LPS in the structure of its cell wall, 
but it does express many membrane-associated lipoproteins. Several of these have been 
shown to stimulate the innate immune response, like OspA and OspB (60-62). 
 
The innate immune response is initiated when PAMPs are recognized by pattern recognition 
receptors (PRRs), expressed by cells of the innate immune system. Each PRR has broad 
specificities for the various conserved and structures of microorganisms (63). Three types of 
PRRs have been described: secreted PRRs such as the LPS-binding protein (LBP), cell surface 
PRRs such as Toll-like receptors (TLRs), and PRRs that are only found intracellularly, such as 
nucleotide-binding oligomerization domain proteins (NOD) (64;65). TLRs are the most 
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characterized PRR class so far. In the case of Borrelia, several types of PRRs have been 
suggested to be involved in its initial recognition : TLRs,  NOD1 and NOD2, and C-type lectin 
receptors such as the mannose receptor (MR) and dectin-1 (figure 3).  
 
Figure 3. Involvement of PRRs in the recognition of Borrelia and intracellular signaling pathways. 
Borrelia spirochetes can be recognized via several different pathogen recognition receptors (PRRs). 
Both extracellular and intracellular receptors are involved. After recognition of Borrelia species by a 
PPR, both pro- and anti-inflammatory cytokine production is induced through transcription of NF-B. 
NF-B is located in the cell nucleus and can be activated through proteins of signaling pathways such 
as the MKK-p38 complex. Which pathway is induced depends on the type of receptor that recognizes 






Toll-like receptors have been found to play an important role in innate immunity and 
inflammation by the host in response to several different microbial components. TLRs are 
expressed by mucosal epithelial cells as well as by professional phagocytes. TLRs are type 1 
integral membrane glycoproteins, which are characterized by a single trans-membrane 
domain and an intra-cytoplasmic domain, also called the TOLL/interleukin-1 receptor 
homology domain (TIR domain). An important characteristic that distinguishes TLRs from 
interleukin-1 receptors is the extracellular domain consisting of 19 to 25 leucine-rich repeats 
(LRR) (figure 3). Although the LRR domains of the several family members of TLRs share 
homology, different TLRs are able to recognize structurally unrelated ligands (57;66). Eleven 
human TLRs have been reported: TLR1 through TLR11; the ligand for TLR10 is not 
determined yet (57), and TLR11 is a truncated molecule in humans (67). The localization of 
the various TLRs differs: TLR3, TLR7, TLR8 and TLR9 are only found in intracellular 
compartments, whereas TLR1, TLR2, TLR4, TLR5 and TLR6 are expressed mainly on the 
surface of the cell membrane, and can be recruited into the phagosomes (57;68-70). 
 
TLR2 
The expression of TLR2 is found on monocytes, macrophages, antigen-presenting cells, NK(T) 
cells, epithelial and endothelial cells (71). TLR2 has a very broad range of ligands: ranging 
from peptidoglycan of Gram-positive bacteria, to bacterial lipoproteins and mycobacterial 
cell-wall lipoarabinomannan (57). This broad range of ligands might be explained by the fact 
that TLR2 can form a functionally active heterodimer receptor with other TLRs such as TLR1 
or TLR6 (72-74), but also with other PRRs such as dectin-1 or CD36 (75;76). TLR1 and TLR6 
discriminate between bacterial lipoproteins that are triacylated or diacylated at the amino-
terminal cysteine residue (77). It was recently demonstrated that TLR2 requires TLR6 to 
efficiently transduce signals in TLR2-transfected endothelial cells and macrophages 
(73;74;78). The role of TLR2 in the pathogenesis of Lyme disease has been studied 
extensively and proven to be important. Wooten and colleagues demonstrated that 
macrophages from TLR2-deficient mice were unable to induce an immune response after 
stimulation with the Borrelia lipoprotein OspA (62). Another study showed that neutrophils 
of patients with Lyme disease have an upregulation of TLR2 mRNA and protein in 
combination with elevated production of IL-6 and IL-1β after recognition of Borrelia (79). 
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Peripheral blood monocytes (PBMCs) of patients with a Arg753Gln mutation in TLR2 give 
impaired cytokine induction after stimulation with Borrelia lysates (80). However, it remains 
unclear whether intact Borrelia spirochetes induce this cytokine response through TLR2 
alone, or whether other TLRs might cooperate with TLR2. For example, in a study with TLR2 
knock-out mice, macrophages do respond to lysates of whole spirochetes, indicating that 
there is also an TLR2-independent mechanism (62). 
 
Whether TLR2 is only important for the host defense against Borrelia, or also induces 
deleterious inflammatory reactions in the pathogenesis of Lyme disease remains unclear. A 
100-fold increase in the load of spirochetes was seen in tissues including ankle joints, ears 
and hearts of TLR2 knock-out mice compared to wild-type mice, which developed a milder 
inflammatory carditis (78). The amount of spirochetes in tissues after four weeks of infection 
was comparable between the TLR2-deficient mice and their wild-type littermates, which 
indicates that TLR2 probably plays an important role in the innate immune response against 
Borrelia. This observation could be confirmed in humans by Schröder et al. (80), who 
reported that a heterozygous mutation in human TLR2 (Arg753Gln) protects against the 
development of late stage Lyme disease, likely due to lower amounts of inflammatory 
cytokines such as TNF-α and IFN-γ were produced. 
 
Most lipoproteins contain a Pam3Cys-modified cystein that harbors the stimulatory effect 
(61;81-83). Lipoproteins which contain Pam3Cys are known to be expressed on B. burgdorferi 
during tick feeding and inflammation in mammals, and OspA is a well known example of 
such a lipoprotein (84;85). The response elicited by lipoproteins is very similar to that of LPS, 
and this is likely due to the similarities between TLR2 and TLR4 signaling pathways (86;87).  
 
TLR4 
TLR4 is expressed by cells of the immune system, mostly by macrophages and dendritic cells 
(63). The main ligand for TLR4 is lipopolysaccharide (LPS) from Gram-negative bacteria (88). 
Borrelia spirochetes do not express LPS on their outer surface (89). Not surprisingly, a role 
for TLR4 in Lyme disease has not been demonstrated. Nonetheless, an elevated expression 
of TLR4 was seen in primary microglia after uptake of B. burgdorferi, and upregulation of 




stimulated with synthetic lipopeptides corresponding to OspC of B. burgdorferi, although 
TLR1 and TLR2 were upregulated as well (90;91).   
 
CD14 
CD14 is a co-receptor of both TLR2 and TLR4, that is able to recognize a variety of microbial 
compounds, thereby enhancing the activity of TLR4 (86;87). Wooten and colleagues were 
the first to report that lipoproteins of Borrelia (OspA and OspC) could activate cells via 
pathways mediated by CD14 (86). CD14 knock-out mice were found to have a more severe 
inflammatory response after infection with Borrelia, and the amounts of spirochetes in 
tissue were higher compared to their wild-type littermates (87). Human neutrophils and 
human umbilical vein endothelial cells (HUVECs) sensitivity after Borrelia stimulation was 
twentyfold decreased after blocking CD14 molecules. However, these cell types were still 
activated when CD14 molecules were absent or blocked, indicating that CD14 is able to 
facilitate signaling, but is not the ligand-specific receptor. In patients with acute Lyme 
disease, CD14 was found to be upregulated in serum, indicating that this protein may play a 
role in the pathogenesis (92).  
 
NOD-like receptors 
Another class of PRR receptors are the NOD-like receptors, also called nucleotide-binding 
domain and leucine-rich repeat containing molecules (NLRs). NLRs sense the presence of 
intracellular bacterial peptidoglycans. Several members of this family have been shown to 
induce signaling pathways by acting as PRRs (93). NOD1 and NOD2 are mainly expressed by 
epithelial cells and antigen-presenting cells (APCs) such as macrophages and dendritic cells 
(94). Cell walls of Gram-positive and Gram-negative bacteria contain peptidoglycans that are 
responsible for providing shape and mechanical rigidity. Peptides derived from 
peptidoglycans, such as muramyl dipeptide (MDP) and γ-D-glutamyl-meso-diaminopimelic 
acid (iE-DAP) are found to be respectively the NOD1 and NOD2 ligands (95-100). 
 
Several groups have reported a role for NOD1 in the recognition and induction of signaling 
pathways of inflammation in a variety of Gram-negative bacteria such as Chlamydia and E. 
coli (101;102). B. burgdorferi was reported to upregulate NOD-proteins on astrocytes after 
exposure to several TLR-ligands (103). Sterka and colleagues found that NOD2, and not 
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NOD1, was highly upregulated on primary murine microglia after stimulation with B. 
burgdorferi (104). This may suggest that NOD-proteins are involved in the induction of 
inflammation. Indeed, it was shown that NOD2 is involved in the release of several different 
inflammatory cytokines induced by Borrelia, such as IL-6. Persons with a non-functional 
NOD2 express lower cytokine levels after stimulation with Borrelia spirochetes (105). 
However, the exact role of NOD2 in the pathogenesis of Lyme disease remains unknown. 
 
C-type lectin receptors 
C-type lectin receptors (CLR) comprise a family of proteins which contain one or more 
structurally related C-type lectin-like domains. In vertebrates 17 subgroups have been 
identified, which can be further divided in soluble lectins and cell-associated 
(transmembrane) C-type lectins, such as dectin-1 and mannose receptor. Many 
transmembrane CLRs are expressed by antigen-presenting cells. They function as PRRs by 
recognizing polysaccharide PAMPs of microorganisms (106).  
 
Mannose receptor 
Mannose is found in glycoproteins on the surface of many microorganisms. It is recognized 
by the mannose receptor family, a subgroup of the C-type lectin superfamily, consisting of 
the M-type phospholipase A2 receptor, DEC-205/gp200-MR-6, Endo180/uPARAP, and 
macrophage mannose receptor (107).  The mannose receptor (MR) is a transmembrane 
protein that is involved in the recognition of several micro-organisms including Candida 
albicans, Pneumocystis carinii, Leishmania donovani, Mycobacterium tuberculosis, and 
Klebsiella pneumoniae via distinct domains (108-113). MR is expressed on several cells of 
innate immune system, like tissue macrophages, dendritic cells and endothelial cells (114). 
Ezekowitz and colleagues demonstrated that MR plays a role in the endocytosis and 
phagocytosis of bound ligands of Candida albicans by macrophages (112). Similar results 
were seen for several different strains of Mycobacterium tuberculosis (113).  
 
The MR possibly plays a role in the host defense against Borrelia infection by facilitating the 
phagocytosis of the bacteria by monocytes and macrophages. Borrelia spirochetes in the 
dermis and epidermis can be processed by Langerhans cells and dendritic cells. The MR on 




recognized and bound by it (114). It was also reported that MR is able to induce the release 
of IL-1β, IL-6 and IL-12 after triggering by other microorganisms (115;116). Whether MR is 




Dectin-1 is the best-known member of the natural killer (NK)-cell-receptor-like C-type lectin 
family, and is the only PRR that is able to transduce its own intracellular signals without the 
help of TLRs (117), through pathways involving CARD9 on one hand, and Raf-1 on the other 
hand (118;119).  The main ligands for dectin-1 are β-(1,3)-glucans. So far there has been no 
study to support a role for dectin-1 in the recognition of Borrelia. In addition, chemical 
analysis of Borrelia did not reveal any potential ligands for dectin-1 in its cell wall (120) .  
Preliminary data reveals that B.burgdorferi might use both Dectin-1 and Dectin-2 as 
inhibitory signal transducers for other PRRs such as TLR2 (unpublished data). 
 
Signaling pathways induced by recognition of Borrelia 
Recognition of Borrelia by the PRRs induces a cascade of signals, which ultimately activates 
the cell.  In the TLR signaling pathway, TLR2 and TLR4 dimerize after binding the ligand, 
which allows the intracellular domain to form a TIR-TIR interface with the TIR domain of the 
MyD88 adaptor molecule (MAL, also known as TIRAP), and in turn with the myeloid 
differentiation factor-88 (MyD88). The amino-terminal death domain of MyD88 induces 
phosphorylation of IL-1R-associated kinase 4 (IRAK4) and IRAK1, allowing to form a complex 
with tumor-necrosis-factor-receptor-associated factor 6 (TRAF6), an ubiquitin ligase. TRAF6 
induces activation of TGF-beta-activated kinase (TAK1). These events activate in the end the 
nuclear transcription factor (NF-κB) by degrading the IKK complex (inhibitor of NF-κB kinase 
complex). NF-κB is thereafter able to translocate to the nucleus and induce transcription of 
inflammatory genes (57;66) (figure 3).  
 
The role of MyD88-dependent signals for the cell activation by Borrelia has recently been 
shown. In MyD88-deficient mice, the number of spirochetes in tissues was considerably 
higher than in wild-type mice (121). Furthermore, MyD88 seems to be necessary for efficient 
clearance of Borrelia (122). However, MyD88-independent pathways are induced by Borrelia 
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as well. Borrelia-infected MyD88-deficient mice were shown to have arthritis similar to wild-
type mice (122) or even more severe (121). This suggests that there are other pathways 
involved in inflammation than through TLRs alone.   
Once intracellular signals are induced by Borrelia, there is a central role for p38 mitogen-
activated protein (MAP) kinase activity in the generation of the pro-inflammatory response. 
The p38 MAP kinase phosphorylates mitogen- and stress-activated protein kinase 1 (MSK1) 
which in turn phosphorylates NF-κB resulting in transcription of pro-inflammatory and host 
defense genes (123). 
 
Production of cytokines and chemokines 
Borrelia has potent stimulatory activities, one of the most important being cytokine 
induction. The expression of the pro-inflammatory cytokines IL-1β, IL-6, IL-12, TNF-α and 
IFN-γ is elevated in vitro when different cells such as PBMCs and mast cells are stimulated 
with Borrelia (124-132). This response is elicited by the outer surface lipoproteins that 
induce translocation of NF-κB through PRR signaling (61;81;132;133). Borrelia is able to 
induce not only the production of pro-inflammatory cytokines, but anti-inflammatory 
cytokines such as IL-10 as well (134). Also chemokines (e.g. IL-8, CXCL13) and adhesion 
molecules (e.g. E-selectin, VCAM-1 and ICAM-1) are expressed in response to Borrelia 
(61;135;136). Together, these molecules direct the recruitment of macrophages and 
neutrophils, which can eliminate the spirochetes by producing oxygen radicals like nitric 
oxide (82;83). Finally, the innate immune system directs the adaptive immune system; co-
stimulatory molecules on antigen-presenting cells are upregulated through PRR signaling 
(65). Furthermore, proliferation of B-cells and production of immunoglobulins is induced by 
Borrelia (137). The several different mechanisms through which TLR-mediated signals might 






Outline of the thesis 
 
Many aspects of the pathological disorder caused by Borrelia spirochetes remain 
unexplained, and the nature of the immune response against this bacterium is only partly 
understood. The aim of this thesis is to study the innate and adaptive defense mechanisms 
against Borrelia to provide insights that contribute to the understanding of Lyme disease and 
to identify potential novel therapeutic targets.  
In Chapter 2 it will be elucidated which TLR2 heterodimer is necessary for Borrelia-induced 
cytokine responses. Genetic mutations in genes coding for PRRs have been linked to altered 
immune responses against pathogens, which are mainly located at the level of single 
nucleotide polymorphisms (SNPs). SNPs are changes in the DNA of individuals in a single 
nucleotide. SNPs are able to cause structural changes and modify the function of the protein, 
influence splicing or transcription of that specific gene, depending of the location of the SNP 
in the gene. Functionally described single nucleotide polymorphisms in TLR1 and TLR6 and 
the response against Borrelia will be studied. In Chapter 3 the function of the novel receptor 
TLR10 and the interaction with on other TLRs, including TLR2, will be studied. Next to TLRs, 
intracellular PRRs, such as Nod-like receptors, were also demonstrated to play an important 
role in the recognition of extracellular pathogens (138). The roles of Nod1, Nod2, and the 
adaptor molecule RICK will be studied in Chapter 4. In this chapter, we will also illustrate the 
consequences of mutations in the NOD1 and NOD2 genes for the innate immune response 
against Borrelia.  
Activation of the immune system by PRR will result in the production of the inactive pro-
inflammatory cytokine Interleukin (IL)-1β. Next to TLR activation, a second signal is necessary 
to secrete the bioactive form of this cytokine. After activation of the immune cells, a protein 
complex called the “inflammasome” is formed, which results in activation of pro-caspase-1 
and subsequent cleavage of pro-IL-1β into its active and mature form, IL-1β. The pivotal 
components of the TLR-signaling pathway and inflammasome in the production of active IL-
1β upon Borrelia stimulation will be investigated in Chapter 5. Also the effect of the several 
inflammasome components in the outcome of murine Lyme arthritis will be described in this 
chapter. The role of the caspase-1-cleaved products IL-1β and IL-18 will be studied in 
Chapter 6. IL-1β, together with IL-23, was shown to be crucial for the induction of IL-17 
production, a cytokine induced predominantly by Th17 cells. Earlier studies have 
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demonstrated that IL-17 was induced after stimulation with Borrelia-derived antigens and 
proposed to play a role in the pathogenesis of murine Lyme arthritis (139;140). The outcome 
in Lyme-associated clinical signs in humans will be studied in Chapter 7, whereby the effect 
of a SNP in IL-23Receptor on the production of Borrelia-induced IL-17 will be elucidated. 
As outlined in the introduction, insights into the pathogenesis of Borrelia are necessary to 
optimize the current treatment methods but may also reveal new therapeutic targets for the 
development of new therapeutics. A summary of the most recent understanding about 
recognition, signaling pathways, and cytokine responses after Borrelia infection will be given 
in Chapter 8. A summary of the new findings and conclusions of this thesis are presented in 
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After infection with Borrelia species, the risk for developing Lyme disease varies significantly 
between individuals. Recognition of Borrelia by the immune system is mediated by pattern 
recognition receptors (PRRs), such as TLRs. While TLR2 is the main recognition receptor for 
Borrelia spp., little is known about the role of TLR1 and TLR6, which both can form 
functionally active heterodimers with TLR2. Here we investigated the recognition of Borrelia 
by both murine and human TLR1 and TLR6. Peritoneal macrophages from TLR1- and TLR6- 
gene deficient mice were isolated and exposed to Borrelia. Human PBMCs were stimulated 
with Borrelia with or without specific TLR1 and TLR6 blocking using specific antibodies. 
Finally, the functional consequences of TLR polymorphisms on Borrelia-induced cytokine 
production were assessed.  
Splenocytes isolated from both TLR1-/- and TLR6-/- mice displayed a distorted Th1/Th2 
cytokine balance after stimulation with B.burgdorferi, while no differences in pro-
inflammatory cytokine production were observed. In contrast, blockade of TLR1 with specific 
neutralizing antibodies led to decreased cytokine production by human PBMCs after 
exposure to B.burgdorferi. Blockade of human TLR6 did not lead to suppression of cytokine 
production. When PBMCs from healthy individuals bearing polymorphisms in TLR1 were 
exposed to B.burgdorferi, a remarkably decreased in-vitro cytokine production was observed 
in comparison to wild-type controls. TLR6 polymorphisms lead to a minor modified cytokine 
production. This study indicates a dominant role for TLR1/TLR2 heterodimers in the 




Ticks of the Ixodes family are able to transmit bacteria of the Borrelia burgdorferi sensu lato 
family, which causes Lyme Disease (1). Within this family, three species are described to be 
pathogenic, namely B.burgdorferi sensu stricto, B.afzelii, and B.garinii, which are 
differentially distributed between the United States and Europe. Clinical signs that develop 
after infection with Borrelia spirochetes are diverse, ranging from skin abnormalities 
(erythema migrans) to arthritis or carditis (2). Infection with Borrelia results in release of 
inflammatory mediators and recruitment of inflammatory cells to the site of infection (3;4). 
To induce inflammation, recognition of the bacteria by pattern recognition receptors (PRRs) 
is necessary.  
Distinct classes of PRRs have been described, including C-type lectins (CLRs), NOD-like 
receptors (NLRs), and Toll-like receptors (TLRs). TLR4, the main receptor for bacterial 
lipopolysaccharides (5), has been shown not to be involved in the recognition of Borrelia (6). 
On the other hand, TLR2 plays an important role in the recognition of Borrelia components. 
It has been demonstrated that TLR2-knockout mice produced significantly lower 
concentrations of antibodies against Borrelia after immunization with OspA (7). TLR2 
knockout mice harbor higher amounts of Borrelia spirochetes at the site of inflammation 
than wild-type animals and hence exhibit more cell influx in infected joints (8;9). In humans, 
TLR2 can recognize several components of Borrelia (10;11), and TLR2 blockade in human 
peripheral blood mononuclear cells (PBMCs) resulted in decreased cytokine production after 
exposure to intact Borrelia spirochetes (6).  In order to recognize its ligands, TLR2 forms 
heterodimers with other members of the TLR family (TLR1 or TLR6) (12). TLR1/TLR2 
heterodimers recognize mainly triacylated lipopeptides, whereas TLR2/TLR6 heterodimers 
recognize diacylated lipopeptides (13;14). TLR1/2 heterodimers induce also a different 
immune response against pathogens as compared to TLR2/6 heterodimers (15;16). When 
TLR1/2 molecules are absent, less induction of early cytokines were observed, whereas 
TLR2/6 seems able to modulate the balance between a Th1/Th2 immune response. 
Limited information is available about recognition of B. burgdorferi by TLR1 and TLR6 in 
murine and human cell systems, and the relative contribution of these receptors as 
components of the heterodimers with TLR2 for the recognition of Borrelia species has not 
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been elucidated for primary cells (7;17-20). In addition, mutations in TLR1 and TLR6 
receptors are associated with differential susceptibility to bacterial and fungal infections 
(15;21), and the question arises to what extent these polymorphisms may lead to changes in 
production of cytokines after exposure to Borrelia species, and hence might influence the 
clinical outcome of Lyme disease. Thus, we investigated the role of TLR1 and TLR6 in the 
recognition of Borrelia species by mouse cells and primary human cells, and assessed 
whether polymorphisms in either the TLR1 or the TLR6 gene influence the cytokine 
responses. We observed an important role for TLR1/2 heterodimers for the recognition of 
Borrelia species and for the induction of an early immune response against Borrelia 
spirochetes in humans. 
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Materials and Methods 
 
Borrelia burgdorferi cultures 
B.burgdorferi, ATCC strain 35210, was cultured at 33°C in Barbour-Stoenner-Kelley (BSK)-H 
medium (Sigma-Aldrich) supplemented with 6% rabbit serum. Spirochetes were grown to 
late-logarithmic phase and examined for motility by dark-field microscopy. Organisms were 
quantitated by fluorescence microscopy after mixing 10 µL aliquots of culture material with 
10 µL of an acridine orange solution and counted using a Petroff-Hauser counting chamber. 
Bacteria were harvested by centrifugation of the culture at 7000 x g for 15 min., washed 
twice with sterile PBS (pH 7.4), and diluted in the specified medium to required 
concentrations of 1x106 spirochetes per mL. Heat-killed B. burgdorferi were prepared by 
heating cultured spirochetes at 52°C for 30 min. before dilution.  
 
Animals 
TLR1-/- and TLR6-/- mice were kindly provided by Dr. Shizuo Akira and are fully backcrossed 
to C57BL/6 background (Osaka University, Japan). C57BL/6 mice were obtained from Charles 
River Wiga (Sulzfeld, Germany). Female wild-type and knock-out mice between 8 and 14 
weeks of age were used. The mice were fed sterilized laboratory chow (Hope Farms, 
Woerden, The Netherlands) and water ad libitum. The experiments were approved by the 
Ethics Committee on Animal Experiments of the Radboud University Nijmegen Medical 
Centre.  
 
In-vitro cytokine production 
Peritoneal macrophages were isolated by injecting 5 mL of ice-cold sterile PBS (pH 7.4) in the 
peritoneal cavity. After centrifugation and washing, cells were resuspended in Roswell Park 
Memorial Institute (RPMI) 1640 containing 1mM pyruvate, 2 mM L-glutamine and 50 mg/L 
gentamicin (culture medium). Cells were counted using a Z1 Coulter Particle Counter 
(Beckman Coulter, Woerden, The Netherlands) and adjusted to 1x106 cells/mL. Cells were 
cultured in 96-well round-bottom microtiter plates (Costar, Corning, The Netherlands) at 
1x105 cells/well, in a final volume of 200 µL. After 24 hours of incubation of cells with 
different stimuli at 37°C in air and 5% CO2, the plates were centrifuged at 1400 x g for 8 min, 
and the supernatant was collected and stored at -20°C until cytokine assays were performed. 
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Spleen cells were isolated by gently squeezing spleens in a sterile 200 µm filter chamber. 
After washing with sterile PBS and centrifugation at 4°C (1200 rpm 5 min), cells were 
resuspended in 4 ml RPMI 1640 in presence of 20% FCS. Cells were counted and 
concentrations were adjusted to 1 x 107 cells/ml. Cells were cultured in 24-wells plates 
(Greiner, Alphen a/d Rijn, The Netherlands) at 5 x 106 cells/well, in a final volume of 1000 µl. 
After 5 days of incubation, supernatant was collected and stored at -80°C until cytokine 
assays were performed. 
 
Study populations 
Individuals in this study were foresters from the ‘Geldersch Landschap’ and ‘Kroondomein 
het Loo’ in the Netherlands. In this cohort, Lyme disease occurs as an occupational disease 
and hence they were invited to participate. The foresters were between 23-73 years old, and 
consisted of 77% males and 23% females. Samples of venous blood of them were drawn 
after informed consent was obtained. Experiments were conducted according to the 
principles expressed in the Declaration of Helsinki. 
 
Isolation of genomic DNA and single nucleotide polymorphism analysis 
DNA was isolated using the Gentra Pure Gene Blood kit (Qiagen), in accordance with the 
manufacturer’s protocol for whole blood. DNA was dissolved in a final volume of 100 µL 
buffer. Polymerase chain reaction (PCR) amplification of TLR1 and TLR6 gene fragments 
bearing the polymorphisms R80T (rs5743611), N248S (rs4833095), and S249P (rs5743810) 
were performed using a pre-designed TaqMan ® SNP genotyping assay (Applied Biosystems) 
in 25 µL reactions containing 2 µL of genomic DNA as well as primers, two specific probes 
(with either VIC or FAM label) and Universal PCR 2x Master mix (Applied Biosystems). Cycling 
conditions were 2 min at 50°C and 10 min at 95°C followed by 40 cycli of 95°C for 15 sec and 
1 min at 60°C. Fluorescence intensities were corrected using a post-read / pre-read method 
for 1 min at 60°C before and after the amplification. The software automatically plotted 
genotypes based on a two-parameter plot with an overall success rate of more than 95%. 
Intermediate samples were excluded from the analysis. Conventional PCR amplification of 
the TLR1 gene fragment containing polymorphism S602I (rs5743618) was performed on the 
Icycler (BioRad) in 50 µL reactions containing 2 µL of genomic DNA, 1,5mM MgCl2, Taq DNA 
polymerase conc. 5 U/µL  (Invitrogen), PCR buffer, 20mM dNTP (Pharmacia), 10 µM Forward 
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primer 5’-CTA CCC GGA AAG TTA TAG AGG AAC C, and 10µM Reversed primer 5’-TTT GGC 
AAT AAT TCA TTC TTC ACC. PCR consisted of one initial denaturation phase of 95˚C for 10 
minutes followed by 40 cycles; each cycle consisted out of one annealing step of 95˚C for 30 
seconds, one polymerization step of 60˚C for 30 seconds, and one elongation step of 72˚C 
for 30 seconds. Subsequently, another cycle of 72˚C for 7 minutes was performed before 
termination. PCR products were sequenced with either 4µM of primers according to the 
Sanger method supported by Big Dye Terminator version 3 of Applied Biosystems. After 
sequencing, samples were analyzed using the 3730 Sequence analyzer and Chromas 2.33 
software (Technelysium). 
 
Isolation of human peripheral blood mononuclear cells and in-vitro cytokine production 
Venous blood was drawn from the cubital vein of foresters into 10mL 
ethylenediaminetetraacetic acid (EDTA) tubes (Monoject). Peripheral blood mononuclear 
cells (PBMCs) were isolated according to standard protocols, with minor modifications. The 
PBMC fraction obtained by density centrifugation of blood diluted 1:1 in phosphate-buffered 
saline (PBS)-buffer over Ficoll-Paque (Pharmacia Biotech). Cells were washed three times in 
PBS and resuspended in RPMI 1640 (Dutch modified) supplemented with 50 mg/L 
gentamicin, 2 mM L-glutamin, and 1mM pyruvate. Cells were counted in a Coulter Counter 
Z® (Beckman Coulter), and adjusted to 5x106 cells/mL. Mononuclear cells (5x105) in a 100mL 
volume were added to round-bottom 96-wells plates (Costar, Corning, The Netherlands) and 
incubated with either 100µL of medium (negative control) or B. burgdorferi (1x106 
spirochetes per mL). In some experiments, PBMCs were pre-incubated with neutralizing 
antibodies for 30 minutes (functional grade anti-human Toll-like receptor 1 (10 µg/mL, 
eBioscience), anti-TLR6 (10 µg/mL, BioLegend), anti-TLR2 (10 µg/mL, eBioscience) or control 
antibody (mouse IgG1к, 10 µg/mL, eBioscience)). After pre-incubation, B. burgdorferi or 
specific TLR ligands were added, such as Pam3Cys or FSL-1 (10 µg/mL or 1 µg/mL, 
respectively). After 24 hours or 7 days (in the presence of 10% human pool serum) 
supernatants were collected and stored at -20°C until being assayed.         
 
Cytokine measurements 
Concentrations of mouse IL-1β were determined by specific radioimmunoassay (RIA; 
detection limit is 20 pg/mL) (22). Mouse IL-6, IL-17, IFN-γ, and IL-10 concentrations were 
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measured by a commercial ELISA kit (Biosource, Camarillo, CA; detection limits 16 pg/mL), 
according to the instructions of the manufacturer. Concentrations of human IL-1β, IL-6, IL-
17, or IFN-γ were determined in duplicates using either specific or commercial ELISA kits 
(PeliKine Compact, Sanquin, Amsterdam, or R&D Systems, Minneapolis), in accordance with 




All experiments in this study were carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health, the Dutch law on Animal experiments, and FELASA regulations. The 
protocol was approved by the Ethics Committee on Animal Experiments of the Radboud 
University Nijmegen Medical Centre. All efforts were made to minimize suffering of the 
animals.  
All human experiments were conducted according to the principles expressed in the 
Declaration of Helsinki. Before taking blood, informed written consent of each human 
subject was provided. The study was approved by the review board of the department of 
Medicine of the Radboud University Nijmegen Medical Centre. 
 
Statistical analysis 
The data are expressed as mean ± SEM unless mentioned otherwise. Differences between 
experimental groups were tested using the two-sided Mann-Whitney U test performed on 




TLR1 activation enhanced the induction of IFN-γ by murine splenocytes after exposure to 
B. burgdorferi. Peritoneal macrophages from TLR1 knockout animals produced the same 
amounts of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, as compared to cells isolated 
from wild-type C57Bl/6 mice (figure 1A-C). However, a significant decrease in IL-10 
production could be observed when TLR1-deficient splenocytes were stimulated with B. 
burgdorferi for 5 days (figure 1D). Moreover, IFN-γ production induced by B. burgdorferi in 
TLR1-deficient splenocytes was significantly higher than in controls (figure 1E). Finally, IL-17 
production was somewhat higher after stimulation of TLR1 knockout cells, but not found to 
be statistically significant (figure 1F). 
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Figure 1. In vitro cytokine production by TLR1-/- cells after stimulation with Borrelia. 1x105 
peritoneal macrophages from five C57Bl/6 mice were stimulated separately for 24 hours with 1x106 
live B.burgdorferi per mL. Levels of IL-1β (A), IL-6 (B), and TNF-α (C) were measured in the 
supernatants and compared to the cytokine production induced by cells deficient in expressing TLR1 
(black bars, represent TLR1-/- cytokine responses). Spleen cells (5x106/well) of both wild-type (black 
bars) and TLR1-/- (white bars) mice were stimulated for 5 days with 1x106 live Borrelia per mL and 
levels of IL-10, IFN-γ, and IL-17 were measured in the supernatant using ELISA (D-F, respectively). Bars 
represent the mean ± SEM of 5 animals per group. **p<0.01 (for comparisons between wild-type and 
knock-out mice), Mann-Whitney U-test, experiments were performed in duplicates. 
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Borrelia-induced IFN-γ production by murine cells is dependent on TLR6. To assess the role 
of TLR6, 1x106 live Borrelia burgdorferi spirochetes per mL were added to freshly isolated 
peritoneal macrophages of either wild-type or TLR6 gene-deficient mice. After 24 hours of 
stimulation, no differences in the production of pro-inflammatory cytokines IL-1β, IL-6, and 
TNF-α could be detected between cells isolated from wild-type or TLR6 knock-out mice 
(figure 2A, 2B, and 2C, respectively). Other cytokines, such as IL-10, IL-17 and IFN-γ are 
known to be involved in the immune response against Borrelia (23;24), splenocytes of wild-
type or TLR6 knock-out mice were incubated for 5 days with Borrelia. Thereafter, the 
production of IL-10, IFN-γ, and IL-17 was measured by ELISA (figure 2D-F). A significant 
decrease in IFN-γ production was detected in mice lacking functional TLR6. IL-10 and IL-17 
production tended to be lower in these mice, but these differences did not reach statistically 
significance (figure 2D and 2F). 
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Figure 2. Recognition of Borrelia species by immune cells of TLR6-/- mice. Peritoneal macrophages 
(1x105/well) of C57Bl/6 wild-type or TLR6 gene deficient mice (n=5 per group) were stimulated for 24 
hours with 1x106 live Borrelia per mL. Using ELISA or RIA, IL-1β (A), IL-6 (B), or TNF-α (C) levels were 
measured in pg/mL. 5x106 spleen cells/well were stimulated with 1x106 live Borrelia per mL. IL-10, 
IFN-γ, and IL-17 levels were determined in the supernatant of 5-days spleen cell culture (D-F, 
respectively). White bars represent cytokine induction after stimulation of wild-type cells, black bars 
the TLR6 knockout cells. An asterisk indicates that the P-value is <0.05 (for comparisons between 
wild-type and knock-out mice), 5 animals per group, Mann-Whitney U-test. Bars represent the mean 
± SEM, experiments were performed in duplicates.  
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Differential role of human TLR1 and TLR6 for the recognition of Borrelia. To investigate the 
relative roles of TLR1 and TLR6 signalling for the recognition of Borrelia by human primary 
cells, neutralizing antibodies were used to inhibit the function of these specific TLRs. When 
PBMCs from 5 healthy individuals were incubated for 24 hours with blocking anti-TLR1, anti-
TLR6, anti-TLR2 antibodies, or control IgG1к antibody alone, no production of pro-
inflammatory cytokines and chemokines could be detected (data not shown). Inhibition of 
cytokines produced upon Pam3Cys stimulation could only be observed when using the anti-
TLR1 antibody and could not be inhibited by TLR6 antibodies (not shown). When human 
PBMCs were incubated with B. burgdorferi in the presence of a specific anti-TLR1 antibody, a 
significant reduction in IL-1β, IL-6 (but not TNFα), and chemokine IL-8 production was 
observed (figure 3A-D). In contrast to TLR1, human TLR6 seems to play a minor role in the 
induction of pro-inflammatory cytokines after Borrelia stimulation of PBMCs. Production of 
IL-6, IL-1β, or IL-8 was not significantly inhibited after a neutralizing TLR6 antibody was 
added to the cultures (figure 3A-D). As demonstrated previously, TLR2 is important for the 
induction of cytokine responses by Borrelia in human PBMCs (figure 3A-D). No significant 
differences in cytokine production could be observed when Borrelia was co-incubated with 
IgG antibody alone (figure 3A-D). 
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Figure 3. Borrelia is recognized by human TLR1 and TLR2. (A) Peripheral blood mononuclear cells 
(PBMCs, 5x105/well) from 6 healthy volunteers were stimulated for 24h with 1x106 B.burgdorferi per 
mL (grey bars). IL-6 production in the supernatant was measured using ELISA and showed in % where 
Borrelia induced cytokine production is set as 100% cytokine induction. Bars represent the means ± 
SEM. **p<0.01; ***p<0.001 (Mann-Whitney). Borrelia IL-6 production 100% was 30271±8607 pg/mL. 
Anti-TLR1, 10µg/mL specific antibody; anti-TLR6, 10 µg/mL specific antibody; anti-TLR2, 10 µg/mL 
specific antibody; control IgG, mouse IgG1к isotype control 10 µg/mL. (B) IL-1β production measured 
in supernatant after 24 hours culture of PBMCs stimulated with or without 1x105 B.burgdorferi  per 
mL or in the presence or absence of 10µg/mL antibody. Borrelia IL-1β production 100% was 576±295 
pg/mL. (C) IL-8 production. Borrelia IL-8 production 100% was 121±33 ng/mL (D) TNF-α production 
after 24 hours of stimulation. Borrelia TNF-α production 100% was 6528±2716 pg/mL Bars represent 
the means ± standard error of the means; *p <0.05; **p<0.01; ***p<0.001, Mann-Whitney U-test. 
The data shown are from three independent experiments each performed in duplicate. 
 
The role of human TLR1 polymorphisms in cytokine production by B. burgdorferi. PBMCs 
isolated from individuals carrying different TLR1 genotypes were incubated for 24 hours with 
Borrelia, or the TLR2 specific ligand Pam3Cys. Cytokine production was significantly lower 
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after stimulation of PBMCs with Pam3Cys in cells isolated from individuals homozygous for  
the R80T, N248S, and S602I polymorphisms in TLR1 (figure 4). For the TLR1 R80T 
polymorphism, we observed a trend towards lower production of IL-1β after PBMC 
stimulation with 1x106 B. burgdorferi microorganisms per mL (figure 4A). These results are in 
line with previous reports showing that the presence of the TLR1 polymorphisms R80T, 
N248S and S602I led to decreased signaling and cytokine production after Pam3Cys 
stimulation (23-26). A significantly decreased IL-1β production after Borrelia exposure could 
be detected in persons heterozygous or homozygous for the TLR1 polymorphism N248S or 
S602I (figure 4B and 4C). Significant differences between the wild-type, heterozygous, and 
homozygous carriers of the TLR1 SNPs were found with respect to IL-6, IL-8, TNF-α, and IL-10 
production, after incubation of their PBMCs with Borrelia or Pam3Cys (supplementary tables 
S1-S3).  
 
Figure 4. Functional consequences of human TLR1 SNPs in cytokine production. Peripheral blood 
mononuclear cells (PBMCs) from healthy volunteers were stimulated for 24h with different stimuli, 
including Borrelia burgdorferi (1x106 spirochetes/mL), and 10 µg/mL Pam3Cys. After stimulation, 
supernatants were collected, and cytokine levels were measured by enzyme-linked immunosorbent 
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assay. The TLR1 status of these individuals was determined before PBMC stimulation, and they were 
separated into 3 groups—one group did not displayed the R80T SNP (A), N248S SNP (B), or S602I SNP 
(C) in TLR1 (white bars; wt; wild-type), one group had a heterozygous mutation (grey bars), and one 
group had a homozygous mutation (black bars). Data are means ± standard errors. IL-1β, interleukin 
1β; RPMI, Roswell Park Memorial Institute 1640 medium; *p<0.05; **p<0.01; ***p<0.001, Mann-
Whitney U-test. The data shown are from three independent experiments each performed in 
duplicate. 
 
Human TLR6 polymorphisms are less involved in cytokine induction after stimulation with 
B. burgdorferi. The non-synonymous polymorphism S249P in the TLR6 gene, believed to 
result in a malfunction in the extracellular domain of the TLR6 molecule, is present with a 
high frequency in several different populations (>10%) (27). However, after PBMC 
stimulation for 24h with the specific TLR2/6 ligand FSL-1, we did not detect differences 
between individuals with or without the TLR6 polymorphism in either IL-1β, IL-6, IL-8, IL-10, 
or TNF-α (figure 5A-E, respectively). On the other hand, we could observe lower  IL-1β, IL-6, 





Figure 5. Less important role for human TLR6 in the induction of cytokines after Borrelia 
stimulation. Peripheral blood mononuclear cells (PBMCs) from 128 healthy volunteers carrying the 
S249N SNP in TLR6 were stimulated with either medium, 1x106 per mL Borrelia spirochetes, or 1 
µg/mL FSL-1 for 24h and cytokines were measured using ELISA; (interleukin 1β [IL-1β],(A); IL-6,(B); IL-
8,(C); IL-10, (D); and tumor necrosis factor α [TNF-α],(E)). Bars represent individuals carrying no SNP 
(wild-type, wt, white bars), heterozygous SNP carriers (he, grey bars), or homozygous variation (ho, 
black bars). Data represent the mean ± SEM, *p<0.05; **p<0.01; Mann-Whitney U-test. The data 
shown are from three independent experiments each performed in duplicate. 
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Human TLR1 is involved in Borrelia-induced IFN-γ. Since we demonstrated that TLR1 
controls the induction of IFN-γ in mice, we assessed whether TLR1 is involved in human IFN-γ 
and IL-17 responses upon encounter of Borrelia species. PBMCs isolated from healthy 
volunteers bearing either a TLR1 or TLR6 polymorphism were stimulated for 7 days with 
either medium, live Borrelia, or Pam3Cys. Pam3Cys-induced IFN-γ was less produced by cells 
isolated from individuals bearing TLR1 SNPs, but no differences could be observed for cells 
with the described TLR6 SNP (data not shown). IFN-γ levels after Borrelia stimulation were 
significantly decreased in individuals lacking a functional TLR1 molecule, whereas TLR6 
seems not to play a major role in the induction of this pro-inflammatory cytokine (figure 6A-
B, respectively). TLR1 might also play a role in the induction of IL-17 after Borrelia exposure, 
a trend towards lower production could be detected, although not found to be significant 
(figure 6C). TLR6 seems not involved in Borrelia-induced IL-17 production (figure 6D).  
 
Figure 6. Human TLR1 is involved in Borrelia-induced IFN-γ. Peripheral blood mononuclear cells 
(PMBCs, 5x105 / well) from individuals bearing a SNP in TLR1 (N248S) or TLR6 (S249P) were 
stimulated with medium, 1x106 Borrelia per mL, or Pam3Cys (10 µg/mL), in the presence of 10% 
human pool serum. After 7 days of incubation, IFN-γ (A, B) and IL-17 (C, D) levels were determined in 
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the supernatant using ELISA. Bars represent individuals carrying no SNP (wild-type, wt, white bars, n ≥ 
3 for TLR1 SNPs and n ≥ 5 for TLR6 SNPs), or individuals bearing the SNP in one allele or in both alleles 
(mutant, mt, black bars, n ≥ 6 for TLR1 SNPs and n ≥ 7 for TLR6 SNPs). Data represent the means ± the 
standard error of the means, Mann-Whitney U test, *p<0.05. The data shown are from three 
independent experiments each performed in duplicate. 
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Discussion  
The present study expands the knowledge regarding the role of both TLR1/2 and TLR2/6 
heterodimers in the recognition of Borrelia spp. We demonstrate that TLR1 in humans is an 
important component for the recognition and induction of an immune response against 
Borrelia. This was demonstrated by experiments using either TLR1- or TLR6 deficient murine 
cells, as well as studies performed in cells isolated from individuals bearing genetic 
polymorphisms in TLR1 or TLR6. Of high interest, a different pattern was found in murine 
cells; genetic disruption of TLR1 resulted in an upregulated IFN-γ response, whereas TLR6 
deficient cells were unable to induce a sufficient IFN-γ response after Borrelia exposure. This 
difference in IFN-γ induction in mice between TLR1 or TLR6 could not be observed in 
humans. Neither TLR1 and TLR6 seem to be involved in the induction of this cytokine upon 
stimulation with Borrelia spirochetes. 
 
TLR1/2 or TLR2/6 heterodimers do not only differ in structure, but also recognize different 
ligands. Whereas TLR1/2 heterodimers mainly recognize tri-acetylated structures such as 
Pam3Cys, di-acetylated proteins are mainly recognized by TLR2/6 heterodimers (13;14).  It is 
known that Borrelia spp. contains tri-acetylated proteins in the cell membrane and this fits 
with our observation that the TLR1 containing heterodimers are more important in 
recognition and signaling of Borrelia.  
The genome of Borrelia burgdorferi encodes at least 105 membrane proteins, including the 
group of immunologically important outer surface proteins (OSPs) (28). It has been 
suggested that Borrelia outer surface protein A (OspA) plays an important role in the 
pathogenesis of Lyme disease caused by Borrelia species. Macrophages isolated from TLR1 
deficient mice display an impaired ability to induce IL-6 after stimulation with OspA 
lipoprotein (7). In contrast to these studies, we were unable to detect any differences in IL-6 
production between wild-type and TLR1 knockout mice, when cells were stimulated with 
intact Borrelia spirochetes. This effect might be due to the presence of multiple ligands that 
are absent in studies that use solely purified OspA protein in supraphysiological 
concentrations. Using intact bacteria, the immune response is likely stimulated through 
several distinct PRR pathways, involving both TLRs and NODs (6).  
Disruption of either the TLR1 or TLR6 gene in mice did not lead to changes in the pro-
inflammatory cytokine production, with the exception of the T-cell-derived IFN-γ and IL-17. 
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This implies that in the mouse the intact TLR1/TLR2 heterodimers dampen the interferon 
gamma response. This effect may be mediated through IL-10, since this cytokine was 
downregulated in mice lacking functional TLR1 molecules. It may be hypothesized that 
murine TLR1 and TLR6 exert counter-regulatory roles for the induction of Th1/Th17 
cytokines by Borrelia bacteria. 
 
Mutations in TLR1 can lead to a decreased surface protein expression of TLR1 on the cell 
surface and diminished activation of NF-кB (25;26). It has been previously suggested that 
defects in TLR1 signaling might play a role in the early induction of the immune response in 
mice against Borrelia spp (7).  As genetic variants have been reported to modify the function 
of TLRs and influence susceptibility to infections in humans, we assessed the role of three 
SNPs in TLR1 and one SNP in TLR6 for their role in the induction of cytokines after 
recognition of Borrelia (21;26). SNPs in TLR1 impair intracellular trafficking of the TLR1, 
which eventually leads to a decreased NF-кB signaling. It was described before that 
intracellular interactions between TLR1 and TLR2 are necessary for optimal immune 
signaling in human cells (29). A different pattern of TLR involvement could be observed in 
peripheral blood mononuclear cells isolated from humans in comparison to the cytokines 
induced by mouse cells. Using cells of individuals with functional genetic polymorphisms in 
the TLR1 gene, we found a marked inhibition of the pro-inflammatory cytokine production 
when these cells were exposed to Borrelia. This was found in individuals carrying the 
polymorphism in both alleles (homozygous) for any of the three SNPs in TLR1 studied. In 
agreement with our data, Johnson et al exposed human monocytes with the S602I SNP in 
the TLR1 gene to TLR1/TLR2 agonists and also observed an blunted pro-inflammatory 
response (26).  
In a recent report, the S602I SNP in TLR1 was linked to the N248S SNP in this gene (25); also 
in our study these two SNPs displayed an 80% linkage. However, no linkage was observed 
with the third SNP in TLR1 (R80T). SNP N248S and R80T have previously been associated 
with invasive aspergillosis (21), and our finding of modulation of cytokines when cells with 
these genetic variations are stimulated with B. burgdorferi warrants studies of these 
polymorphisms in patients with Lyme disease. 
The presence of the TLR6 S249N SNP did also influence IL-1β, IL-6, and IL-8 production 
induced by B. burgdorferi. TNF-α and IL-10 levels induced by Borrelia were not changed in 
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the presence of the SNP. However, it did not influence cytokine responses induced by 
TLR6/2 ligand FSL-1. Until now, the precise function of this SNP is still unknown, although it 
has been negatively correlated with ulcerative colitis and the development of clinical signs of 
malaria, and probably offers protection against the development of asthma (27;30;31). 
These genetic findings are in agreement with those we obtained in cultures in which human 
PBMCs were exposed to antibodies against TLR1 or TLR6. In these experiments we found 
that TLR6 had only a marginal effect on cytokine production (some effect on TNF-α 
production), whereas TLR1 clearly mediates Borrelia-induced cytokine production. TLR1 is 
also responsible for T-cell derived cytokines after recognition of Borrelia. We observed 
decreased IFN-γ and IL-17 production when TLR1 molecules were dysfunctional through the 
presence of polymorphisms.  
In conclusion, the present study demonstrates an important role for TLR1/TLR2 
heterodimers for the recognition of Borrelia in humans. Furthermore, the presence of 
genetic variants of TLR1 gene leads to impaired cytokine responses upon challenge of PBMCs 
with Borrelia. On the one hand, since initiation of host defense responses against Borrelia is 
dependent on multiple pattern recognition receptors, more research is needed to elucidate 
the precise role of TLR1/2 in the pathogenesis of Lyme disease. On the other hand, these 
results give novel information regarding the mechanisms of Borrelia recognition and the role 
of TLR1 in this process, and warrants future studies in the role of this receptor for the 








Supporting Information  
Table S1. Cytokine production by PBMCs with R80T SNP in TLR1. 
   Averages in pg/mL ± SEM 
SNP Stimulus Group IL-1β IL-6 IL-8 (ng/mL) TNF-α IL-10 
R80T RPMI Wt 23 ± 2 46 ± 24 1.8 ± 0.4 80 ± 0 7 ± 0 
  He 37 ± 17 17 ± 1 1.2 ± 0.2 80 ± 0 7 ± 0 
  Ho 20 ± 0 15 ± 0 0.6 ± 0.07 80 ± 0 7 ± 0 
 B.burgdorferi Wt 326 ± 44 5327 ± 755 72.2 ± 8.0 154 ± 31 32 ± 4 
  He 319 ± 76 4455 ± 1470 59.8 ± 14.8 113 ± 20 22 ± 5 
  Ho 151 ± 124 770 ± 530a 13.5 ± 4.5a 80 ± 0 7 ± 0a 
 Pam3Cys Wt 821 ± 133 10110 ± 1072 15.1 ± 10.7 289 ± 40 187 ± 25 
  He 777 ± 394 6197 ± 1829 116.3 ± 23.2 209 ± 66 156 ± 57 
  Ho 373 ± 83 7150 ± 4250 160.5 ± 80.5 210 ± 60 60 ± 6 
a Wt versus Ho p<0.05; b Wt versus Ho p<0.01; c He versus Ho p<0.05; d He versus Ho p<0.01; e He 
versus Ho p<0.001 
Table S1. 
Cytokine production in pictograms per milliliter after stimulation of PBMCs isolated from healthy 
volunteers carrying R80T SNP in TLR1 molecules. All values are depicted as means plusminus the 
standard error of the means. 
 
Table S2. Cytokine production by PBMCs with N248S SNP in TLR1. 
   Averages in pg/mL ± SEM 
SNP Stimulus Group IL-1β IL-6 IL-8 (ng/mL) TNF-α IL-10 
N248S RPMI Wt 20 ± 0 16 ± 1 2.1 ± 0.7 80 ± 0 7 ± 0 
  He 24 ± 4 20 ± 3 2.5 ± 0.8 80 ± 0 7 ± 0 
  Ho 26 ± 5 19 ± 3 1.1 ± 0.2 80 ± 0 7 ± 0 
 B.burgdorferi Wt 428 ± 55 7167 ± 784 95.3 ± 6.9 80 ± 0 70 ± 13 
  He 414 ± 71 6949 ± 1203 97.1 ± 13.1 203 ± 58 38 ± 6 
  Ho 245 ± 43a,c 3078 ± 657a,d 46.1 ± 6.9a,e 106 ± 18 21 ± 4a,d 
 Pam3Cys Wt 842 ± 67 20167 ± 2146 232.7 ± 32.3 187 ± 44 387 ± 
155 
  He 1538 ± 
265 
14129 ± 1475 201.1 ± 15.0 441 ± 74 308 ± 39 
  Ho 318 ± 67a,e 4996 ± 741b,e 103.1 ± 9.0b,e 166 ± 21d 78 ± 13a,e 
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a Wt versus Ho p<0.05; b Wt versus Ho p<0.01; c He versus Ho p<0.05; d He versus Ho p<0.01; e He 
versus Ho p<0.001 
 
Table S2. 
Cytokine production in pictograms per milliliter after stimulation of PBMCs isolated from healthy 
volunteers carrying N248S SNP in TLR1 molecules. All values are depicted as means plusminus the 
standard error of the means. 
 
Table S3. Cytokine production by PBMCs with S602I SNP in TLR1. 
   Averages in pg/mL ± SEM 
SNP Stimulus Group IL-1β IL-6 IL-8 (ng/mL) TNF-α IL-10 
S602I RPMI Wt 20 ± 0 16 ± 1 2.1 ± 0.7 80 ± 0 7 ± 0 
  He 23 ± 3 22 ± 4 2.4 ± 0.6 80 ± 0 7 ± 0 
  Ho 27 ± 6 20 ± 4 1.1 ± 0.1 80 ± 0 7 ± 0 
 B.burgdorferi Wt 428 ± 55 7167 ± 784 95.3 ± 6.9 80 ± 0 70 ± 13 
  He 386 ± 61 7170 ± 1092 91.7 ± 11.5 185 ± 48 36 ± 6 
  Ho 250 ± 50 2600 ± 615a,e 41.3 ± 7.3a,e 111 ± 21 20 ± 4a,c 
 Pam3Cys Wt 842 ± 67 20167 ± 2146 232.7 ± 32.3 187 ± 44 387 ± 
155 
  He 1427 ± 
227 
14170 ± 1269 196.6 ± 13.0 421 ± 63 270 ± 31 
  Ho 212 ± 29b,e 3607 ± 552b,e 92.8 ± 8.8b,e 143 ± 16 56 ± 8b,e 
a Wt versus Ho p<0.05; b Wt versus Ho p<0.01; c He versus Ho p<0.05; d He versus Ho p<0.01; e He 
versus Ho p<0.001 
 
Table S3. 
Cytokine production in pictograms per milliliter after stimulation of PBMCs isolated from healthy 
volunteers carrying S602I SNP in TLR1 molecules. All values are depicted as means plusminus the 
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Toll‐Like  Receptor  (TLR)  10  is  the  only  pattern  recognition  receptor  without  known  ligand 
specificity  and  biological  function. Here we  demonstrate  that  blocking  TLR10  by  antagonistic 
antibodies and siRNA enhances proinflammatory cytokine production specifically after exposure 




not  produced.  Furthermore,  individuals  bearing  TLR10  polymorphisms  display  an  increased 
capacity  to  produce  proinflammatory  cytokines  upon  ligation  of  TLR2,  but  not  of  TLR4,  in  a 




Highly conserved molecular structures of  invading microorganisms are  recognized by  immune 
cells  through pattern  recognition  receptors  (PRRs), of which Toll‐like  receptors  (TLRs) are  the 
best documented. In humans, ten members of the TLR‐family have been described, that interact 
with  specific  ligands  (1).  In  general,  ligation  of  TLRs  leads  to  induction  of  proinflammatory 


























RPMI  1640  (Dutch modification) was  used  as  PBMC  culture medium.  Before  use,  RPMI was 
supplemented with  50 mg/L  gentamycin,  2 mM  L‐glutamin,  and  1 mM  pyruvate.  LPS  (E.coli 
serotype  055:B5,  Sigma) was  re‐purified  as  previously  described(10).  Synthetic  Pam3Cys was 
purchased  from EMC Microcollections. Borrelia spirochetes and C. albicans were cultured and 
prepared  as  described  before  (9),(11). Neutralizing  anti‐TLR10  antibody was  purchased  from 
Abcam  (Clone  3C10C5,  endotoxin‐free,  Cambridge,  United  Kingdom)  and  mouse  IgG1к 
monoclonal  antibody was used  as  isotype  control.    SB202190  (p38 MAPK  inhibitor,  0.3 µM); 






cells/mL. Cells  (5x105)  in  a 100µL  volume were  added  to  round‐bottom 96‐wells plates  (Greiner)  and 
incubated with stimuli. PBMCs were stimulated  for 24 hours at 37C and 5% CO2. Pam3Cys  (10 µg/ml) 






measured using  specific  sandwich ELISA kits  for  IL‐1β, TNF‐α, and  IL‐1Ra.  IL‐6 and  IL‐10 were 




Peripheral blood mononuclear cells  (PBMC) were derived  from buffycoats of healthy donors  (Sanquin, 









for  3‐4  hours  at  37°C.  Then,  TLR2  ligands  Pam3CSK4  and  Pam3CSK4  variants were  added  at  titrating 
concentrations  in supplemented RPMI medium. After 24 hours of  incubation at 37°C, supernatant was 
harvested and  IL12p40 ELISA was performed on  the supernatants  (BioLegend, London, UK). The moDC 




After overnight  incubation at 37°C on Fast‐Media Blas agar plates  (Invivogen, USA), a  single colony of 
GT110 E.coli containing  the pUNO‐hTLR10 vector  (Invivogen, USA) was  transferred  to 3 ml Fast‐Media 
Blast‐TB medium (Invivogen, USA) and  incubated overnight at 37°C and 225 rpm. QIAGEN Plasmid Mini 
isolation  was  performed  according  to  manufacturer’s  instructions  (Qiagen,  Germany).  DNA 










6‐well  plates  (NUNC,  BD  Biosciences).  Cells  were  transiently  transfected  with  several  TLR  encoding 
plasmids (Invivogen, USA). Per transfection 3 µl Fugene6 (Roche, Switzerland) was added to 97 µl serum 
free  DMEM  F12 medium  and  after  5 min  incubation  at  RT  1µg  DNA  was  added. Monolayers  were 


















Total  RNA  was  extracted  using  Trizol  reagent  (Invitrogen)  according  to  the  manufacturer’s 
instructions.  Isolated  RNA  was  transcribed  into  complementary  DNA  using  iScript  cDNA 
Synthesis Kit (BioRad, USA). Quantitative PCR was performed  in 25µL end volume using SYBR® 
green  PCR master mix  (Applied  Biosystems, USA),  1  µM  forward  primer  and  1  µM  reversed 
primers  (for  sequence,  see  supplementary  table  1).  Target mRNA  levels were  compared  to 
mRNA levels of housekeeping gene β2‐microglobulin. All qPCR assays were performed using the 

































was done using  the MicroPoly(A)Purist Kit  (Ambion) according  to manufacturer’s  instructions, 
starting with 5μg of total RNA and using two rounds of Oligo(dT) selection. Whole transcriptome 
library  preparation  was  performed  using  the  SOLiD  Total  RNA‐Seq  Kit  (STaR  Kit,  Life 
Technologies) and the corresponding Low input protocol (Life Technologies, version July 2011). 
In brief, 25ng high quality poly(A) RNA was fragmented by RNAse III digestion, cleaned up using 
the  PureLink  RNA Micro  Kit  (Invitrogen)  and  checked  for  quantity  and  size‐distribution  on  a 
Agilent 2100 Bioanalyzer. RNA adapters were hybridized and  ligated  to  the  fragmented RNA, 
followed by reverse transcription. After purification and size‐selection of cDNA using Agencourt 
AMPure XP Reagent beads,  the  cDNA was  amplified  and used  as  input  for  the  SOLiD  system 
bead preparation using  the SOLiD Easy bead  system  (E120  scale). Paired‐end  sequencing was 





insert  size was  set  to 110 bases. For all genes  the FPKM  (Fragments per Kilobase per Million 
mapped reads) values were calculated using Cufflinks (version 2.0.2) (13). Fold changes and p‐
values were calculated  for each gene by performing an Analysis of Variance  (ANOVA) on  log2 
(with  an  offset  of  1.0)  transformed  FPKM  expression  values.  The  genome  wide  FPKM  fold 
change differences were calculated. Because we enriched for poly(A)RNA, The FPKM values for 
Micro RNAs (MIRs) and Small Nucleolar RNAs (SNORs) were excluded from our calculations. Of 







mM phenylmethylsulfonyl  fluoride). The cell homogenate was  frozen,  thawed and afterwards 
centrifuged  for 10 minutes at 14000  rpm. Supernatant was  taken  for Western Blotting. Equal 
amounts of protein were subjected to SDS‐PAGE using 15% polyacrylamide gels at 100V. After 
SDS‐PAGE, proteins were transferred to a PVDG membrane. The membrane was blocked in 5% 
(w/v) BSA  in TBS‐Tween buffer  for 1 hour at RT  followed by O/N 4C  incubation with primary 
antibody  in 5% BSA/TBST.   After O/N  incubation, blots were washed  in TBST  for 3  times and 
incubated with HRP‐conjugated anti‐rabbit antibody (1:5000) in 5% (w/v) BSA in TBST for 1h at 





T‐testing  (GraphPad  Prism, GraphPad  Software,  Inc. USA). Values  of  p<0.05 were  considered 







Blocking  TLR10  increases  cytokine  production  by  primary  human  cells.  Freshly  isolated 








from  11‐17  individuals were  pre‐incubated  for  1  hour  at  37C with  either  10 µg/mL  aTLR10  antibody 
70 
(aTLR10, clone 3C10C5), or 10 µg/mL IgG isotype control (IgG). After pre‐incubation, cells were stimulated 
for 24 hours with TLR2  ligand Pam3Cys  (10 µg/mL), or  live Borrelia burgdorferi  (B.b). After stimulation, 
cell supernatants were collected and pro‐inflammatory cytokines were measured using ELISA (A‐D). Bars 
represent the mean and the standard error of the mean. Paired t‐test; *p<0.05, **p<0.01, ***p<0.001 
Similar  data  were  obtained  when  the  cells  were  exposed  to  viable  B.burgdorferi  (B.b),  the 
causative organism of Lyme disease, of which we have shown before that is a potent TLR1/TLR2 












ligand Pam3Cys  (10 µg/mL), or  live Borrelia burgdorferi  (B.b). After stimulation, cell supernatants were 
collected and pro‐inflammatory cytokines were measured using ELISA (A‐B). Bars represent the mean and 
the standard error of the mean. For IL‐10, n=4; for IL‐1RA, n=10. (C) mRNA expression levels of Suppressor 
of Cytokine  Signaling  (SOCS)‐1  in 5  individuals after  stimulation of peripheral blood mononuclear  cells 




immune  cells,  human  monocyte‐derived  dendritic  cells  (moDCs)  were  exposed  to  either 
Pam3Cys or modified variants of  this TLR1/2  ligand  in  the presence or absence of anti‐TLR10 
antibody.  Production  of  IL‐12p40  by  Pam3Cys‐stimulated moDCs  was  significantly  increased 
(P<0.05) in the presence of anti‐TLR10 antibody (figure 2A). Modified Pam3Cys structures were 




Figure  2.  TLR10  inhibits  moDC‐IL‐12p40  production.  5x104  monocyte‐derived  dendritic  cells  from  3 
individuals were  pre‐incubated  for  2.5  hours  at  37C with  either  10 µg/mL  aTLR10  antibody  (aTLR10, 
clone 3C10C5, depicted as +), or 10 µg/mL IgG  isotype control (IgG, depicted as ‐). After pre‐incubation, 
cells were stimulated for 24 hours with TLR2 ligand Pam3Cys (10 µg/mL) or modified Pam3Cys (10 µg/mL, 
variants  1‐3).  After  stimulation,  cell  supernatants were  collected  and  IL‐12p40 were measured  using 
72 




gene  for  TLR10  in  monocyte‐derived  macrophages.  In  these  silenced  cells  TLR10  mRNA 
concentrations were  found  to be  downregulated  (figure 3A). After  silencing  the  TLR10  gene, 
cells were stimulated  for 24 hours with B.burgdorferi. A slight upregulation  in  IL‐6 production 
















cells  was  extremely  low  (figure  S2A).  After  transfection,  expression  of  specific  TLRs  was 
significantly upregulated (figure S2B).  
 
Figure  S2.  mRNA  expression  levels  of  HEK  cells.  (A)  mRNA  expression  of  TLR‐members  in  human 
embryonic  kidney  (HEK)‐293  cells.  (B)  After  transfecting  HEK293  cells  with  either  TLR2,  TLR10,  or  a 
combination  of  TLR2  and  TLR10, mRNA  expression  levels  of  TLR1,  TLR2,  and  TLR10 were  determined. 






showed  strong  reduction  of  IL‐8  production  (figure  4A‐B).  This  inhibitory  effect  of  TLR10 
transfection was also observed when transfected HEK cells were exposed to the TLR2/6  ligand 
















hours  after  transfection  for  22  hours with  specific  TLR  ligands  Pam3Cys  or  FSL‐1.  IL‐8  production  (in 
pg/mL) was measured in the cell‐free supernatant using ELISA. (C) HEK293 cells transiently infected with 
TLR5 or TLR5/10 plasmids. After 24 hours of  recovery, cells were  stimulated  for 22 hours with a dose‐
response of recombinant flagellin. IL‐8 production was measured by ELISA. Bars represent the mean of six 
separate experiments ± SEM. Mann‐Whtiney U test, two sided, **p<0,01. 
Functional polymorphisms of the human TLR10 gene.   A strong argument  in  favour of TLR10 
being  a  functional  receptor  is  that  the  TLR10  gene  is  under  selection  pressure  in  European 
populations; non‐synonymous polymorphisms within the human TLR10 gene are considered to 
influence  TLR10  function  (15).  Two  of  these  single  nucleotide  polymorphisms  (SNPs), N241H 
(rs11096957) and M326T (rs11466653), have been found to be associated with reduced risk of 
prostate  cancer  and  were  described  to  be  possibly  damaging  the  TLR10  gene(15,  16). We 




response by PBMCs obtained  from healthy  individuals with different TLR10 genotypes.  In our 
group of 112 volunteers, 40 were  identified as wild‐type, 60 were heterozygous, and 12 were 
homozygous for the N241H SNP. PBMCs were incubated with either medium (RPMI), Pam3Cys, 
live Borrelia, or  LPS  for  24 hours.  Thereafter,  cytokine  concentrations were measured  in  the 




without the Asn241His polymorphism  (wt; wild‐type; white bars), 60  individuals with  the SNP  in one of 
both  alleles  (he;  heterozygous;  grey  bars),  and  12  homozygous  individuals  (ho;  black  bars)  were 
stimulated for 24 hours at 37C with either RPMI, Pam3Cys, B.burgdorferi, or LPS.  IL‐1β (A), IL‐6 (B), IL‐8 









the  Asn241His  polymorphism  (wt; wild‐type; white  bars),  60  individuals with  the  SNP  in  one  of  both 
alleles (he; heterozygous; grey bars), and 12 homozygous individuals (ho; black bars) were stimulated for 







mutation.  Despite  the  low  prevalence  of  the  M326T  polymorphism,  increased  cytokine 
production was also observed with cells bearing this SNP (Figure S4).  
 
Figure S4.SNP M326T also affects cytokine production. 5x105 PBMCs  from 105  individuals without  the 
M326T polymorphism  (wt; wild‐type; white bars), and 7  individuals with  the SNP  in one of both alleles 
(he; heterozygous; grey bars), were stimulated for 24 hours at 37C with RPMI, Pam3Cys, or B.b..  IL‐1β, 









the  rs11096955 polymorphism  (wt; wild‐type; white bars), 33  individuals with  the  SNP  in one of both 










rs4129009 polymorphism  (wt; wild‐type; white bars), 20  individuals with  the SNP  in one of both alleles 
(he; heterozygous; grey bars), and 1 individual with the SNP in both alleles (ho; homozygous; black bars), 
were  stimulated  for  24  hours  at  37C  with  RPMI,  or  B.b..    IL‐6,  TNF‐α,    IL‐1β,  IL‐8,  and  IL‐10  were 
measured in the supernatant using ELISA. Results are shown in pg/mL. Bars represent the means ± SEM. p 





Our  findings  in  these  volunteers  concur with  the  recent  report  showing  that  variation  in  the 
TLR10/TLR1/TLR6 locus is the major genetic determinant of inter‐individual differences in TLR2‐
mediated cytokine  responses  (18). This  study  showed  that SNPs  in  the TLR10 gene affect  the 
cytokine responses elicited by specific TLR2 ligands, determined by whole blood assays. 






several  genes  that  were  upregulated;  pathway  analysis  performed  on  the  induced  genes 
underscores  the  induction of modulatory pathways  such  as wound healing,  chemokines,  and 
growth  factors  as  being  specifically  up‐regulated  by  TLR10‐induced  stimulation  (Figure  6A). 
Among these, the gene encoding  for  IL‐1Receptor antagonist  (IL‐1RN) stood out as being very 
strongly upregulated (Figure 6A). IL‐1Ra is the natural inhibitor of excessive IL‐1 signalling and it 
blocks  both  IL‐1α  as well  as  IL‐1β  (19,  20).  It  downmodulates  cytokine  responses  in  several 
immune cells after exposure to pathogens or specific ligands of pathogens by interfering with IL‐
1 action. 
Indeed, we  found  remarkable  upregulation  of  IL‐1Ra mRNA  expression  by  the  PBMCs  after 
cross‐linking TLR10  (Figure 6B).  In addition  to mRNA expression, protein  levels of  IL‐1Ra were 
enhanced when PBMCs were  incubated for 24 hours with plate‐bound anti‐TLR10 antibody, as 
compared  to  IgG  isotype  control  (Figure  6C).  Individuals  bearing  TLR10‐damaging 
polymorphisms were  also  found  to  produce  less  IL‐1Ra  after  stimulation  (Figure  S7).  In  the 
supernatants of the cross‐linking experiments, no  IL‐8,  IL‐6, TNF� or  IL‐1� production could be 
detected after TLR10 cross‐linking (Figure 6E). The PI3K/Akt pathway is needed for the induction 




complete  inhibition of  IL‐1Ra  in the crosslinking experiments on mRNA  level as well as protein 
secretion (Figure 6F).  









IgG  isotype control were coated  to 24‐wells  flatbottom plates and  incubated  for 2 hours at 37C. After 
washing  and  blocking,  5x106  PBMCs were  added  and  incubated O/N  at  37C.  (A)  genes  found  to  be 
upregulated after adding anti‐TLR10 antibody. (B) mRNA expression levels and (C) protein secretion of IL‐
1Ra,  and  (D)  protein  secretion  of  IL‐1β,  IL‐6,  TNF‐α,  and  IL‐8 were  determined.  10  µg/mL  anti‐TLR10 
antibody or 10 µg/mL IgG isotype control were coated to 96 well flatbottom plates. After blocking, 5x105 
PBMCs were added to the coated plates and incubated for 24 hours at 37C. Bars represent mean ± SEM 











Figure  S7.  SNPs  in  TLR10  affects  IL‐1Ra    production.  5x105  PBMCs  from  individuals  without 







potent  inhibitory effect on  TLR2  signalling. Using  specific neutralizing  antibodies, we  showed 
that  blocking  TLR10  resulted  in  enhanced  cytokine  production when  cells were  exposed  to 








These data  lead  to  the  conclusion  that TLR10  is  the only TLR  family member  that acts  as an 
inhibitory  receptor,  while  ligation  of  all  other  TLRs  lead  to  pro‐inflammatory  cytokine 
production. Additional reports also hint for a modulatory function of TLR10. Mulla et al. provide 
evidence  that  TLR10, which  is  expressed  on  trophoblast  during  gestation,  induces  apoptosis 
through activation of caspase‐3 (7). They also found the trigger for this response to be a TLR2 
ligand,  i.e. peptidoglycan. No effect on  IL‐6 production was  found  in  these studies  (7). Within 
the  TLR  family,  TLR10  is  most  closely  related  to  TLR1  and  TLR6,  the  two  TLR  that  form 
heterodimers with  TLR2  and hence  function  as  co‐receptors  (2). Given  the  results of our  co‐
transfection  experiments  it  is  highly  likely  that  the  inhibitory  effect  of  TLR10  is  mediated 
through an interaction of TLR10 with TLR2 and perhaps also with TLR1 and TLR6 (Figure 7).  
Regarding the molecular mechanisms through which TLR10 exerts its inhibitory effects, broadly 
three  types of mechanism could be envisaged:  i. competition  for  ligands with  the stimulatory 
TLRs, ii. competition for dimerisation with the other members of the TLR2 family and iii. TLR10‐






Currently, the specific  ligand  for TLR10  is unknown. Since TLR10 expressed on the transfected 
cells  responded  to Pam3Cys and Borrelia burgdorferi,  it  is  conceivable  that  these TLR  ligands 
also directly  interact with  TLR10. However,  transfection may have  led  to overexpression  and 
hence  to  some  spontaneous  heterodimerisation  of  TLR10 with  TLR2.  Still,  analogous  to  the 
differential ligation of the TLR2/TLR1 complex and the TLR2/TLR6 complex (Pam3Cys and FSL‐1, 




are  IL‐1R  type  II  and  SIGIRR.  Such  receptors  may  exert  their  suppressive  effect  through 
competition with  the  stimulatory  receptors  (e.g.  the decoy  receptor  IL‐1RII), while others act 
through  inhibitory  intracellular  signals  (e.g.  SIGIRR). Members  of  other  classes  of  PRR  also 
display  suppressive  activities,  such  as  the  C‐type  lectin  receptors  DC‐SIGN  and  mannose 
receptor (23, 24).  
The finding of a suppressive function of TLR10 has  important consequences. On the one hand, 



























































































































































































Recognition of  Borrelia burgdorferi by 
NOD2 is central for the induction of an 
inflammatory reaction 
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Abstract 
 
Toll-like receptor (TLR) 2 plays an important role in the recognition of Borrelia, the causative 
agent of Lyme Disease, but the existence/importance of additional receptors in this process 
has been hypothesized. In the present study we confirm the role of TLR2 for the recognition 
of Borrelia bacteria, but also demonstrate a crucial role for the intracellular peptidoglycan 
receptor NOD2 for the sensing of the spirochete. Cells from individuals which are 
homozygous for the loss-of-function mutation 3020insC in the NOD2 gene were defective in 
cytokine release after stimulation with Borrelia species and this was confirmed in peritoneal 
macrophages of RICK knock-out mice, the adaptor molecule used by NOD2. In contrast, 
NOD1 had no major role for the recognition of Borrelia spirochetes. This raises the intriguing 
possibility that the recognition of Borrelia is exerted by TLR2 in combination with NOD2, and 
both receptors are necessary for an effective induction of cytokines by Borrelia spp. The 
interplay between TLR2 and NOD2 might be necessary not only for induction of a proper 








Lyme disease (LD) is the most common vector-borne disease in the United States and 
Western Europe, and it is transmitted through infected ticks (1). The disease is caused by 
bacteria of the species Borrelia burgdorferi sensu lato (s.l.), including B.burgdorferi sensu 
stricto, B.afzelii, and B.garinii. Dependent on the subspecies of B.burgdorferi s.l., chronic 
borreliosis is associated with arthritis (B.burgdorferi), skin disorders like ACA (acrodermatitis 
chronic atrophicans, B.afzelii) or neurological involvement (B.garinii) (2). The mechanism 
through which Borrelia is able to cause disease remains largely unknown. In vitro studies 
point out that lipid-modified proteins play a major role in the pathogenesis of Borrelia (3-7). 
Lipids and other pathogen-associated molecular patterns (PAMPs) are recognized by pattern 
recognition receptors (PRRs), of which Toll-like receptors (TLRs) are the best known. After 
recognition of pathogens, signaling pathways are induced which often result in 
phosphorylation and activation of NF-кB (8). A recently identified group of intracellular PRRs, 
named the NACHT-LRR (NLR) proteins, are also able to a induce signaling cascade in 
response to pathogen recognition, resulting in the activation of NF-кB (8;9).  
Two NLR family members, NOD1 and NOD2, are involved in the bacterial sensing by 
recognizing peptidoglycans (10-12). Gram-negative bacteria cell wall contains peptidoglycan 
structures containing meso-diaminopimelic acid (mDAP) which can be recognized through 
NOD1(10;13). In contrast, NOD2 recognizes muramyl dipeptide (MDP), a component of 
peptidoglycans present in both Gram-negative, and Gram-positive bacteria (11;14). 
Mutations in NOD2-receptors are associated with auto-inflammatory diseases, such as 
Crohn’s disease and Blau syndrome (15;16). Crohn’s disease patients often carry a mutation 
in the NOD2 gene which is caused by a frameshift mutation through a cystein insertion, 
which results in an amino acid substitution at position 1007 (Leu1007fsinsC), and is 
sometimes present in combination with other mutations such as Gly908Arg or Arg702Trp. 
The process of NF-кB phosphorylation and upon activation with peptidoglycans of cells of 
individuals carrying these mutations is disturbed (14). In contrast, an insertion/deletion 
(ND1-32656) mutation in NOD1 is associated with increased cell influx in inflammation and 
increased cytokine production (Plantinga et. al., submitted). It was demonstrated that these 
NOD1 splicing variants have a shorter LRR domain and therefore display reduced capacity to 
detect their ligands (17). The increased cell influx and higher levels of cytokines produced 
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due to the NOD1-mutation were seen in multiple autoimmune diseases, including arthritis 
and asthma (18;19). 
 
Two recent studies demonstrate an interplay between TLR-signaling and Nod-like receptor-
signaling, with RICK (receptor-interacting serine/threonine kinase, also named RIP2 or 
CARDIAK) being the key signaling molecule (20;21). Cells of RICK knockout mice stimulated 
with TLR2 ligands showed severely reduced production of pro-inflammatory cytokines (21). 
Interestingly, RICK is the adaptor molecule shared by NOD1 and NOD2, which is recruited 
after recognition of their respective ligands (22). It was already shown that immune 
responses against several microorganisms, including S.aureus and M.tuberculosis, can be 
induced by recognition through TLRs and by Nod-proteins that synergize for the activation of 
an efficient host defense (10;23-26).  
 
Previous studies have demonstrated that TLR2 is an important receptor in the recognition of 
Borrelia spirochetes (27-29). However, the role of Nod-proteins and the adaptor molecule 
RICK in the Borrelia-induced immune response have never been described. The role of RICK, 
NOD1 and NOD2 for the activation of the host response against Borrelia was assessed in this 
study. We demonstrate that cells of RICK-/- mice are unable to induce inflammatory cytokine 
production after Borrelia stimulation. Furthermore, through experiments performed with 
cells isolated from individuals carrying mutations in NOD1 or NOD2 we show that NOD2, but 
not NOD1, has an important role for recognition of the spirochete and the induction of 





Materials and Methods 
 
Borrelia burgdorferi and Borrelia afzelii cultures.  
Borrelia species were cultured at 33°C in Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-
Aldrich) supplemented with 6% rabbit serum. Spirochetes were grown to late-logarithmic 
phase and examined for motility by dark-field microscopy. Organisms were quantitated by 
fluorescence microscopy after mixing 10 µL aliquots of culture material with 10 µL of an 
acridine orange solution (100 µg/mL). Bacteria were harvested after centrifugation of the 
culture at 7000 x g for 15 min., washed twice with sterile PBS (pH 7.4), and diluted in the 
specified medium to required concentration. Heat-killed B.burgdorferi and B.afzelii were 
prepared as described above except for heating at 52°C for 30 min. before dilution.  
 
Animals. 
C57Bl/6 mice were obtained from Charles River Wiga (Sulzfeld, Germany). Generation of 
RICK knock-out mice was described previously (21).  Male mice between 6 and 8 weeks of 
age were used. The mice were fed sterilized laboratory chow (Hope Farms, Woerden, The 
Netherlands) and water ad libitum. The experiments were approved by the Ethics 
Committee on Animal Experiments of the Radboud University Nijmegen and protocols 
approved by the  St. Jude Children’s Research Hospital Committee on Use and Care of 
Animals. 
 
Isolation of human PBMC’s  and stimulation of cytokine production. 
 After obtaining informed consent, venous blood was drawn from the cubital vein of 
volunteers into 10 ml EDTA tubes (Monoject). Isolation of peripheral blood mononuclear 
cells (PBMC) was performed according standard protocols, with minor modifications. The 
PBMC fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-free 
saline over Ficoll-Paque (Pharmacia Biotech). Cells were washed twice in saline and 
suspended in medium (RPMI 1640) supplemented with gentamicin 10 mg/mL, L-glutamine 
10 mM and pyruvate 10 mM. The cells were counted in a Coulter counter (Coulter 
Electronics) and the number was adjusted to 5x106 cells/mL. 5x105 MNC in a 100 µL volume 
were added to round-bottom 96-wells plates (Greiner) and incubated with either 100 µL of 
culture medium (negative control), or a dose range of Borrelia burgdorferi or Borrelia afzelii 
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(1x104 to 1x106 spirochetes/mL). In some experiments, PBMCs were preincubated for 1 h 
with antagonist / antibody (TLR4-antagonist, 10 µg/mL, and anti-TLR2, 10 µg/mL blocking 
antibody) before stimulation with Borrelia. Bartonella-LPS (TLR4-antagonist) was obtained as 
previously described (30). After 24h or 48h, the supernatants were collected and stored at -
20°C until assayed. After detection, samples were stored at -80˚C. 
Isolation of genomic DNA and SNP analysis 
DNA was isolated using the Gentra Pure Gene Blood Kit (Qiagen, Minneapolis, MN) 
according to the manufacturer’s protocol. PCR amplification of NOD1 gene fragments 
bearing the insertion-deletion polymorphism (ND1+32656) was carried out as described 
before (18).  Genotyping of NOD2 variants 3020insC, R702W, and G908R were described 
previously (15;16).  
Cytokine determination 
Concentrations of  mouse IL-1β and TNF- α were determined by specific radioimmunoassay 
(detection limit is 20 pg/mL). Mouse IL-6, KC (IL-8), and IL-10 concentrations were measured 
by a commercial ELISA kit (Biosource, Camarillo, CA; detection limits 16 pg/mL), according to 
the instructions of the manufacturer. Human IL-1β, IL-8, IL-10, TNF-α and IL-6 were 
determined in duplicate by using either specific or commercial Enzyme-Linked 
Immunosorbent Assay (ELISA) kits (PeliKine Compact, Sanquin, Amsterdam, The Netherlands 
or R&D Systems) according to the manufacturer’s instructions. The sensitivity of the assays 
were 20 pg/mL. 
 
Statistical Analysis 
The data are expressed as mean ± SEM unless mentioned otherwise. Differences between 
experimental groups were tested using the Mann-Whitney U test performed on GraphPad 






Dose-response induction of cytokines by  Borrelia. 
To determine the capacity of Borrelia spirochetes to induce cytokines, peritoneal 
macrophages from C57Bl/6N wild-type mice were stimulated for 24 hours with different 
doses of heat-killed B.burgdorferi and B.afzelii, ranging from 1x104 to 1x106 spirochetes per 
ml.  
A dose-dependent upregulation of both IL-1β and IL-6 production was detected after 
exposure of murine macrophages to Borrelia spp. (figure 1A). In line with these results, a 
dose-dependent induction of pro-inflammatory cytokines could also be found in human 
peripheral blood mononuclear cells (PBMCs, figure 1B). Borrelia afzelii induced less potently 
production of cytokines in human PBMCs.  
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Figure 1. Dose-dependent cytokine induction by Borrelia species.  (A) Peritoneal macrophages 
(1x105/well) of five wild type C57Bl/6 mice were stimulated with different doses of heat-killed Borrelia 
afzelii  or B. burgdorferi for 24h. IL-1β and IL-6 levels were measured in the supernatant using ELISA. 
(B) Peripheral blood mononuclear cells (1x105/well) of six healthy volunteers were stimulated with 
different doses of heat-killed B.afzelii or B.burgdorferi for 24h (IL-6, IL-1β, TNF-α). Results are shown 
in pg/mL, the bars indicate the means together with the standard errors of the means in the error 
bars. An asterisk indicates that the P-value is <0.05 for comparisons of RPMI (depicted in figures as 





TLR2, but not TLR4, plays an important role in Borrelia-induced cytokine production. 
Macrophages of TLR2 gene deficient mice showed a significant decrease in IL-6, IL-1β, and IL-
8 production after stimulation (figure 2A). When spleen cells of TLR2 knock-out mice were 
stimulated for 5 days with Borrelia, levels of produced IL-10 were also significantly decreased 
(figure 2B). This decrease in cytokine production could also be observed in human cells when 
TLR2 was blocked by a specific antibody (figure 2C). The role of TLR4 for recognition of 
Borrelia was examined in both murine macrophages and human cells. Therefore, peritoneal 
macrophages and spleen cells of TLR4 gene deficient mice were stimulated with Borrelia. 
After 24 hours of stimulation, no effect of TLR4 on Borrelia-induced IL-6 and IL-1β production 
could be observed, while TLR4 absence inhibited LPS-stimulation (figure 2D). No differences 
in IL-10 release were found after cell stimulation of TLR4 gene deficient mice (figure 2E). 
When TLR4 in human PBMCs was inhibited by Bartonella LPS (a specific TLR4 antagonist) and 
stimulated with either RPMI, B.afzelii or B. burgdorferi, no differences in IL-1β production 
could be observed (figure 2F).  
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Figure 2. TLR2 plays an important role in induction of cytokines, not TLR4. Peritoneal macrophages 
(A) or spleen cells (B) of five wild-type C57Bl/6 mice and five TLR2 gene deficient mice were 
stimulated for 24 hours (A) or 48 hours (B) with RPMI, Pam3Cys, or heat-killed B.burgdorferi (1x10^6 
spirochetes per ml). Cytokine levels were measured using RIA or ELISA and are depicted in pg/mL or 





alone (depicted as medium in the graph), in presence of the antibody (inh), or either in presence of 
the antibody-control (control). (D) peritoneal macrophages isolated from wild-type C57Bl/6 or TLR4 
knock-out mice were stimulated for 24 hours with either heat-killed Borrelia or specific TLR-ligands 
(10 µg/mL Pam3Cys or 10 ng/mL LPS). IL-10 production in pg/mL was measured after 48-hours 
stimulation of spleen cells of these mice (E). (F) IL-1β production was measured after stimulation of 
peritoneal macrophages isolated from wild-type C57Bl/6 mice in the presence of either medium 
(RPMI) or a specific TLR4 antagonist (TLR4 antag). Results are shown in pg/mL, the bars indicate the 
means together with the standard errors of the means in the error bars. An asterisk indicates that the 
P-value is <0.05. 
 
RICK is involved in cytokine induction after Borrelia exposure. 
PBMCs isolated from healthy volunteers and stimulated with heat-killed Borrelia in the 
presence or absence of a potent RICK inhibitor (31) demonstrated an important role of RICK 
for cytokine stimulation by Borrelia spp. (figure 3A). Since the used RICK-inhibitor is not 
specific (p38 can also be inhibited), we conducted studies with RICK knock-out cells. To 
determine the specific role of RICK signaling after Borrelia stimulation, peritoneal 
macrophages of RICK knock-out mice were stimulated for 24 hours with heat-killed Borrelia. 
Significant reduction in IL-1β, IL-6, and as well as in IL-8 production was observed when RICK 
knock-out cells were compared to cells of their wild-type littermates (figure 3B). 
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Figure 3. RICK is involved in Borrelia-induced cytokine production. (A) Peritoneal macrophages of 
five wild-type C57Bl/6 mice were stimulated for 24 hours with 1x10^6 sp/mL heat-killed Borrelia in 
the presence or absence of the RICK-inhibitor. IL-1β and IL-6 levels were measured in the supernatant 
using ELISA or RIA. Results are shown in pg/mL. (B) Peritoneal macrophages of five C57Bl/6 or five 
RICK gene deficient mice were stimulated for 24 hours with 1x10^6 sp/mL heat-killed B.burgdorferi. 





NOD1 is not involved in cytokine induction by Borrelia. 
Because the importance of RICK in Borrelia-induced cytokine production, the contribution of 
NOD1 and NOD2 in this process was also investigated. EDTA-blood was collected from 
healthy volunteers and the NOD1 status of these individuals was determined. Volunteers 
were divided in three groups, one consisting of individuals homozygous for the wild-type 
NOD1 allele, one group heterozygous and the third group homozygous for the insertion-
deletion polymorphism. PBMCs were stimulated with two doses of heat-killed Borrelia or LPS 
for 24 hours. A dose-dependent Borrelia-induced cytokine production was observed in all 
the three groups, independent of the NOD1 status (figure 4A-D, respectively). Overall, no 
significant differences in cytokine induction between NOD1 wild-type, NOD1 heterozygous 
for insertion-deletion allele, or NOD1 homozygous individuals could be found. 
 
Figure 4. NOD1 does not play an important role in induction of cytokines after Borrelia stimulation. 
Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were stimulated for 24h with 
different stimuli, including heat-killed B.burgdorferi (B.b) in 2 concentrations (1x105 and 1x106 
4
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spirochetes per ml, respectively), or 10 ng/mL LPS. After stimulation, supernatants were collected and 
cytokine levels were measured using ELISA. NOD1 status of these individuals was determined before 
PBMC stimulations and were separated in 3 groups, one group expressed no mutation in NOD1 (+/+, 
n=24), one group had an heterozygous mutation (+/-, n=22) and the third group with an homozygous 
mutation (-/-, n=7). Results are shown in pg/mL or ng/mL, the bars indicate the means together with 
the SEM in the error bars.  
 
NOD2 is essential for induction of cytokines after Borrelia exposure. 
Since we detected no important role for NOD1 in Borrelia-induced cytokine induction, the 
role of NOD2 in this signaling process was investigated. PBMCs from healthy volunteers 
expressing a wild-type genotype of NOD2 were stimulated for 24 or 48 hours with two 
strains of Borrelia. Cytokine levels were compared with PBMCs isolated from individuals 
homozygous for the NOD2 3020insC polymorphism. As a control, PBMCs were stimulated 
with TLR4 ligand LPS (negative control) or MDP, which is the main ligand for NOD2. As 
expected, cytokine levels were completely downregulated in NOD2-mutated individuals 
when PBMCs were stimulated with MDP (figure 5). LPS stimulation did not result in 
significant differences. IL-6, IL-1β, IL-10, as well as TNF-α production was significantly 







Figure 5. NOD2 plays an important role in induction of cytokines after Borrelia stimulation. 
Peripheral blood mononuclear cells (PBMCs) from healthy volunteers (n=5) carrying no mutations in 
NOD2 (wild-type) and from individuals carrying mutations in the NOD2 molecule (n=5) were 
stimulated for 24h (IL-6, IL-1β, TNF-α) and 48h (IL-10) with different stimuli, including 10 ng/mL LPS, 
10 ug/mL MDP, 1x106 heat-killed B.burgdorferi or B.afzelii per ml, respectively. Results are shown in 
pg/mL, the bars indicate the means together with the standard errors of the means in the error bars. 
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Discussion 
In the present study, we investigated the role of several different PRRs including TLR2, TLR4, 
NOD1, NOD2, and the adaptor molecule RICK for the induction of cytokines after stimulation 
with Borrelia spp. The present study demonstrates that TLR2 plays a major role in cytokine 
induction by Borrelia, whereas TLR4 is not involved. In addition, we demonstrate for the first 
time that NOD2 and its intracellular adaptor RICK are crucial for recognition of the 
spirochete and cytokine induction after stimulation with Borrelia spp. NOD1 is not involved 
in this process. 
 
Earlier studies have suggested that RICK may play a role in the immune response against 
these pathogens, since mRNA levels coding for RICK are increased in astrocytes and 
microglia exposed to Borrelia, although induction of signaling pathways through this 
receptor in human cells exposed to Borrelia species has never been described before 
(32;33). In other studies it was also demonstrated that mice lacking RICK were unable to 
induce a proper adaptive T cell response against specific TLR ligands (21).  
When RICK knock-out cells were stimulated with several intracellular pathogens including 
L.monocytogenes and C.pneumoniae, production of pro-inflammatory cytokines was 
severely decreased (34;35). This is in line with our results: when cells of RICK gene deficient 
mice were stimulated with Borrelia, significantly decreased production of pro-inflammatory 
cytokines could be observed. This finding indicates that RICK not only plays an important role 
against intracellular pathogens, but also in Borrelia-induced inflammation. 
 
RICK is the adaptor molecule for NOD1 and NOD2 intracellular peptidoglycan receptors. 
NOD1 is known to be important in cytokine induction after recognition of E.coli (36), 
P.aeruginosa (37), and S.flexneri (38), but the exact role of NOD1 in in vivo situations is yet 
unclear. It is known that some pathogens are recognized by NOD1 in vitro, but studies in vivo 
revealed no role for this receptor (39). The role for NOD1 in recognition of Borrelia was 
never described before, although it was earlier shown that mRNA levels of NOD1 on 
astrocytes were not upregulated after stimulation with Borrelia species (32). We were also 
not able to detect a major difference in cytokine induction between wild-type individuals 
and persons expressing a truncated form of the molecule. This finding indicates that NOD1 is 






NOD2 is known to play a role in controlling infection, and regulating the expression of anti-
microbial α-defensin peptides (40). Three single nucleotide polymorphisms (SNPs) in this 
gene have been linked to a disturbed phosphorylation and activation process of NF-кB and 
could therefore influence cytokine production after recognition of specific pathogen 
associated ligands (41). When cells of patients with Crohn’s disease carrying these NOD2 
SNPs were stimulated with MDP, reduction in cytokine production was observed (42;43). 
The latter is consistent with our data, in which NOD2-/- cells stimulated with heat-killed 
Borrelia showed a significant decrease in cytokine production, most likely due to defective 
recognition of bacterial peptidoglycans of Borrelia. These data demonstrate an until know 
unknown role of NOD2 in the recognition of Borrelia, and makes tempting to speculate 
whether individuals bearing NOD2 polymorphisms may have an increased susceptibility to 
Lyme Disease. 
 
Collaboration between PRRs is an important component of the fine-tuning of the 
inflammatory response. It has been proposed that absence of NOD2 is associated with 
increased TLR2 responses and that inhibition of NOD2 results in enhancement of production 
of pro-inflammatory cytokines (44). However, it is also reported that cells stimulated with 
Borrelia in absence of TLR2 produced significantly less pro-inflammatory cytokines (45). We 
have confirmed a role of TLR2 for Borrelia recognition. However, even in the presence of a 
blocking anti-TLR2 antibody, the cytokine production after stimulation with Borrelia species 
was not completely abrogated, and a significant residual production of cytokines was still 
present. This indicates that also additional signaling pathways are involved in induction of 
the immune response against Borrelia, which we show are mediated by NOD2. TLR2 and 
NOD2 are therefore the main receptors for an optimal induction of cytokines after 
recognition of Borrelia species, as proposed in figure 6.  
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Figure 6. Borrelia uses TLR2 and NOD2 signaling for efficient cytokine induction. Schematic 
presentation of Borrelia recognition by immune cells. 
 
Synergistic effects between TLR2 on the one hand or  NOD2 on the other hand were already 
described before, but those experiments were carried out with only purified ligands instead 
of stimulation with intact pathogens (45;46). Borrelia spirochetes can be recognized through 
TLR2, and this induces a danger signal in host cells. After uptake and degradation in 
lysosomes, Borrelia-derived peptidoglycans are recognized by active NOD2 molecules, RICK 
adaptor molecule is recruited, ultimately leading to activation of NF-кB and transcription of 
cytokines (figure 6). However, the precise mechanisms for uptake of Borrelia spirochetes are 
not known. Mannose receptor (MR) might play a role in this process, as it is already known 
that this receptor plays a role in the binding to Borrelia, but uptake of spirochetes through 





The main conclusion of present study is that TLR2 and NOD2 are the most important 
receptors for Borrelia spirochetes and they mediate the immune response to the 
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Murine Borrelia arthritis is highly 
dependent on ASC and caspase-1, but 
independent of NLRP3 
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The protein platform called the Nod-Like-Receptor-family member (NLRP)-3 inflammasome 
needs to be activated to process intracellular caspase-1. Active caspase-1 is able to cleave 
pro-Interleukin (IL)-1β, resulting in bioactive IL-1β. IL-1β is a potent pro-inflammatory 
cytokine, and thought to play a key role in the pathogenesis of Lyme arthritis, a common 
manifestation of Borrelia burgdorferi infection. The precise pathways through which 
B.burgdorferi recognition leads to inflammasome activation and processing of IL-1β in Lyme 
arthritis has not been elucidated. In the present study, we investigated the contribution of 
several pattern recognition receptors and inflammasome components in a novel murine 
model of Lyme arthritis. 
Lyme arthritis was elicited by live B.burgdorferi, injected intraarticularly in knee joints of 
mice. To identify the relevant pathway components, the model was applied to wild-type, 
NLRP3-/-, ASC-/-, caspase-1-/-, NOD1-/-, NOD2-/-, and RICK-/- mice. As a control, TLR2-/-, 
Myd88-/- and IL-1R-/- mice were used. Peritoneal macrophages and bone marrow-derived 
macrophages were used for in vitro cytokine production and inflammasome activation 
studies. Joint inflammation was analyzed in synovial specimens and whole knee joints. 
Mann-Whitney U tests were used to detect statistical differences. 
We demonstrate that ASC/caspase-1-driven IL-1β is crucial for induction of B.burgdorferi-
induced murine Lyme arthritis. In addition, we show that B.burgdorferi-induced murine 
Lyme arthritis is less dependent on NOD1/NOD2/RICK pathways while the TLR2-MyD88 
pathway is crucial. Murine Lyme arthritis is strongly dependent on IL-1 production, and B. 
burgdorferi induces inflammasome-mediated caspase-1 activation. Next to that, murine 
Lyme arthritis is ASC and caspase-1-dependent, but NLRP3, NOD1, NOD2, and RICK 
independent. Also, caspase-1 activation by B. burgdorferi is dependent on TLR2 and MyD88. 
Based on present results indicating that IL-1 is one of the major mediators in Lyme arthritis, 
there is a rationale to propose that neutralizing IL-1 activity may also have beneficial effects 





Lyme disease is a complex infectious disease, caused by spirochetes of the Borrelia 
burgdorferi sensu lato family. The initial host response towards Borrelia is mediated by the 
innate immune system through recognition by pattern recognition receptors (PRRs) (1-3).  
Toll-like receptor 2 (TLR2) recognizes Borrelia species. Cells from TLR2-deficient mice show 
decreased cytokine production after exposure to Borrelia species (4), and infection with live 
B.burgdorferi in these mice results in up to 100-fold more spirochetes in their joints (5). Cells 
of humans bearing a single nucleotide polymorphism (SNP) in their TLR2 gene show reduced 
cytokine production when exposed to Borrelia derived antigens (6). Furthermore, we and 
others have found that TLR1/2, but not TLR2/6, heterodimers are essential for B.burgdorferi-
dependent cytokine production (7, 8). The crucial role for a TLR-mediated pathway was 
further underlined by studies using MyD88 gene deficient mice (9, 10). When Myd88-
deficient mice were injected with live B.burgdorferi, highly elevated spirochetal burden was 
found in several organs of the mice, indicating the pivotal role of Myd88 in innate host 
defense against Borrelia (11). 
B.burgdorferi is recognized by the intracellular receptor nucleotide-binding oligomerization 
domain-containing protein 2 (NOD2), a member of the NLR family. Recently, it was 
demonstrated that NOD2 is needed for optimal cytokine production after B.burgdorferi 
stimulation in mice, but does not affect the spirochetal burden (12). Cells from humans 
bearing the NOD2 frameshift mutation produced less IL-1β when exposed to B.burgdorferi,  
indicating that this PRR is also important in Lyme disease (3).  
The pro-inflammatory cytokine interleukin (IL)-1β is known to play a major role in the 
pathogenesis of Lyme arthritis (13-15). Synthesis of its inactive precursor pro-IL-1β is 
initiated by signals induced through PRRs (16), processing of pro-IL-1β to yield the active 
cytokine requires cleavage by caspase-1 (17). In turn, caspase-1 activation needs assembly of 
a protein platform known as the inflammasome, of which the NLR-family member NLRP3 is 
the most studied (18).  
In the present study, we explored the signaling pathways involved in recognition of 
B.burgdorferi by immune cells and their effect on the induction of cytokines. We 
investigated the two major recognition pathways for B.burgdorferi, TLR2-MyD88 and  NOD2-
RICK in the induction of Lyme arthritis. In addition, the role of components of the NLRP3 
inflammasome for Borrelia-induced Lyme arthritis was explored.  
5
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Materials and Methods 
Borrelia burgdorferi cultures.  
B.burgdorferi ATCC strain 35210, was cultured at 33°C in Barbour-Stoenner-Kelley (BSK)-H 
medium (Sigma-Aldrich) supplemented with 6% rabbit serum. Spirochetes were grown as 
described by Oosting et al (19). 
 
Animals 
IL-1R knockout mice were from Jackson Laboratories (B6.129S7-Il1r1tm1Imx/J). Female wild-
type (C57Bl/6J) and knock-out mice between 8-10 weeks of age were used. The mice were 
fed sterilized laboratory chow (Hope Farms, Woerden, The Netherlands) and water ad 
libitum. The protocol was approved by the Ethics Committee on Animal Experiments of the 
Radboud University Nijmegen Medical Centre (RU-DEC-2011-013). MyD88-/-, TLR2-/-, NOD1-
/-, NOD2-/-, RICK-/-, ASC-/-, NLRP3-/-, and caspase-1-/- mice were bred and maintained in 
the St. Jude Children’s Research Hospital, Memphis, TN, USA, as previously described (4, 20-
25). Female wild-type (C57Bl/6J) and knock-out mice between 8-10 weeks of age were used. 
Animal studies were conducted under protocols approved by St. Jude Children’s Research 
Hospital Committee on Use and Care of Animals. 
 
In vitro cytokine production 
Bone marrow was isolated according to Oosting et al (19). Bone marrow was cultured in 
Iscove’s modified Dulbecco’s medium (IMDM) supplemented with 30% L929-conditioned 
medium containing macrophage-stimulating factor, 10% heat-inactivated foetal bovine 
serum (FBS), 5 mL non-essential aminoacids (Invitrogen), 50 µg/mL penicillin, and  50 µg/mL 
streptomycin at 37˚C in a humidified atmosphere containing 5% CO2. After 3 days of culture, 
new enriched IMDM medium was added. At day 5, bone marrow derived macrophages 
(BMDMs) were collected using rubber scrapers and seeded at different concentrations and 
cultured an additional 24 hours before use. For stimulation of BMDMs, 0.5x106 cells were 
seeded in a 96-well flat-bottom plate, and incubated for 24 hours at 37˚C in a humidified 
atmosphere containing 5% CO2. At the day of stimulation, culture supernatant was removed 
and cells were washed once with warm sterile phosphate-buffered saline (PBS, pH7.4). 
Thereafter, 0.2 mL of either medium, live Borrelia spirochetes (5x106/mL), or LPS (10 µg/mL) 
plus 3 mM ATP (last 30 minutes) was added to the cells as a stimulus, all made in medium 
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without antibiotic additions. Cells were stimulated for 4 and 24 hours at 37˚C, 5% CO2. 
Mouse IL-1β, IL-6, KC, and TNFα concentrations were measured using Luminex (Bio-Rad, 
Hercules, CA), according to the instructions of the manufacturer. Concentrations of mouse 
(intracellular) IL-1β were determined by specific radioimmunoassay (RIA; detection limit is 
20 pg/mL) (1).  Levels of bioactive IL-1 was measured using a murine thymoma cell line 
EL4/NOB1 that produces IL-2 in response to active IL-1 as described before (2). IL-2 levels 




Western Blot analysis was performed according to the procedure described by Oosting et al. 
(19). 
 
Induction of Borrelia-induced joint inflammation and histology 
Joint inflammation was induced by intra-articular injection (i.a.) of 1x107 live B.burgdorferi in 
10 µL of PBS into the right knee joint of naïve or knock-out mice. 4 hours after i.a. injection, 
mice were sacrificed and synovial specimens were isolated. After 24h, knee joints were 
removed for histology. Before removal of the joints, macroscopic score of the thickness of 
the joints (without skin) was performed ranging from no swelling (score is 0) or very severely 
swollen joints (score is referred as 3). Whole knee joints were removed and fixed in 4% 
formaldehyde for 7 days before decalcification in 5% formic acid and processing for paraffin 
embedding. Histology of 7 µM knee sections was performed as described before (19). 
 
RNA isolation and real-time quantitative PCR 
RNA from mouse cells was isolated using TRIzol reagent (Invitrogen) following the 
manufacturer’s instructions. Isolated RNA was reversed transcribed into complementary 
DNA using iScript cDNA synthesis kit (Bio-Rad Laboratories, Veenendaal, the Netherlands). 
Quantitative real-time PCR was performed using Power SYBR Green PCR Master Mix (Applied 
Biosystems) using a 7300 Real-time PCR system (Applied Biosystems). In each PCR reaction a 
melting curve analysis was included to control for aspecific PCR amplification. Primers used 
for the experiments (final concentration 10 µM) are below. Real-time qPCR data were 
corrected for expression of the housekeeping gene mouse-β actin. Mouse IL-1β; Forward 
5
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sequence 5’: GCA-ACT-GTT-CCT-GAA-CTC-AAC-T, Reversed sequence 5’: ATC-TTT-TGG-GGT-
CCG-TCA-ACT. Mouse IL-6; Forward sequence 5’:  CAA-GTC-GGA-GGC-TTA-ATT-ACA-CAT-G, 
Reversed sequence 5’: ATT-GCC-ATT-GCA-CAA-CTC-TTT-TCT. Mouse TNF-α; Forward 
sequence 5’: CAG-ACC-CTC-ACA-CTC-AGA-TCA-TCT, Reversed sequence 5’: CCT-CCA-CTT-
GGT-GGT-TTG-CTA. Mouse β actin; Forward sequence 5’: GGC-TGT-ATT-CCC-CTC-CAT-CG, 
Reversed sequence 5’: CCA-GTT-GGT-AAC-AAT-GCC-ATG-T. Cycling conditions were 2 min at 
50°C and 10 min at 95°C followed by 40 cycli of 95°C for 15 sec and 1 min at 60°C.  
 
Isolation of patella biopsies and patella washout assays 
After resection of the patella with surrounding tissue, biopsies for mRNA expression assays 
were isolated using 3 mm disposable biopsy punches (Miltex, Integra, Germany) and 
immediately after isolation frozen in liquid nitrogen. Samples were stored at -80°C until RNA 
was extracted according to the method described above. Before RNA isolation, biopsies 
were lysed using the MagNALyser (Roche Applied Science, Germany). Patella washout assays 
were performed as described before (19). 
 
Statistical Analysis 
The data are expressed as mean ± SEM. Differences between experimental groups were 
tested using the two-sided Mann-Whitney U test performed on GraphPad Prism 4.0 software 
(GraphPad). P values of ≤0.05 were considered significant. 
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Results  
Induction of murine Lyme arthritis by intraarticular injection of live B.burgdorferi. Infection 
of C3H/HeN mice is a standard model for Lyme arthritis. C3H/HeN mice are highly 
susceptible to develop severe Lyme arthritis upon intradermal injection with Borrelia. 
C57Bl/6 mice are known to develop only mild symptoms caused by Borrelia species (26). To 
induce murine Lyme arthritis in C57Bl/6 mice, we have used several application routes, 
ranging from intraperitoneal, intravenous, and intradermal in the lower back. However, 
none of these injection routes resulted in the development of detectable arthritis in wild-
type C57/Bl6 mice (data not shown). In addition, we performed studies with dose-ranges up 
to 1x107 spirochetes per injection. No signs of Borrelia-induced joint inflammation were seen 
in the C57/Bl6 mice (data not shown).  
It has been demonstrated in patients with Lyme arthritis that Borrelia spirochetes were 
detected in synovial-fluid or -tissue using either PCR or culture (27, 28). Therefore, we 
injected live Borrelia directly into knee joints of C57Bl/6 mice to mimic the clinical practice of 
patients with active Lyme arthritis. We were able to induce joint inflammation resulting in 
joint swelling and cell influx into the joint cavity up to day 7 after intra articular (i.a.) of 
spirochetes (Fig. 1A/B). Using this novel model of Lyme arthritis we could address the goal of 
the current study, to investigate the upstream mediators of Borrelia burgdorferi-induced 
activation of the inflammasome and the contribution of individual components of the 
inflammasome in Lyme arthritis. 
 
Murine Lyme arthritis is strongly dependent on IL-1 production. IL-1 was shown already to 
play an important role in the pathogenesis of Lyme disease, but the role in the development 
of murine Lyme arthritis was never been described so far (15). To corroborate the role of IL-1 
in the induction of our novel murine model of Lyme arthritis, IL-1R-deficient mice were 
injected intraarticularly (i.a.) with live B.burgdorferi. Compared to wild-type mice, IL-1R-/- 
mice exhibited significantly reduced joint swelling at early (4h) and late (48h) time points 
(figure 1A). This was reflected by histology: IL-1R gene deficient mice displayed a 
considerable reduction in the numbers of inflammatory cells in the joint cavity when 
compared to wild-type mice (figure 1B). At 24h and 48h after induction of Lyme arthritis, the 
cell influx was decreased in IL-1R-/- mice (figure 1C, upper left). In these mice, significantly 
reduced protein concentrations of IL-1β and the chemokine KC were found in patella 
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washouts (figure 1C, upper right). Synovial tissue explants of IL-1R-/- mice showed less IL-1β, 
and IL-6 mRNA expression, 4 hours after induction of Lyme arthritis (figure 1C, lower left). KC 
mRNA expression was found to be similar between wild-type and IL-1R-/- mice (figure 1C, 
lower left). No differences between wild-type and IL-1R knockout mice were observed in IL-
1β, IL-6, and KC production of peritoneal macrophages stimulated with B.burgdorferi (figure 




Figure 1. Murine Lyme arthritis is IL-1 dependent. (A) Macroscopic score of the knees in either wild-
type (white bars), or IL-1Receptor-/- mice (black bars). After 4, 24, and 48 hours of intra-articular 
injection of 1x10^7 live B.burgdorferi, at least 10 knees per group. Data are mean±SEM from 8 
animals in each group;  ***p<0.0001; Mann–Whitney U test, two-tailed.  (B) Murine Lyme arthritis in 
WT, or IL-1R-/- mice. Histology (H&E staining) 24, and 48 hours after i.a. injection of B.burgdorferi in 
knee joints. 200x magnification; P, patella; F, femur; JC, joint cavity; SL, synovial lining. Scale bar 
represents 100 µM. (C) Upper left: Scored cell influx after 24 and 48 hours of i.a. injection with 
B.burgdorferi. Upper right and lower left: 4 hours after i.a. injection of 1x10^7 live B.burgdorferi in 10 
µL of PBS, patellae were cultured for 1h and IL-1β, IL-6 and KC protein levels and mRNA expression 
levels were measured using Luminex and qPCR, respectively. Lower right: After 24 hours of infection, 
1x10^5 peritoneal macrophages were stimulated for 24 hours with live B.burgdorferi. White bars 
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represent cytokine induction by wild-type mice, black bars are IL-1R gene deficient mice, at least 5 
animals/group. *p<0.05, **p<0.01; Mann-Whitney U-test, two-sided. 
 
Borrelia-induced IL-1β production is NOD1/2 and RICK independent. In humans, 
B.burgdorferi-induced IL-1β was partly NOD2-dependent, but the role of this PRR in the 
development of arthritis was never been demonstrated. The roles of murine NOD1, NOD2, 
and RICK were explored using mouse cells. BMDMs isolated from wild-type, NOD1, NOD2, or 
RICK deficient mice were stimulated with either medium or B.burgdorferi. A clear induction 
of mRNA coding for IL-1β was seen in wild-type BMDMs upon stimulation with B.burgdorferi 
(figure S1). Surprisingly, NOD1, NOD2, and RICK appeared not to be important for the 
induction of IL-1β after B.burgdorferi recognition, whereas – as expected – TLR2 and MyD88 
were (figure 2A). In the absence of NOD1, IL-1β mRNA as well as IL-1β protein levels were 
higher than in cells of wild-type mice, indicating an inhibitory role of NOD1 in B.burgdorferi-
induced IL-1β production (figure S1 and S2A). The IL-1 induced by BMDMs was bioactive in 
the IL-2 induction assay (figure 2B). NOD1-, NOD2-, and RICK-deficient cells induced IL-6 and 
TNF-α production after exposure to B.burgdorferi (figure S1). 
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Figure S1. IL-1β mRNA expression is TLR2 and MyD88 dependent.  (A) IL-1β mRNA expression levels 
(x1000) in bone marrow derived macrophages isolated from wild-type, TLR2-, MyD88-, NOD1-, NOD2- 
and RICK-gene deficient mice. mRNA expression after 24 hours of stimulation with either medium or 
5
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5x10^6 B.burgdorferi per mL. At least 5 animals per group, bars represent mean±SEM. *p<0.05; 
Mann–Whitney U test, two-tailed.  IL-6 (B) and TNF-α (C) mRNA expression and protein production (in 
ng/mL for IL-6, and pg/mL for TNF-α, respectively) by bone marrow derived macrophages isolated 
from wild-type, TLR2-, MyD88-, NOD1-, NOD2-, and RICK-gene deficient mice. mRNA expression after 
24 hours of stimulation with either medium or 5x10^6 B.burgdorferi per mL. At least 5 animals per 
group, bars represent mean±SEM. 
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Figure S2. Inflammasome-independent IL-1β transcription.  (A) IL-1β mRNA expression levels (x1000) 
in bone marrow derived macrophages isolated from wild-type, NLRP3-, ASC-, and caspase-1-gene 
deficient mice. mRNA expression after 24 hours of stimulation with either medium or 5x10^6 
5
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B.burgdorferi per mL. At least 5 animals per group, bars represent mean±SEM. IL-6 (B) and TNF-α (C) 
mRNA expression and protein production (in ng/mL for IL-6, and pg/mL for TNF-α, respectively) by 
bone marrow derived macrophages isolated from wild-type, NLRP3-, ASC-, and caspase-1-gene 
deficient mice. mRNA expression after 24 hours of stimulation with either medium or 5x10^6 
B.burgdorferi per mL. At least 5 animals per group, bars represent mean±SEM. 
 
TLR2 and MyD88 mediated pathways are crucial for the Borrelia-induced IL-1β production. 
BMDMs isolated from wild-type, TLR2-/-, and MyD88-/- mice were exposed to either 
medium or B.burgdorferi. TLR2 and MyD88 are not only crucial for the induction of IL-1β-
mRNA, but also important for the B.burgdorferi-induced IL-1β protein secretion in the 
supernatant (figure S1, and figure 2A).  
The IL-1β induced by BMDMs from wild-type mice was bioactive in the IL-2 assay, whereas 
no bioactive IL-1 production was seen by BMDMs of TLR2-/- and MyD88-/- mice (figure 2B). 
In line with previous results, TLR2 and MyD88 are also critical for B.burgdorferi-induced IL-6 






Figure 2. TLR2 and MyD88 drive Borrelia-induced IL-1β production. (A) 0.5x10^6 BMDMs from wild-
type (WT), TLR2-/-, MyD88-/-, NOD1-/-, NOD2-/-, and RICK-/- mice were stimulated for 24 hours with 
either medium (Med), or 5x10^6 spirochetes per mL live B.burgdorferi (black bars). IL-1β protein 
levels in supernatant expressed in picograms per mL after BMDM exposure for 24 hours to 
B.burgdorferi. BMDMs are isolated from at least 5 animals per group, protein measurements were 
5
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performed in duplicates. (B) IL-2 protein levels in nanograms per mL after BMDM stimulation with 
medium (Med), or 5x10^6 B.burgdorferi per mL for 24 hours, using cells from different knockout mice. 
(C) 3x10^6 Bone marrow derived macrophages from 5 WT C57Bl/6, TLR2-/-, MyD88-/-, NOD1-/-, 
NOD2-/-, or RICK-/- mice were incubated for 24 hours with or without 1x10^6 B.burgdorferi with ATP 
(3mM) for 30 minutes. Cleaved caspase-1 was detected by Western Blotting using antibodies to 
detect the inactive caspase-1 (p45) or active caspase-1 (p20). The control conditions were already 
published in an earlier article by our group (19). Borrelia and ATP by itself are unable to induce 
caspase-1 activation, the combination of the two are crucial for inducing cleavage. 
 
Caspase-1 activation by B.burgdorferi is dependent on TLR2 and MyD88. Inactive pro-
caspase-1 needs to be cleaved to yield active caspase-1 before it can process pro-IL-1β. To 
identify the signaling cascades involved in B.burgdorferi-induced caspase-1 activation, 
BMDMs of TLR2-, MyD88-, NOD1-, NOD2-, or RICK-deficient mice were exposed to either 
medium (control) or B.burgdorferi plus ATP. Thereafter, Western Blot analysis was 
performed using a specific antibody detecting the active subunit of caspase-1. Wild-type 
cells stimulated with B.burgdorferi and ATP expressed the cleaved caspase-1 (figure 2C). 
Surprisingly, activation of caspase-1 in BMDMs by B.burgdorferi is entirely dependent on 
TLR2 and Myd88 mediated pathways, whereas NOD1, NOD2, and RICK signaling pathways 
are not required for caspase-1 activation (figure 2C). 
 
B.burgdorferi induces murine Lyme arthritis through TLR2 and MyD88. As described before, 
both TLR2 and MyD88 play a critical role in B.burgdorferi-induced caspase-1 activation and 
subsequent IL-1β production  in vitro. To assess the roles of these molecules in vivo, we 
induced Lyme arthritis by injecting live B.burgdorferi spirochetes into knee joints of wild-
type, TLR2-, or MyD88-deficient mice. In addition, we investigated NOD1, NOD2, and RICK 
knockout mice. Lyme arthritis, detected as joint swelling of the injected knee, could be 
clearly seen in wild-type mice. Both TLR2-, and MyD88-deficient mice displayed significantly 
less joint swelling 4 hours after induction of Lyme arthritis (figure 3A). The lack of joint 
swelling was still noticeable after 24 hours (figure 3A). Interestingly, NOD1 knockout mice 
displayed severe swelling, similar to that seen in wild-type mice. The expression of Lyme 
arthritis in NOD2 and RICK knockout mice was significantly lower than in wild-type animals, 
both at early (4h) and late (24h) phases (figure 3A). Next to joint swelling, the cell influx into 
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the joint cavity at 24h was assessed. In wild-type mice, the synovial lining was thickened and 
more cells, mainly neutrophils infiltrated into the joint cavity (figure 3B and 3C). In both 
TLR2-, and MyD88-gene deficient mice the synovial lining was less inflamed and significant 
reduced cell influx could be observed (figure 3B and 3C).  
 
Figure 3. B.burgdorferi-induced murine Lyme arthritis is dependent on TLR2 and MyD88. (A) 
Macroscopic score of the knees in WT, TLR2ko, MyD88ko, NOD1ko, NOD2ko, and RICKko mice. After 4 
hours and 24 hours of intra-articular injection of 1x10^7 live B.burgdorferi, at least 10 knees per 
group. Data are mean±SEM from 10 knees in each group; **p<0.01; ***p<0.0001, Mann–Whitney U 
test, two-tailed. (B) Scored cell influx 1 day after i.a. injection of B.burgdorferi. Data are mean±SEM 
from 10 knees in each group; **p<0.01; Mann–Whitney U test, two-tailed.  (C) Murine Lyme arthritis 
in WT, TLR2ko, MyD88ko, NOD1ko, NOD2ko, and RICKko mice. Histology (H&E staining) 1 day after 
i.a. injection of B.burgdorferi in knee joints. 200x magnification; P, patella; F, femur; JC, joint cavity; 
SL, synovial lining. Scale bar represents 100 µM.  
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Inflammasome-mediated activation of caspase-1 by B.burgdorferi. The roles of 
inflammasome components ASC, and NLRP3 in the B.burgdorferi-induced caspase-1 
activation were assessed. Caspase-1 activation could be clearly detected when BMDMs of 
wild-type mice were exposed to B.burgdorferi, but was completely absent in cells from mice 
deficient in NLRP3, ASC, or caspase-1 (figure 4A). Subsequently, NLRP3, ASC, and caspase-1 
are crucial for total IL-1β protein production after B.burgdorferi stimulation (figure 4B). 
Interestingly, a significantly decreased concentration of bioactive IL-1 could be observed in 
absence of ASC, NLRP3, or caspase-1, as compared to wild-type mice (figure 4C). 
Transcription of IL-1β mRNA was not influenced by deficiency of the inflammasome 
components after B.burgdorferi stimulation of BMDMs (figure S2A). No differences in mRNA 
and protein levels of both IL-6 and TNF-α could be detected between wild-type, ASC-, 




Figure 4. Inflammasome components are necessary for B.burgdorferi-induced IL-1β. (A) 3x10^6 
BMDMs from wild-type, NLRP3-, ASC-, and caspase-1-gene deficient mice were stimulated for 24 
hours with or without 1x10^6 B.burgdorferi with ATP (3mM) for 30 minutes. Cleaved caspase-1 was 
detected by Western Blotting using antibodies to detect the inactive caspase-1 (p45) or active 
caspase-1 (p20). (B) IL-1β protein levels in the supernatant expressed in picograms per milliliter after 
BMDM exposure for 24 hours to B.burgdorferi, using WT, NLRP3-, ASC-, or caspase-1-gene deficient 
mice. BMDMs are isolated from at least 5 animals per group, protein measurements were performed 
in duplicates. (C) IL-2 protein levels in nanograms per mL after BMDM stimulation with medium 
(Med), or 5x10^6 B.burgdorferi per mL for 24 hours, using cells from different knockout mice.  
5
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Murine Lyme arthritis is ASC and caspase-1-dependent, but NLRP3 independent. To assess 
the role of the inflammasome components in vivo, wild-type (WT) mice, NLRP3-/-, ASC-/-, 
and caspase-1-/- mice were injected with live B.burgdorferi and joint swelling was assessed 
after 4 and 24 hours (figure 5A). ASC and caspase-1 knockout mice showed significantly 
reduced joint swelling after local B.burgdorferi injection, whereas NLRP3-gene deficient mice 
displayed joint inflammation similar to wild-type animals (figure 5A). ASC and caspase-1 
knockout mice had also less thickened synovial linings than WT animals, and less cell influx 
into the joint cavity could be observed in these mice (figure 5B/C). Of interest, NLRP3 is not 
critical in the induction of murine Lyme arthritis. 
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Figure 5. ASC and caspase-1- dependent role in murine Lyme arthritis. (A) Macroscopic score of the 
knees in WT, NLRP3, ASC, and caspase-1 knockout mice. After 4 hours and 24 hours of intra-articular 
injection of 1x10^7 live B.burgdorferi, at least 10 knees per group. Data are mean±SEM from 10 knees 
in each group; **p<0.01; ***p<0.0001; Mann–Whitney U test, two-tailed. (B) Scored cell influx 1 day 
after i.a. injection of B.burgdorferi. Data are mean±SEM from 10 knees in each group; *p<0.05; 
Mann–Whitney U test, two-tailed. (C) Murine Lyme arthritis in WT, NLRP3, ASC, and caspase-1 
knockout mice. Histology (H&E staining) 1 day after i.a. injection of B.burgdorferi in knee joints. 200x 
magnification; P, patella; F, femur; JC, joint cavity; SL, synovial lining. Scale bar represents 100 µM.  
 
NLRP3-independent local cytokine production after B.burgdorferi injection. The strong 
reduction of arthritis was in line with the findings that the local cytokine production was 
ablated in both TLR2-, and MyD88-deficient mice (figure 6). Synovial tissue explants revealed 
that both the mRNA expression as the protein production of IL-1β, IL-6, and KC was almost 
absent in TLR2 and MyD88 knockout mice (figure 6A/C). A remarkable finding was the fact 
that NOD1, NOD2, and RICK signaling does not seem to be involved in the cell influx as 
similar numbers of inflammatory cells were found in the joint cavity as in wild-type mice 
(figure 3B). This is in sharp contrast to the strongly reduced synovial production of IL-6, and 
KC in NOD1-/-, NOD2-/-, and RICK-/- mice, although NOD1 deficient mice produced similar 
amounts of IL-1β as wild-type mice and NOD2-/- and RICK-/- mice showed only 50% 
reduction in IL-1β (figure 6). The inhibitory effect of NOD1 seen in figure 3 for Borrelia-
induced IL-1β production could not be observed using BMDM stimulation. 
Next, we examined the local cytokine production in patellae after injection of B.burgdorferi. 
Levels of IL-1β, IL-6, and KC mRNA expression in synovial tissue of ASC and caspase-1 
deficient mice was found to be significantly lower, with exception of NLRP3 deficient mice as 
compared to wild-type mice (figure 6A). Similar results were observed for synovial IL-6 and 
KC mRNA expression (figure 6B/C). Cytokine measurements in patella washouts showed that 
IL-1β production by the inflamed synovium was dependent on ASC and caspase-1, but not on 
NLRP3 (figure 6A). This was also true for induction of IL-6, and KC (figure 6B/C). Both ASC and 
caspase-1 are pivotal components for the induction of the latter cytokines.  
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Figure 6. TLR2 and MyD88 dependent and NLRP3 independent local cytokine production in 
synovium. (A) IL-1β mRNA expression and protein levels, IL-6 mRNA expression and protein (B), or KC 
mRNA expression and protein (C),  in biopsies isolated from synovial tissues from either wild-type, 
TLR2-, MyD88-, NOD1-, NOD2-, RICK-, NLRP3-, ASC-, and caspase-1-gene deficient mice. 4 hours after 
intra-articular injection with 1x10^7 live B.burgdorferi. At least 5 animals per group, bars represent 
mean±SEM; *p<0.05; **p<0.01; ***p<0.0001, Mann-Whitney U-test, two-sided. (A-C Right panels) 
Four hours after intra-articular (i.a.) injection of 1x10^7 live B.burgdorferi in 10 mL of PBS, patellae 
from 5 WT C57BL/6 mice or knockout mice were cultured for 1h and IL-1β (A), IL-6 (B), and KC (C) 
levels were measured using Luminex. Data are represented as mean±SEM; 5 animals in each group; 




In the present study, we describe for the first time the role of TLR2 and MyD88 in vivo in a 
murine model of Lyme arthritis elicited by local injection of B.burgdorferi. TLR2 and MyD88 
are crucial for B.burgdorferi-dependent caspase-1 activation and subsequent IL-1β 
production in vitro by bone marrow-derived macrophages. Mice deficient in TLR2 or MyD88 
display less joint swelling after intra-articular injection of B.burgdorferi and fewer cells are 
attracted towards the joint cavity. In addition to TLR2 and MyD88, the inflammasome 
components ASC and caspase-1 are essential for IL-1β production by B.burgdorferi-
stimulated BMDMs in vitro, and also are pivotal in the development of murine Lyme 
arthritis. The NOD1/NOD2/RICK pathway is also involved in synovial cell activation by 
B.burgdorferi, but is not essential for the production of IL-1β and for the influx of 
inflammatory cells into the joint cavity. 
 
It is known that genetic background of mice influences the susceptibility for several 
experimental disease models (29, 30). This holds also true for the induction and 
maintenance of experimental murine Lyme Disease. C3H/HeN mice are highly susceptible to 
develop severe arthritis upon intradermal injection with Borrelia. However, these C3H/HeN 
mice also display a defect in IL-12 production and therefore lack IL-12/IL-18 induced IFN-γ 
production upon stimulation with pathogens (31). This is in contrast to cells from C57Bl/6 
mice which produce IFN-γ after Borrelia exposure (19). This might explain the susceptibility 
of the C3H/HeN mice to the development of Lyme arthritis. Lacking IFN-γ production results 
in less killing of invading Borrelia bacteria, resulting in dissemination through the body. In 
our study, we used C57Bl/6 mice, which do not display any defects in immune responses and 
therefore will reflect the disease development in humans more appropriate. 
 
It has been suggested earlier (15), that IL-1 is a key player in the pathogenesis of Lyme 
arthritis. Patients with Lyme arthritis who were found to have elevated synovial 
concentrations of IL-1Receptor antagonist (IL-1Ra) in combination with low concentrations 
of  IL-1β showed a rapid resolution of Lyme arthritis. These data are in line with the results of 
the present study in murine Lyme arthritis. Mice deficient for the IL-1 receptor showed 
significantly attenuated B.burgdorferi-induced arthritis. In addition, decreased levels of IL-1β 
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were noted in mice without functional IL-1R. Both mRNA expression and protein 
concentrations of IL-1β were lower in synovial cells lacking IL-1R, when compared to wild-
type mice. These findings point towards an amplification loop in the local production of IL-1β 
via its receptor during the onset of Lyme arthritis. 
Before active IL-1β can be secreted, the inflammasome needs to be assembled intracellularly 
by heteromultimerization (17). NLRP3 is seen as one of the major NLRs that activate the 
inflammasome, followed by the cleavage of pro-caspase-1. In our hands, using caspase-1 
deficient mice, caspase-1 seems to be the major enzyme to cleave pro-IL-1β. However, at 
later time points after Borrelia exposure, caspase-1 might play a different role. Liu et al., (32) 
showed that caspase-1 knockout mice display higher arthritis scores at day 14 post infection. 
On day 45, the arthritis scores in these mice are lower as compared to wild-type mice. 
However, the inoculation method between this study and our data differs and might cause a 
different amount of spirochetes in the joint at early time points. Next to this, recently it was 
demonstrated that the caspase-1 knockout mice used in these studies were in fact double 
knock-out, they also lack functional caspase-11 (33). Recently, it was demonstrated that 
mice deficient for only caspase-1 were more susceptible for intracellular infections (34). The 
caspase-1/11 deficient mice were less susceptible, indicating that caspase-11 may dampen 
the effect of caspase-1 in our findings. Taken this together, caspase-1 plays an important 
role in the induction of an inflammatory response against Borrelia spirochetes in the joint, 
but is less important in controlling spirochete burden at later time points. 
 
Here we show that in vitro activation of caspase-1 in BMDMs after B.burgdorferi exposure, 
as well as production of IL-1β protein and bioactive IL-1β, is indeed NLRP3-dependent (Fig.4). 
However, intraarticular injection of B.burgdorferi did not differ between NLRP3 knockout 
and wild-type mice in terms of joint inflammation and cytokine production. These results 
support recent reports showing that NLRP3 is not involved in other murine models of 
arthritis, such as antigen-induced arthritis, collagen-induced arthritis,  or gouty arthritis (35-
37). We cannot fully explain the difference in NLRP3 dependency between the in vitro and in 
vivo induction of IL-1β by B.burgdorferi. Explanations may be sought in in vivo activation of 
additional inflammasomes, or triggering of ASC-caspase-1 independently of NLRs (38-40), 
but this remains to be demonstrated. 
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Interestingly, ASC was found to be pivotal in the induction of Lyme arthritis. It is known that 
ASC is not just an adaptor protein within the inflammasome, but also has a role in antigen 
presentation and lymphocyte migration. It addition, it has been demonstrated that ASC 
controls mRNA stability and expression of Dock2, which is involved in Rac activation in 
immune cells (41). Finally, ASC has been associated with NFкB signaling (42), which is the 
major pathway in the production of several cytokines.      
In contrast to TLR2-MyD88, neither NOD1 nor NOD2 were involved in the B.burgdorferi-
triggered caspase-1 activation and bioactive IL-1β production in BMDMs (Fig.2B/C). 
However, in vivo we note a NOD1/NOD2/RICK-dependent cytokine production in synovial 
explants from mice with Lyme arthritis (figure 6). The latter findings are in line with a recent 
report (3) in humans lacking functional NOD2, which show that Borrelia-induced IL-1β 
production is partly NOD2 dependent. Apparently the recognition of B.burgdorferi by murine 
or human immune cells through PRRs differs. Although earlier results demonstrate a specific 
role for RICK and NOD2 in the recognition and induction of Borrelia-dependent IL-1β 
production by human cells, we were unable to detect the important role for NOD2 in vivo for 
cell influx in murine Lyme arthritis (3). However, the role of these PRRs in the in vitro 
cytokine induction using murine cells could be confirmed in the present study.  
An inhibitory role for NOD1 could be demonstrated in this manuscript, but was not found 
when studying human cytokine responses upon Borrelia stimulation. These discrepant 
observations might certainly be explained by differences between host species, it is 
described that humans express different PRR and explore different methods to induce a 
proper immune response against pathogens. Murine cells produce pro-inflammatory 
cytokines after B.burgdorferi exposure, such as IL-1β, KC, and TNF-α. Whether this difference 
is caused by hyperactive TLR2 signaling or lack of NOD2 mediated suppression is not 
elucidated yet. 
The role of MyD88 in experimental Lyme disease, but also in the host response against 
B.burgdorferi was studied previously (43-45). MyD88 deficient mice displayed severely 
higher amounts of spirochetes in several tissues, including the joints (11, 43). It was shown 
that MyD88 knockout mice infected with live B.burgdorferi displayed more severe arthritis 
and cell influx as compared to infected wild-type mice (43). Therefore, it was concluded in 
this study that Lyme arthritis occurs without the presence of the MyD88 molecule. However, 
these findings can be explained by the fact that MyD88 deficient mice suffer from a higher 
5
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spirochetal burden than wild-type mice. The excessive spirochetal load in the organs causes 
hyperinflammation that is MyD88-independent. 
In the present study we detected an important role for MyD88 in the development of early 
murine Lyme arthritis. Mice deficient in this adaptor molecule were not able to develop 
arthritis after intra-articular injection of B.burgdorferi. TLR2 gene deficient mice were also 
unable to induce Lyme arthritis at early time points after injection of spirochetes. These data 
suggest that TLR2-MyD88 signaling is very important during the onset of Lyme arthritis. 
 
The treatment of patients suffering from Lyme arthritis is a challenge for clinicians, as 
treatment is often ineffective. Patients suffering from gout, rheumatoid arthritis, or other 
inflammatory joint diseases benefit from treatment with the IL-1receptor antagonist 
(Anakinra) (46, 47). Based on  present results indicating that IL-1 is one of the major 
mediators in Lyme arthritis, there is a rationale to propose that neutralizing IL-1 activity may 
also have beneficial effects in chronic Lyme arthritis. Apart from IL-1Ra, anti-IL-1β antibodies 
like Canakinumab might be useful for treatment of Lyme disease since these antibodies 
express a long half-life in humans. Thus, understanding the precise pathogenesis of Lyme 
disease may reveal novel therapeutic modalities in the near future.  
 
In the present study, we have demonstrated that murine Lyme arthritis is strongly 
dependent on IL-1 production. Next to that, murine Lyme arthritis is ASC and caspase-1-
dependent, but NLRP3, NOD1, NOD2, and RICK independent. Caspase-1 activation by B. 
burgdorferi is dependent on TLR2 and MyD88. In light of these findings, we propose a critical 
role for TLR2-MyD88-NLR-ASC-caspase-1 cascade mediated IL-1β production in the 
pathogenesis of Lyme arthritis. The treatment of patients suffering from Lyme arthritis is still 
challenging for clinicians, and treatment for patients with chronic Lyme disease is often 
ineffective. Based on the present results indicating that IL-1 is one of the major mediators in 
Lyme arthritis, it is rationale to propose that neutralizing IL-1 activity may also have 
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Chapter 6 
 
Borrelia species induce inflammasome 
activation and IL-17 production 
through a caspase-1-dependent 
mechanism 
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 Abstract 
Borrelia burgdorferi spirochetes cause Lyme Disease, which can result in severe clinical 
symptoms such as multiple joint inflammation and neurological disorders. IFN-γ and IL-17 
have been suggested to play an important role in the host defense against Borrelia, and in 
the immunopathology of Lyme Disease. The caspase-1 dependent cytokine IL-1β has been 
linked to the generation of IL-17-producing T cells, whereas caspase-1-mediated IL-18 is 
crucial for IFN-γ production. In this study, we show by using knockout mice the role of 
inflammasome-activated caspase-1 for the regulation of cytokine responses by 
B.burgdorferi. Caspase-1 deficient cells showed significantly less IFN-γ and IL-17 production 
after Borrelia stimulation. A lack of IL-1β was responsible for the defective IL-17 production, 
whereas IL-18 was crucial for the IFN-γ production. Caspase-1 dependent IL-33 played no 
role in the Borrelia-induced production of IL-1β, IFN-γ or IL-17. In conclusion, we describe for 
the first time the role of the inflammasome-dependent caspase-1 activation of cytokines for 
the regulation of IL-17 production induced by Borrelia spp. As IL-17 has been implicated in 
the pathogenesis of chronic Lyme disease, these data suggests that caspase-1 targeting may 
represent a new immunomodulatory strategy for the treatment of complications of late 




Lyme Disease  is caused by spirochetes of the genus Borrelia, of which B.burgdorferi sensu 
stricto is causing disease mainly in the United States, and B.afzelii and B.garinii mainly cause 
disease in Europe and Asia (1;2). Clinical Lyme disease can be divided into early localized 
infection that is often characterized by skin manifestations, and in either the early or late 
disseminated stage of the disease joint and skin inflammation, as well as neurologic 
disorders can be seen (3). The various Borrelia strains appear to cause different clinical 
symptoms in Europe. B.burgdorferi sensu stricto is the main cause of Lyme arthritis, B.garinii 
most often induces neurologic manifestations, while B.afzelii is mainly responsible for skin 
disorders (4;5).  
Cytokines play an important role in the pathogenesis of Lyme disease by regulating the 
immune responses against Borrelia. (6). It has been reported that Borrelia is able to induce a 
pro- inflammatory cytokine response, characterized especially by production of IL-1β (7). In 
patients diagnosed with a typical skin disorder near the location of the tick bite, called an 
erythema migrans (EM), high amounts of both IL-1β and IFN-γ were found (8).  Furthermore, 
the recently described IL-17-producing T-cells, called Th17 cells, are capable of producing 
high amounts of IL-17 after exposure to Borrelia-derived stimuli (9). Burchill et al. (10) 
proposed an important role for IL-17 in the chronic stage of murine Lyme disease. In a 
mouse model of Borrelia infection, severe destructive arthritis could be induced in IFN-γ 
knock-out mice after challenge with Borrelia spirochetes. When mice were given antibodies 
against IL-17, the development of Lyme arthritis was strongly reduced, with the diminished 
severity of joint swelling (10).  
Caspase-1 is an enzyme involved in processing of the cytokines IL-1β, IL-18, and is activated 
by a protein platform called the inflammasome (11;12). Host defense against several 
pathogens have been linked to the proper activation of the inflammasome, including 
Francisella (13) , Salmonella (14), Listeria (15), and  Legionella (16). Interestingly, IL-1β has 
been implicated in Th17 development (17-20), while IL-18 that was first called IGIF (IFN-γ 
inducing factor) is associated with the induction of Th1 cells (21). 
In the present study we investigated the role of caspase-1 in the host defense against 
Borrelia. Caspase-1 deficient cells were unable to induce a Th1 or Th17 response upon 
challenge with Borrelia. Importantly, IL-1β was responsible for the induction of the IL-17 
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pathway induced by Borrelia, while IL-18 was crucial for the induction of IFN-γ. In contrast, 
IL-18 has an inhibitory effect on IL-17 production, providing further evidence for counter-
regulatory regulation between Th1 and Th17 responses.  
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Materials and Methods 
 
Borrelia burgdorferi and B. afzelii cultures.  
B.burgdorferi pKo strain and B.afzelii, patient isolate, were cultured at 33°C in Barbour-
Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit serum. 
Spirochetes were grown to late-logarithmic phase and examined for motility by dark-field 
microscopy. Organisms were quantitated by fluorescence microscopy after mixing 10 µl 
aliquots of culture material with 10 µL of an acridine orange solution to concentrations. 
Bacteria were harvested by centrifugation of the culture at 7000 x g for 15 min., washed 
twice with sterile PBS (pH 7.4), and diluted in the specified medium to required 
concentrations between 1-3 x 106 spirochetes per ml. Heat-killed B.burgdorferi and B.afzelii 
were prepared as described above except for heating at 52°C for 30 min. before dilution. 
Heat-inactivated bacteria were used according to Wang et al (6). 
 
Animals 
C57BL/6 and Balb/c mice were obtained from Charles River Wiga (Sulzfeld, Germany). IL-1β 
gene deficient mice were kindly provided by J. Mudgett, Merck (Rahway, NJ, USA). Caspase-1 
deficient mice were originally obtained from R.A. Flavell, New Haven, CT, USA and 
generation of these mice were previously described (22;23). The generation of IL-18 knock-
out mice were previously described (24). Male wild-type and knock-out mice between 6 and 
8 weeks of age were used. The mice were fed sterilized laboratory chow (Hope Farms, 
Woerden, The Netherlands) and water ad libitum. The experiments were approved by the 
Ethics Committee on Animal Experiments of the Radboud University Nijmegen.  
 
Preperation of BMDM and Western blot 
Bone marrow from mice (age between 8-20 weeks) was flushed out after dissecting mouse 
legs. Differentiation into macrophages occurred in 5 days at 37°C (5% CO2) in the presence of 
Iscove’s modified Dulbecco’s medium (IMDM) supplemented with 30% of L929 supernatant 
containing 10% fetal bovine serum (heat-inactivated, Invitrogen), 100 U/mL penicillin and 
100 mg/mL streptomycin. Ultrapure LPS was purchased from Invitrogen and used in a 
concentration of 10 µg/mL. ATP was from Sigma and used in a final concentration of 3 mM. 




40)  which  was  supplemented  with  a  Roche  protease  inhibitor  cocktail  tablet.  After 
clarification  and  denaturation  with  SDS  buffer,  samples  were  boiled  for  5  minutes. 
Separation  of  the  proteins was  done  by  using  SDS‐PAGE  and  thereafter  transferred  to  a 
nitrocellulose  membrane.  These  membranes  were  coated  with  primary  antibodies  and 





peritoneal  cavity. After  centrifugation and washing,  cells were  resuspended  in RPMI 1640 
containing 1 mM pyruvate, 2 mM L‐glutamine and 100 µg/mL gentamycin (culture medium). 
Cells were  counted  using  a  Z1  Coulter  Particle  Counter  (Beckman  Coulter, Woerden,  The 
Netherlands) and adjusted to 1 x 106 cells/mL. Cells were cultured in 96‐well round‐bottom 
microtiter plates (Costar, Corning, The Netherlands) at 1 x 105 cells/well, in a final volume of 




Investigating  the  role  of  IL‐33  was  performed  by  incubation  of  peritoneal macrophages 
which were stimulated with RPMI or Borrelia  in the presence or absence of 10 µg/mL anti‐
mouse IL‐33 antibody (R&D Systems). After 48 hours of incubation, IL‐4 and IL‐5 levels were 
measured  using  ELISA  kits  (eBioscience).  ELISA’s  were  performed  according  to  the 
manufacturer’s  instructions.  Spleen  cells  were  isolated  by  gently  squeezing  spleens  in  a 
sterile 200 µM filter chamber. After washing with sterile PBS and centrifugation at 4°C (1200 
rpm 5 min), cells were resuspended  in 4 ml RPMI 1640  in presence of 20% FCS. Cells were 
counted and  concentrations were adjusted  to 1  x 107  cells/mL. Cells were  cultured  in 24‐







Concentrations  of    mouse  IL‐1β  were  determined  by  specific  radioimmunoassay  (RIA; 
detection  limit  is 20 pg/mL) as described by Netea et. al (25). Mouse  IL‐6,  IL‐17, and  IFN‐γ, 
concentrations  were  measured  by  a  commercial  ELISA  kit  (Biosource,  Camarillo,  CA; 
detection  limits 16 pg/mL), according to the  instructions of the manufacturer.  IL‐4 and  IL‐5 
levels  were  measured  using  mouse  ELISA  Ready‐SET‐Go!  Kits  (eBioscience,  San  Diego, 
California, USA; detection limits 4 pg/mL), according to the instructions of the manufacturer. 
In brief,  IL‐4  and  IL‐5 were detected using biotinylated monoclonal  antibodies, which  are 











Protein  levels  of murine  IL‐1β,  IL‐6  or  KC were measured  in  patellae washouts.  4h  after 
injection  of  1x105  sp  B.burgdorferi,  patellae were  isolated  from  inflamed  knee  joints  and 
cultured 1 hour at RT in RPMI 1640 medium containing 0.1% bovine serum albumin (200 µL / 
patella). Thereafter supernatant was harvested and centrifugated for 5 minutes at 1000 x g. 
For  intracellular  IL‐1β  levels,  patellae were  frozen  directly  after  isolation.  After  repeated 




Mice were sacrificed by cervical dislocation. Whole knee  joints were removed and  fixed  in 
4%  formaldehyde  for  7  days  before  decalcification  in  5%  formic  acid  and  processing  for 
paraffin  embedding.  Tissue  sections  (7  µM)  were  stained  with  Haematoxylin/Eosin. 











experimental  groups  were  tested  using  the  two‐tailed  Mann‐Whitney  U  test  (95% 




Borrelia  induces  inflammasome  activation  and  bioactive  IL‐1β.  It  has  been  previously 
reported  that caspase‐1  is activated by  several different microorganisms  (14‐16). Here we 
demonstrate  for  the  first  time  that caspase‐1  is also activated by Borrelia  in bone marrow 
derived macrophages  (BMDM)  from wild‐type C57BL/6 mice. After stimulation  for 4 hours 
with 1x106  /mL heat‐killed  spirochetes, with  the  last 30 minutes  in  the   presence of ATP, 
cleaved  caspase‐1 was  clearly  induced  (figure  1A).  As  a  control  for  caspase‐1  activation, 
BMDMs were stimulated with LPS plus ATP, which also resulted in cleaved caspase‐1 (figure 
1A).  Since  we  found  strong  caspase‐1  activation,  we  next  examined  whether  IL‐1β 
production  by murine macrophages  could  be  induced  by  Borrelia  burgdorferi.  Peritoneal 
macrophages  from  wild‐type  mice  stimulated  for  24  hours  with  1x106/mL  heat‐killed 
spirochetes. Borrelia exposure  induced  IL‐1β production  in peritoneal macrophages  (figure 
1B). In addition, IL‐6 was strongly produced in peritoneal macrophages (figure 1B). 
 To confirm that caspase‐1 is specifically involved in the induction of the cytokines IL‐1β and 
IL‐6,  these  stimulation  experiments  were  repeated  with  caspase‐1  deficient  peritoneal 
macrophages. Peritoneal macrophages of caspase‐1 knock‐out mice were stimulated for 24 
hours with either B.afzelii or B.burgdorferi. Both strains were able to induce IL‐1β and IL‐6 in 
peritoneal  macrophages  of  wild‐type  mice.  Macrophages  from  caspase‐1  deficient  mice 
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Figure 1. Borrelia induces caspase-1-dependent IL-1β production. (A) 1 x 106 Bone marrow derived 
macrophages per ml from 5 WT C57/BL6 mice were incubated for 24 hours with or without 1 x 105 
spirochetes/mL heat-killed B.burgdorferi or LPS (10 µg/mL) with or without ATP (3 mM) for 30 
minutes. Cleaved caspase-1 was detected by Western blot using antibodies to detect the inactive 
caspase-1 (p45) or cleaved or active caspase-1 (p20). (B, C) Peritoneal macrophages (1 x 105/well)  
from 5 WT C57BL/6 mice and 5 caspase-1 knock-out mice were incubated for 24 hours with (B) 3 x 106 
spirochetes/mL heat-killed B.burgdorferi or (C) 1x106/mL B.afzelii (B.afz) or B.burgdorferi (B.burg) or 
medium alone. Supernatant cytokine levels were determined by RIA (IL-1) or ELISA (IL-6). Data are 
mean ± SEM (pg/mL, 5 animals per group); *p<0.05,Mann-Whitney U test, two-tailed. 
 
  
Interleukin-17 and Interferon-γ induction by Borrelia is dependent on caspase-1. Borrelia is 
able to elicit IL-β and IL-6 production, cytokines which are often associated with 
inflammatory processes. In addition, production of IL-17 and IFN-γ by Th17 and Th1 subsets, 
respectively, have been suggested to play a role in the immune response against Borrelia 
(9;28). To investigate whether spleen cells of naïve mice are able to produce IL-17 and IFN-γ 
after Borrelia exposure, spleen cells of wild-type mice were stimulated for five days with 
1x106/mL spirochetes. A significant amount of IL-17 production after Borrelia stimulation 
could be detected (figure 2A). In addition, IFN-γ production was also potently induced after 
exposure to Borrelia (figure 2A). Since it was shown that Borrelia activates caspase-1, the 
contribution of caspase-1 in the induction of IFN-γ and IL-17 was investigated. A significant 
decrease in both IL-17 and IFN-γ production was detected in spleen cells of caspase-1 gene 
deficient mice stimulated with Borrelia spp. (figure 2B).  
6
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Figure 2. Induction of IL-17 and IFN-γ by Borrelia is caspase-1-dependent. 
(A, B) Spleen cells (5x106/well) from 5 WT C57BL/6 mice or 5 caspase-1 KO mice were incubated with 
1x106/mL B.afzelii or B.burgdorferi species or medium alone (RPMI). Supernatants were collected 
after 5 days for measurement of cytokines by ELISA. Data are mean ± SEM of 5 mice per group; 
*p<0.05, two-tailed Mann-Whitney U-test.  
 
Borrelia-induced joint inflammation depends on caspase-1. Since we know that caspase-1 
plays an important role in the induction of cytokines, we examined the role of caspase-1 in 
vivo. Borrelia spirochetes were injected directly into knee joints of naïve (Wt) and caspase-1 
knockout mice. After 4 hours, patellae were collected and cytokine levels were measured in 
patella washouts. Highly significant differences in IL-1β, IL-6 and KC production could be 
detected when wild-type patellae were compared with caspase-1 gene deficient patellae 
(figure 3A).  In addition, the influx inflammatory cells into the joint cavity of caspase-1ko 
mice was decreased as compared to wild-type mice. Lower amounts of polymorphonuclear 
cells (PMNs) could be seen in caspase-1 -/- mice as well as less thickening of the synovial 
lining (figure 3B). When we counted the cell influx, we were able to see approximately 30% 






and  KC  levels  were  measured  using  Luminex.  Data  are  mean  ±  SEM;  5  animals  in  each  group; 
**p<0.01; Mann‐Whitney U‐test, two‐tailed.  (B) Histology (H&E staining) 1 day after i.a. injection of 
heat‐inactivated  Borrelia.  Arrows  highlight  areas  of  cell  influx  and  the  synovial  lining;  200x 
magnification; P, patella; F, femur; JC, joint cavity; Scale bar represents 50 µM. (C) Scored cell influx 1 
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Borrelia-induced IL-17 production is dependent on IL-1β. We explored whether IL-1β might 
play a role in the induction of IL-17 during Borrelia host defense. Peritoneal macrophages 
and spleen cells of IL-1β gene deficient mice were stimulated with 1x106/mL B. afzelii and 
B.burgdorferi for 24 hours or 5 days, respectively. No differences in IL-6 production could be 
observed between wild-type and IL-1β deficient cells (figure 4A). Significant reduced IL-17 
concentrations were detected in spleen cells from mice lacking IL-1β that were stimulated 
with Borrelia, while IFN- production by IL-1β deficient cells did not differ from that of wild-
type cells (figure 4B).  
 
Figure 4. IL-1β is critical for induction of IL-17 by Borrelia. 
(A) Peritoneal macrophages (1 x 105 / well) and (B) spleen cells (5 x 106 / well) from 4 WT 129SvBl/6 
mice and 4 IL-1β knock-out mice were incubated with 3 x 106 B.burgdorferi spirochetes/mL for 24h 
and 5 days, respectively. Supernatants were collected for measurement of cytokines by ELISA (IL-6, 
IFN-γ and IL-17) or RIA (IL-1). Data (n = 4  per group) are mean ± SEM; *p<0.05; Mann-Whitney U-
test, two-tailed. 
 
IL-18 suppresses the induction of IL-17 by Borrelia species. As demonstrated in figure 4B, IL-
1β is not important in the regulation of IFN-γ production after Borrelia exposure. Since 
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caspase-1 is still functional in IL-1β deficient cells, it will still be able to process pro-IL-18. To 
determine whether IL-18 was responsible for the induction of IFN-γ by Borrelia, spleen cells 
of wild-type and IL-18 deficient mice were exposed to Borrelia. IFN-γ levels were significantly 
reduced in the IL-18 gene deficient cells stimulated with Borrelia (figure 5A). Of high interest, 
IL-17 concentrations were significantly enhanced in IL-18 deficient spleen cells after 
stimulation with B.burgdorferi when compared to wild-type spleen cells (figure 5B). 
Stimulation of cells with B.afzelii led to similar results, but this difference was not found to 
be statistically significant.  
 
 
Figure 5. (A) IL-18 is crucial for Borrelia induced IFN-γ but not IL-33 production. 
(A, B) 5 x 106 /well spleen cells of 5 WT C57BL/6 mice and 5 IL-18 knock-out mice were incubated with 
1 x 106 spirochetes/mL B.burgdorferi or B.afzelii or medium alone for 5 days. Supernatants were 
collected for measurement of (A) IFN-γ or (B) IL-17 by ELISA .  Data are mean ± SEM in pg/mL; 5 mice 
per group *p<0.05 two-tailed Mann-Whitney U test. (C) Spleen cells (5 x 106 /well) of 3 wild-type 
6
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Balb/c mice were cultured for 5 days  in RPMI alone or with 1 x 106/mL B.burgdorferi in the 
presence/absence of 10 µg/mL IL-33 antibody or 10 µg/mL control goat IgG antibody. Supernatants 
were collected and IL-17 was measured by ELISA. Data are mean ± SEM; pg/mL; 3 animals per group. 
 
IL-33 is not involved in Borrelia-induced production of IL-17. It has been suggested by an 
earlier study that apart from IL-1β and IL-18, also IL-33 is cleaved by caspase-1 (29). To 
examine the contribution of this novel cytokine in anti-Borrelia host defense, spleen cells 
from wild-type mice were stimulated with Borrelia spirochetes with or without the presence 
of a neutralizing anti-murine IL-33 antibody. The neutralizing activity of the anti-IL-33 
antibody was confirmed in an IL-33 bioassay, in which the IL-33-induced IL-5 production was 
inhibited (data not shown). When spleen cells were stimulated with heat-killed Borrelia, a 
slight decrease in IL-17 levels could be observed after blockade of IL-33, but this difference 
was not found to be significant (figure 5C). Also, Borrelia-induced IL-1β, IL-6, and IFN-γ 
production did not reveal any differences after blockade of endogenous IL-33 (data not 
shown). 
Discussion 
Activation of  caspase‐1  and  subsequently  IL‐1β  and  IL‐18 by  the  inflammasome has been 
suggested  to  represent  an  important  host  defense mechanism.  In  the  present  study we 
demonstrate  that  Borrelia  spp.  are  strong  inducers  of  inflammasome  activation.  Other 
research  groups  demonstrated  already  the  role  of  inflammasome  components  in  sensing 
pathogens,  for example  Listeria monocytogenes  (30).  In addition, our data also  show  that 




not  via  IL‐18  or  IL‐33.  IFN‐γ  induction  is  regulated  through  caspase‐1‐dependent  IL‐18‐
production.  Furthermore,  there  is  an  important  counter‐regulatory mechanism  between 
IFN‐γ and IL‐17 responses during anti‐Borrelia host defense. In addition, caspase‐1 plays an 
important role in Borrelia‐induced arthritis.  
Recently,  it  has  been  suggested  that  caspase‐1  plays  a minimal  role  in  a murine Borrelia 
infection model  (31). However,  in  this  study  caspase‐1  knock‐out mice were  significantly 
more  susceptible  to  acute  infection with Borrelia, when  acute  joint  inflammation  seen  in 
knock‐out mice was  compared  to wild‐type mice.  It was  already  known  that  caspase was 





IL‐6,  IL‐17, and  IFN‐γ  (figure 1).  In addition, after  intra articular  injection with Borrelia we 
observed less cell influx and cytokine production in caspase‐1 deficient animals as compared 
to the wild‐type animals (figure 3). We observed differences in IL‐6 production after Borrelia 
stimulation between  caspase‐1 deficient peritoneal macrophages and PMNs  isolated  from 
the knee of caspase‐1 knockout animals. This difference can be explained by  the  fact  that 
different  type of cells are  involved and different  time points were used  in  these assays.  In 






cells  were  only  4  hours  exposed  to  Borrelia  whereas  the  peritoneal macrophages  were 
treated for 24 hours with Borrelia. 
We also describe  that Borrelia‐induced  IL‐1β,  is  the main  inducer of  IL‐17 production after 
stimulation with Borrelia (figure 4). Furthermore, caspase‐1‐cleaved  IL‐18  is responsible for 
induction of IFN‐γ by Borrelia species (figure 5A). 
Caspase‐1  is  crucial  for  Borrelia‐induced  IFN‐γ  production,  as  caspase‐1  deficient  mice 
produced almost no  IFN‐γ. The exact role of  IFN‐γ  in the host defense against Borrelia has 
not yet been elucidated. On the one hand, the    induction of Borrelia‐induced arthritis does 
not seem dependent on IFN‐γ (36‐38), and  it has been reported that mice with a disrupted 
IFN‐γ  gene  are  more  susceptible  to  autoimmune  disorders  such  as  experimental 
autoimmune encephalomyelitis  (EAE)  and  collagen‐induced  arthritis  (39;40). On  the other 
hand,  several  groups  have  proposed  a  role  for  IFN‐γ‐producing  T  cells  in  Lyme  arthritis 
(40;41).  In patients  infected with Borrelia, high  levels of  IFN‐γ were measured  (42).  In  line 
with this, we found that IFN‐γ is produced in large amounts by spleen cells after stimulation 





Elevated  levels of  IL‐1β were  induced by  cells  stimulated with Borrelia, and  it was  shown 
before that IL‐1β is needed for the induction of Th17 and IL‐17 production (46). We also now 
formally demonstrate activation of the inflammasome by Borrelia. When spleen cells of mice 
lacking  IL‐1β were  stimulated with Borrelia,  IL‐17 production was  significantly diminished, 
which  also  raises  the  hypothesis  the  IL‐1β  is  also  involved  in  induction  of  Th17  cells  by 
Borrelia  species.  IL‐17  is  associated  with  more  severe  disease  progression  in  several 
autoimmune  disorders,  such  as  rheumatoid  arthritis  (RA)  or  multiple  sclerosis  (47).  In 
patients  diagnosed with RA,  elevated  levels  of  IL‐17 were  found  in  synovial  fluid  (48;49). 
Since  several  clinical  symptoms  between  RA  and  Lyme  arthritis  are  similar,  it  has  been 
proposed that IL‐17 might be involved in the development of Lyme arthritis (10). In line with 
this  hypothesis,  it  has  been  demonstrated  that  blockade  of  endogenous  IL‐17  in  IFN‐γ 
deficient mice results in complete protection against development of arthritis after infection 
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by Borrelia  (50). These data  indicate  that  controlling  the  IL‐17  response by  IFN‐γ plays an 
important role in chronic Lyme Disease.  
IL‐33  is a member of  the  IL‐1  family and  is mainly  involved  in  induction of T‐helper 2‐like 
cytokines, such as IL‐4 and IL‐5 (29). Although it was shown that IL‐33 is cleaved by caspase‐
1,  the activity of  the mature protein has never been assessed.  IL‐33 can be secreted  from 
cells  after  caspase‐1  stimulation  (51),  very  recent  data  suggest  that  IL‐33  activity  is 
independent of caspase‐1 (52;53).  More recently it was shown that IL‐33 can be functionally 
active  and  bind  to  its  receptor  ST2  without  being  cleaved  by  caspase‐1,  and  that  this 
cytokine  is more  related  to  IL‐1α  than  to  IL‐1β or  IL‐18  (54).  It was also described  that  IL‐
33/ST2 binding  results  in  the  regulation of mainly Th2  responses, which  is  in  line with our 
results. IL‐33 seems not to be involved in either IL‐17 or IFN‐ production by Borrelia species 
(29).  In  the  present  study  we  also  demonstrate  that  IL‐33  does  not  play  a  role  in  the 
regulation  of  pro‐inflammatory  cytokines  such  as  IL‐1β  and  IL‐6  induced  after  Borrelia 
exposure. 
 The present study demonstrates modulation of  IFN‐γ /  IL‐17 responses by Borrelia species 
through  inflammasome and caspase‐1 activity. These  findings are  the  first  to demonstrate 
the  existence  of  a  counter‐regulatory  mechanism  of  Th1  versus  Th17  cytokines  during 




early  immune  response  against  spirochetes.  Induction  of  large  amounts  of  Th1  cells will 
represent effective killing of  invaded spirochetes by the host  immune responses already  in 
the first stage of disease which might prevent the development of chronic Borrelia‐infection. 
On  the other hand, when  IL‐1β  is highly produced by host cells after Borrelia  recognition, 
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In summary, Borrelia is a strong inducer of inflammasome activation and caspase-1-
mediated IL-1β induction amplifies the production of IL-17 after Borrelia exposure. The 
Borrelia-induced IL-17 production is modulated by the IL-18-driven IFN-γ. These data 
indicate that caspase-1-dependent cytokines IL-1β and IL-18 determine the development 
and clinical outcome of Lyme disease which was also demonstrated by our in-vivo data. This 
findings give more insight in the pathogenesis of Lyme disease and may provide useful 
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Abstract 
Interleukin (IL)-23 is known to play a crucial role in the development and maintenance of T 
helper 17 cells. It has been previously demonstrated that IL-17 is involved in experimental 
Lyme arthritis, caused by Borrelia bacteria. However, the precise role of IL-23(R) for the 
Borrelia-induced IL-17 responses or human Lyme disease has not been yet elucidated. IL-23R 
SNP rs11209026 was genotyped using Taqman assay. Functional studies were performed 
using peripheral blood mononuclear cells and cytokines were measured using ELISA. 
Dose-dependent production of IL-23 and IL-17 by B. burgdorferi could be observed. 
Interestingly, when IL-23 bioactivity was inhibited by a specific antibody against IL-23p19, IL-
17 production was significantly downregulated. In contrast, production of IFN-γ was not 
affected after blockade of IL-23 activity. Moreover, individuals bearing a single nucleotide 
polymorphism in the IL-23R gene (Arg381Gln) produced significantly less IL-17 after Borrelia-
stimulation, compared with wild-type individuals. Despite lower IL-17 production, the IL-23R 
polymorphism did not influence the development of chronic Lyme in a cohort of Lyme 
disease patients. This study demonstrates that IL-23R signaling is needed for Borrelia-
induced IL-17 production and that an IL-23R SNP leads to impaired IL-17 production. 
However, the IL-23R polymorphism is not crucial for the pathogenesis of chronic Lyme. 
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 Introduction  
Lyme disease begins in most individuals with a localized skin infection (EM; erythema 
migrans) caused by the pathogenic Borrelia spirochetes after transmission by an infected 
tick. When dissemination of Borrelia occurs, the second stage of Lyme disease is established 
which eventually leads to persistent Lyme disease. Several chronic inflammatory processes 
can be distinguished in Lyme patients, including inflammation of the central nervous system 
(neuroborreliosis), inflamed skin (ACA; acrodermatitis chronica atrophicans) or joint 
inflammation (Lyme arthritis) (1). The precise immunological mechanisms leading to 
development of persistent Lyme disease are still unclear. While detection of live Borrelia 
microorganisms in the patients is difficult, chronic Lyme disease displays clinical similarities 
with autoimmune disorders such as rheumatoid arthritis (RA) and multiple sclerosis (MS), in 
which T cells are known to play important roles. Pathogenic Th17 cells (CD4+ T cells) play a 
prominent role in the pathogenesis of these diseases (2-4).  
Of interest, pro-inflammatory cytokine IL-1β is essential for the development of Th17 
responses, and Borrelia is a potent inducer of IL-1β (5). Recently, it was also demonstrated 
that caspase-1 is crucial for Borrelia-induced IL-17 responses (6). Patients diagnosed with 
chronic Lyme disease, both mononuclear- and T-cells can be detected in inflamed tissues, 
which are able to produce IL-1β and IL-17 (7;8). It was previously described that IL-17 is 
important for the development of experimental Lyme arthritis (9). Neutralization of 
endogenous IL-17 in IFN-γ knockout mice with Lyme arthritis resulted in a diminished cell 
influx, reduction of swelling in the inflamed joints and less production of pro-inflammatory 
cytokines. Since patients diagnosed with chronic Lyme disease often suffer from arthritis-like 
symptoms, Th17 cells and/or IL-17 might be involved. Not only IL-17 might be related to the 
development of Lyme arthritis, but also other cytokines such as IL-6, IL-1β and IL-23 have 
been linked to the inflammatory reaction caused by Borrelia species (10-12).  
IL-23 is a heterodimeric member of the IL-12 family which shares the p40 subunit but 
contains a specific p19 subunit which can be recognized by the IL-23 receptor (13). Whereas 
IL-6 and IL-1β are necessary for induction of Th17 cells, IL-23 is responsible for the 
maintenance of this T helper cell population and production of IL-17 (14-16). In vitro studies 
revealed that only IL-1β and IL-23 are essential to generate Th17 cells (17). It has been 
demonstrated that IL-23 also plays an important role in the induction of IL-17 after cells 
were stimulated in vitro with Borrelia burgdorferi (18). It is also known that transgenic mice 
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that overexpress IL-23 are spontaneously developing autoimmune disorders. Moreover, it 
was also shown that IL-23 was involved in the development of murine Lyme arthritis (19). 
Induction of Lyme arthritis could not be observed when Borrelia exposed animals were 
treated with antibodies against the p19 subunit of IL-23. In addition, IL-17 levels in these 
animals were significantly decreased when compared to control animals (13). Recently it has 
been demonstrated that a non-synonymous single nucleotide polymorphism (SNP) in IL-23 
receptor (Arg381Gln, rs11209026) is associated with the protection from several 
autoimmune disorders, including Crohn’s disease, psoriasis and rheumatoid arthritis (20;21). 
This polymorphism is found in the cytoplasmic JAK-2 binding domain of IL-23R and variations 
in this area are known to interfere within the binding of IL-23 to IL-23R (22). When variations 
occur, it was hypothesized that this will prevent activation of Th17 cells and thereby be 
protective against (chronic) disease.  At this moment, IL-23 is used as a therapeutic target in 
the treatment of several autoimmune diseases such as Crohn’s disease, psoriasis, and 
rheumatoid arthritis (23). 
The precise role of IL-23 in Lyme disease patients has not been elucidated yet. We describe 
for the first time that IL-17 production by Borrelia burgdorferi in humans is dependent on IL-
23R signaling and genetic variation at the level of IL-23R gene. In addition, we assessed 
whether IL-23R (Arg381Gln) polymorphism contributes to the pathogenesis of chronic Lyme 
disease.  
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Materials and Methods 
 
Bacterial cultures  
B.burgdorferi ATCC 35210 strain, was cultured at 33°C in Barbour-Stoenner-Kelley (BSK)-H 
medium (Sigma-Aldrich) supplemented with 6% rabbit serum. Spirochetes were grown to 
late-logarithmic phase and examined for motility by dark-field microscopy. Organisms were 
quantified by fluorescence microscopy after mixing 10 µL aliquots of culture material with 10 
µL of an acridine orange solution. Bacteria were harvested by centrifugation of the culture at 
7000 x g for 15 minutes, washed twice with sterile PBS (phosphate buffered saline, pH 7.4. 
Stock solutions were divided and stored at -20 Degrees until use. Borrelia was diluted in PBS 
to required concentrations, 1x105 up to 1x107 spirochetes per mL. Viability after freezing was 
confirmed using dark-field microscopy.  
 
Isolation of human peripheral blood mononuclear cells and in vitro cytokine production  
After obtaining informed consent, venous blood was drawn from the cubital vein of healthy 
volunteers and patients into 10 mL ethylenediaminetetraacetic acid (EDTA) tubes 
(Monoject). Peripheral blood mononuclear cells (PBMCs) were isolated according to 
standard protocols, with minor modifications. The PBMC fraction was obtained by density 
centrifugation of blood diluted 1:1 in PBS over Ficoll-Pague (Pharmacia Biotech). Cells were 
washed three times in PBS and resuspended in RPMI 1640 (Dutch modified) supplemented 
with 50 mg/L gentamycin, 2 mM L-glutamin, and 1 mM pyruvate. Cells were counted in a 
Coulter Counter Z ® (Beckman Coulter), and adjusted to 5 x 106 cells / mL. Mononuclear cells 
(5 x 105) in a 100 mL volume were added to round-bottom 96-wells plates (Greiner) and 
incubated with either 100 µL of medium (negative control) or  B.burgdorferi at a dose range 
between 1x104 and 1x106 spirochetes per mL. In some experiments, PBMCs and added 
stimuli were co-incubated with antibody (anti-hIL-23p19, 5 µg/mL, R&D systems) or control 
antibody (normal goat IgG, 5 µg/mL, R&D systems). After 24 hours or 7 days (in the presence 
of 10% human pool serum) supernatants were collected and stored at -20°C.         
 
Study populations 
Healthy volunteers. Individuals used in this study were foresters from the ‘Geldersch 
Landschap’  and ‘Kroondomein’ in the Netherlands. In this cohort, Lyme Disease occurred as 
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an occupational disease and these persons were selected to participate due to their 
relatively high risk of infection with Borrelia species. The individuals were between 23-73 
years old, the cohort consisted out of 77% males and 23% females. Venous blood of these 
individuals was drawn after informed consent was obtained.   
 
Lyme disease patients.  
From September 2008 until August 2010, individuals suspected of persistent Lyme disease 
were recruited from the out-patient clinic of the Department of Medicine, Radboud 
University Nijmegen Medical Centre. Patients were divided into three groups, based on 
diagnostic clinical criteria. Proven Lyme was diagnosed when patients displayed verified 
erythema migrans or ACA (Borrelia PCR positive), arthritis (Borrelia PCR or culture positive in 
synovial fluid) or meningitis (radiculitis, pleiocytosis in liquor, or facialis paresis). Next to 
these criteria, at time of inclusion proven Lyme patients also displayed clinical signs such as 
persistent tiredness, muscoskeletal complaints, paraesthesia, memory- and concentration 
disorders, or neuralgia. Probable Lyme was diagnosed by patients that were clinically 
comparable with the proven Lyme patients, but did not display active disease during 
inclusion. Patients with Lyme history were known to suffer (>1 year ago) from clinical signs 
such as EM, ACA, or arthritis and positive Westernblot or ELISA, but any of the described 
symptoms of disease were absent at time of inclusion. ‘No Lyme’ was diagnosed when EM, 
ACA, arthritis, or meningitis were absent together with negative Borrelia Western blot and 
ELISA. These individuals often displayed persistent tiredness, muscoskeletal complaints, 
paraesthesia, or  memory- and concentration problems. 
All patients were tested for Borrelia infection by IgG and IgM ELISAs and Western blot. 
Genotyping was performed on DNA isolated from 228 patients between 16 and 80 years old. 
46% of the study population was male and 54% female. After informed consent was 
obtained, blood was drawn as described before. All experiments were conducted according 
to the principles expressed in the Declaration of Helsinki. 
 
Isolation of genomic DNA and single nucleotide polymorphism analysis  
DNA was isolated using the Gentra Pure Gene Blood kit (Qiagen), according with the 
manufacturer’s protocol for whole blood, and dissolved in a final volume of 100 µL. 
Polymerase chain reaction amplification of IL-23R gene fragments bearing the polymorphism 
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Arg381Gln (rs11209026) was performed using a pre-designed TaqMan® SNP genotyping 
assay (Applied Biosystems) in 25 µL reactions containing 2 µL of genomic DNA as well as 
primers, two specific probes (with either VIC or FAM label) and Universal PCR 2x Master mix 
(Applied Biosystems). Cycling conditions were 2 min at 50°C and 10 min at 95°C followed by 
40 cycles of 95°C for 15 sec and 1 min at 60°C. Fluorescence intensities were corrected using 
a post-read / pre-read method for 1 min at 60°C before and after the amplification. The 
software automatically plotted genotypes based on a two-parameter plot with an overall 
success rate of >95%. Intermediate samples were excluded from the analysis. 
 
Cytokine measurements 
Concentrations of human IL-1β, IL-6, IL-17, or IFN-γ were determined using either specific or 
commercial ELISA kits (PeliKine Compact, Sanquin Amsterdam, or R&D Systems, 
Minneapolis), in accordance with the manufacturers’ instructions. Detection limits were 40 
pg/mL, except for IFN-γ ELISA (12 pg/mL). IL-23 was measured using Ready-SET-Go!® ELISA 
from eBioscience, with a sensitivity of 15 pg/mL. 
 
Statistical analysis  
Data are expressed as mean ± SEM unless mentioned otherwise. Differences between 
experimental groups were tested using the Mann-Whitney U test performed on GraphPad 
Prism 4.0 software (GraphPad). P values of ≤0.05 were considered significant and marked 
with an asterisk. 
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Results  
Exposure of PBMCs to Borrelia burgdorferi induces IL-17 production. To determine the 
capacity of live Borrelia burgdorferi to induce pro-inflammatory cytokine production by 
freshly isolated peripheral blood mononuclear cells (PBMCs), cells were stimulated with 
spirochetes in a dose-range between 1x105-1x107 per mL. After 7 days of incubation a dose-
dependent production of IL-17 was detected (figure 1A). Since it is known that for the 
development of Th17 cells and IL-17 production IL-1β, IL-6 and IL-23 are needed, we 
analyzed the production of these cytokines after Borrelia exposure. IL-1β (figure 1B) as well 
as IL-23 (figure 1C) production could be observed in a dose-dependent manner. In addition, 
Borrelia is a potent inducer of IL-6 production (Fig 1B). To confirm that both IL-1β and IL-23 
are essential for IL-17 production by PBMCs, we stimulated PBMCs for 7 days in the presence 
of IL-1β and IL-23. Figure 1D shows that IL-1β and IL-23 induce IL-17 production. In addition 
to IL-17, IL-22 was also detected in high amounts (figure 1D). When medium was used as a 




Figure 1. PBMCs exposed to Borrelia induces elevated IL-17 production (A)  5x105 peripheral blood 
mononuclear cells (PBMCs) from at least 6 healthy volunteers were stimulated with different doses 
(ranging from 1x105 - 1x107 sp/mL) of B.burgdorferi.  After 7 days, IL-17 was measured in the 
supernatant using enzyme-linked immunosorbent assay (ELISA). Bars represent the means ± SEM in 
pg/mL. *p<0.05; two-sided Mann-Whitney U-test. (B) PBMCs were stimulated with different 
concentrations of B.burgdorferi for 24 h. After stimulation, ELISA was used to measure IL-1β and IL-6 
in the supernatant and are represented as ng/mL in the graphs. Bars are means ± SEM. *p <0 .05, **p 
<0.01 using Mann-Whitney U-test. (C) IL-23 was measured in the supernatant after 24 h of PBMC 
stimulation with 1x105 – 2.5x106 live B.burgdorferi per mL. Bars are means ± standard errors or the 
means, at least 6 healthy individuals were used. **p <0.01, ***p <0.001; Mann-Whitney U-test. (D) 
PBMCs from 7 healthy volunteers were stimulated for 7 days in the presence of 10 ng/mL IL-1β and 1 
ng/mL IL-23. IL-17 and IL-22 production were measured in the supernatant using ELISA, bars 
represent the means ± SEM . 
 
Borrelia-induced IL-17 production is dependent on IL-23. To investigate whether IL-17 
production by B.burgdorferi (figure 1A) is indeed dependent on IL-23, we neutralized 
endogenous IL-23 using an antibody against IL-23/p19. While exposure of PBMCs to 1x105 
live B. burgdorferi spirochetes per mL induced high IL-17 production in the presence of an 
isotype control antibody, almost no IL-17 production could be detected when IL-23 was 
neutralized by the anti-IL-23p19 antibody (figure 2A). To examine whether blockade of IL-23 
influences the production of cytokines other than IL-17, we analyzed IFN-γ, IL-1β and IL-6. 
Both IL-23 and IL-12 belong to the IL-12-family of cytokines and share a common p40 
subunit. Since it is known that IL-12 is mainly involved in IFN-γ induction by Borrelia, we 
examined whether the anti-IL-23 antibody modulates Borrelia-induced IFN-γ production 
(24). No differences in IFN-γ levels could be observed  after Borrelia-exposure to PBMCs for 7 
days in combination with the anti-IL-23p19 antibody (figure 2B). In addition, no differences 
in IL-1β and IL-6 production could be found when the anti-IL-23p19 antibody was added 
together with live B. burgdorferi to PBMCs (figure 2C and figure 2D).  
7
186 187 180 
 
Figure 2. Borrelia-induced IL-17 is highly dependent on IL-23 (A) Peripheral blood mononuclear cells 
(PBMCs, 5x105/well) from 4 healthy volunteers were stimulated for 7 days with either medium (RPMI, 
white bars) or 1x105 live B.burgdorferi per mL (black bars). IL-17 production in the supernatant was 
measured using ELISA and showed in pg/mL. Bars represent the means ± SEM. *p < 0.05 (Mann-
Whitney). RPMI, medium; anti-IL-23, 5 µg/mL specific antibody against p19 subunit of IL-23; isotype 
control, goat IgG1 isotype control 5 µg/mL. (B) IFN-γ production measured in supernatant after 7 days 
culture of PBMCs stimulated with or without 1x105 B.burgdorferi  per mL or in the presence or 
absence of 5 µg/mL antibody. (C) IL-1β production in pg/mL. (D) IL-6 production in ng/mL after 7 days 
stimulation. RPMI, white bars; B.burgdorferi, black bars; Bars represent the means ± standard error of 
the means. 
 
PBMCs isolated from individuals bearing the IL-23R Arg381Gln polymorphism produce less 
IL-17 after exposure to B.burgdorferi. To further dissect the role of IL-23 in the production 
of IL-17, PBMCs isolated from individuals carrying different allele of the Arg381Gln SNP of 
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the IL-23R subunit of IL-23R were stimulated for 24 hours or 7 days with B. burgdorferi 
(figure 3). Healthy individuals heterozygous for IL-23R Arg381Gln polymorphism displayed a 
significantly lower production of IL-17 compared to individuals homozygous for the wild-type 
allele (figure 3A). Interestingly, no differences could be observed in IL-1β or IL-6 production 
after 24 hours of PBMC stimulation between individuals bearing wild-type or heterozygous 
alleles (figure 3B and 3C, respectively). As expected, no differences in IL-23 production after 
Borrelia stimulation by PBMCs from both wild-type and heterozygous individuals could be 




Figure 3. Impaired IL-17 production in individuals bearing the IL-23R SNP Arg381Gln (A)  Peripheral 
blood mononuclear cells (PBMCs, 5 x 105/well) from 63 healthy individuals without the Arg381Gln 
polymorphism (wt; wild-type; white bars) and 18 heterozygous individuals (he; black bars) were 
stimulated for 7 days with either RPMI or B.burgdorferi (B.b.; 1 x 106 sp/mL). IL-17 production in the 
supernatant was measured using ELISA and showed in pg/mL. Bars represent the means ± SEM. 
**p<0.01; two-sided  Mann-Whitney U test. (B) IL-1β  and (C) IL-6 production in pg/mL in supernatant 
collected after 24 hours of stimulation with RPMI or B. burgdorferi. (D) IL-23 levels were measured 
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after 24 hours of stimulation of PBMCs isolated from healthy individuals without (white bars; wild-
type; wt) or with presence of the IL-23R SNP (black bars; heterozygous; he). 
 
IL-23R Arg381Gln polymorphism does not influence clinical signs of chronic Lyme disease. 
IL-17 is linked to the pathogenesis of chronic inflammatory diseases, and a fundamental role 
for IL-17 in chronic Lyme Disease has been suggested (9). Since we showed that the IL-23 
pathway is crucial for the Borrelia-driven IL-17 production, we investigated whether 
individuals bearing the IL-23R Arg381Gln SNP have different presentation of clinical signs of 
chronic Lyme disease. We analyzed a cohort of 228 individuals (possible Lyme disease 
patients) in total, in which several  individuals were present that expressed clinical signs of 
chronic Lyme disease, including arthritis and skin disorders (ACA). We found little differences 
in the incidence of EM occurrence between individuals carrying wild-type or heterozygous 
allele for the IL-23R (table 1). Moreover, the percentage of anti-Borrelia antibodies, both IgM 
and IgG, was similar in both genotypes of the IL-23 receptor. In addition, there was no 
decreased expression of signs of chronic Lyme disease in individuals bearing the IL-23R 
(Arg381Gln) SNP.  
 
Table 1. Clinical characteristics of patients with a suspicion of chronic Lyme disease, divided on the 
basis of the IL-23R SNP  
  IL-23R Wt IL-23 He % IL-23R 
Wt 
% IL-23 He 
n 188 40   
F/M 100/88 22/18 53/47% 55/45% 
Age (mean) 16-80 (48) 17-66 (50)   
          
Lyme history 26 5 14% 13% 
possible Lyme 134 30 71% 75% 
proven 28 5 15% 12% 
     
Clinical signs:         
EM 87 21 46% 53% 
 joint 108 17 57% 43% 
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heart 29 7 15% 18% 
 ACA 12 2 6% 5% 
        
ELISA  IgG positive 77 17 41% 43% 
ELISA IgM positive 26 8 14% 2% 
Blot IgG positive 84 21 45% 53% 
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Discussion  
 
We assessed the role of the IL-23/ IL-23R pathway for the induction of  IL-17 by Borrelia 
spirochetes in humans. IL-23 plays an important role in the induction and maintenance of 
Th17 cells, but its role for Borrelia-induced Th17 or IL-17 production was not described yet. 
We identify that IL-23 is crucial for the IL-17 production by PBMCs after exposure to Borrelia 
spirochetes. Blockade of IL-23R using neutralizing IL-23p19 antibodies resulted in a highly 
significant suppression of IL-17 production after Borrelia stimulation. Of interest, we 
demonstrated that individuals carrying a non-synonymous SNP of the IL-23R (Arg381Gln) 
showed a significantly reduced IL-17 production after cell-stimulation with Borrelia. Despite 
the downmodulation of the IL-17 response by the IL-23R (Arg381Gln) polymorphism, there 
was no difference on clinical or serological markers of acute Lyme disease or the occurrence 
of chronic symptoms of Lyme between Borrelia-exposed individuals carrying wild-type or 
heterozygous alleles. These results indicate that carrying the IL-23R SNP is probably not 
essential for the development of chronic Lyme disease. 
IL-23 is known to play an important role for the induction and maintenance of Th17 cells and 
the production of IL-17 (14-16). It has been demonstrated that Borrelia-induced IL-17 
production in mice is dependent on IL-23 (18). Cells from mice lacking bioactive IL-23 (p19 
deficiency) were unable to produce IL-17. Here we showed that human PBMCs incubated 
with a neutralizing anti-IL-23p19 antibody produced significantly lower amounts of IL-17. IL-
23 is a member of the IL-12 family and IL-12 itself is a cytokine which is known to drive IFN-γ 
production (24). Blockade of endogenous IL-12 ameliorates murine Lyme arthritis (25), and 
that T helper-1 cell responses (e.g. IFNγ) promotes the development Lyme arthritis. 
However, these studies used anti-IL-12p40 antibodies that neutralize both IL-12 and IL-23, 
and it therefore cannot be excluded that IL-23 blockade, rather than that of IL-12, leaded to 
decreased severity of Lyme arthritis in these mice through reduction of IL-17. We found that 
specific IL-23(p19) blockade or a Arg381Gln polymorphism in IL-23R do not modulate IFNγ 
production by Borrelia in primary cells.     
Borrelia spirochetes are potent inducers of IL-17 production by human PBMCs. This is in line 
with previous reports that demonstrated enhanced IL-17 production in both murine and 
human T cells, after stimulation with outer surface proteins isolated from Borrelia 
spirochetes (26). Here we demonstrated that human PBMCs exposed to live Borrelia 
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produce robust IL-17 levels, which is in line with previous reports showing that microbial 
components, especially originated from Borrelia species are potent inducers of Th17 and/ or 
IL-17 (26-28). Interestingly, it was shown that IL-17 contributes to the development of 
murine Lyme arthritis and that blocking of the IL-17 pathway leads to amelioration of this 
chronic disease (9). These data clearly indicates that Th17 or IL-17 are valid target candidates 
for therapeutic approaches in Lyme disease. This is in line with recent reports that anti-IL-17 
treatment of RA patients results in suppression of disease activity (29). 
As shown before, human PBMCs exposed to Borrelia produce pro-inflammatory cytokines 
such as IL-1β and IL-6 in a dose-dependent manner. These pro-inflammatory cytokines are 
known to be necessary for an optimal Th17/IL-17 response. Next to that, it was also 
demonstrated that human mononuclear cells (PBMC) release IL-23 after stimulation with live 
Borrelia (30). However, this group did not show a dose-dependent induction of IL-23 
production by Borrelia species. So far, it was only demonstrated that murine bone marrow 
derived dendritic cells (BMDCs) were able to produce IL-23 after exposure to Borrelia species 
(18). In addition, human neutrophils were able to induce IL-23 after stimulation with 
neutrophil-activating protein (Nap)A isolated from Borrelia (27). Interestingly, when 
neutrophils were exposed to Borrelia-derived outer surface protein A (OspA), which is 
commonly used as an Borrelia antigen, IL-23 production was not observed (27). In the 
present study we used viable Borrelia burgdorferi in order to stimulate the IL-23 production 
by PBMCs.  
The function of both IL-17 and IL-23 in the development of human chronic Lyme is not 
demonstrated yet. Although, it has been suggested that both IL-17 and IL-23 may be 
important mediators in chronic Lyme disease, this was not confirmed in functional studies 
(31). In rheumatoid arthritis (RA) it was already demonstrated that the IL-17/IL-23 axis plays 
an important role and that individuals with the single nucleotide polymorphism in IL-23R are 
protected against the development of RA (21). However, the functional mechanisms that 
mediate these findings were not investigated until know. This is the first study that describes 
the functional consequences of  the Arg381Gln IL-23R SNP. It was already proposed that this 
polymorphism might interfere with JAK-STAT binding and therefore inhibit the activation of 
Th17 cells (22). In our hands, IL-17 production by PBMCs from individuals with the IL-23R 
SNP is indeed significantly reduced after stimulation with live Borrelia.  
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Despite the significant consequences of this SNP for the release of IL-17 in vitro, individuals 
bearing the polymorphism for the IL-23R Arg381Gln were not protected from developing 
clinical signs of acute or chronic Lyme disease. The infection rate between individuals 
carrying wild type or IL-23R SNP was similar, indicating that the risk of symptomatic Borrelia 
infection in the situation of high exposure was equal between individuals bearing the various 
IL-23R genotypes. In addition, the percentage of individuals with anti-Borrelia antibodies 
(IgG or IgM) was roughly the same (table 1). Moreover, in a cohort of patients examined for 
a suspicion of chronic Lyme disease, individuals heterozygous for IL-23R polymorphism 
showed similar symptoms of chronic Lyme disease, such as ACA or cardiac problems, when 
compared to individuals homozygous for the wild-type allele. Interestingly, the incidence of 
joint problems was lower in the group heterozygous for the polymorphism (43% versus 54%) 
when compared to wild-type allele. However, this difference was not found to be significant. 
It was shown before that TLR2 Arg753Gln polymorphism may protect for the development 
of late stage Lyme disease due to a reduced signaling via TLR-2/TLR-1 (32). Several reports 
showed that both Borrelia- as well as Pam3Cys (TLR2 ligand originated from Borrelia), are 
potent inducers of IL-23. Therefore, lacking functional TLR2 could have led to reduce IL-23 
production followed by lower Th17 responses upon exposure to Borrelia. This hypothesis is 
not supported by the lack of influence of the clinical presentation by the IL-23R 
polymorphisms (table 1).  
Since IL-17 blockade was shown to be effective in suppressing murine Lyme disease in IFN-γ 
deficient mice, it was tempting to speculate about therapeutic value of anti-IL-17 antibodies 
in human Lyme disease (9). Anti-IL-17 antibodies are in development for treatment of RA 
patients and the results are promising (29). Here we demonstrated that a polymorphism 
resulting in a non-functional IL-23R leads to reduced IL-17 production did not influence the 
susceptibility or severity of Lyme disease in humans. While this may be an argument against 
therapeutic usage of anti-IL-17 antibodies in chronic Lyme disease, one important aspect 
may be represented by the degree of IL-17 blockade attained by therapeutic antibodies. This 
may be much higher than that of the IL-23R polymorphism. 
In conclusion, the contribution of the IL-23/IL-17 axis to the development of chronic stages 
of Lyme disease is limited and other pathological pathways need to be explored in the 
future. Apart from IL-17, Borrelia spirochetes are potent inducers of IL-1β, which is a classic 
pro-inflammatory cytokine (5). This latter cytokine is linked to the development of several 
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auto-inflammatory diseases, such as gout and fever syndromes, and may represent a more 
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Abstract  
 
The recognition of Borrelia species represents a complex process in which multiple 
components of the immune system are involved. In this review, we summarize the interplay 
between the host innate system and Borrelia spp. Toll-like receptor (TLR)-2 is important in 
the recognition of outer surface protein A from Borrelia spp., but recently it was also 
demonstrated that TLR2 together with TLR8 is important for the phagocytosis of the 
microorganism and production of Borrelia-dependent type I interferons. In addition, 
intracellular TLR7, and TLR9 were found to mediate type I interferon induction after Borrelia 
stimulation, while cooperation between complement receptors and TLR2 for Borrelia-
induced immune responses have also been described. Borrelia induces the production of 
pro-inflammatory cytokines such as interleukin-1 (IL-1) and T-helper cell derived cytokines, 
which are responsible for the inflammation during Lyme disease. Understanding the 
regulation of host defense mechanisms against Borrelia has the potential to lead to the 
discovery of immunotherapeutic targets to improve the therapy against these infections. 
 
 193 
 Lyme disease is one of the most frequently occurring zoonoses. The disease is mainly 
distributed in the Northern hemisphere of the world with high occurence in Europe and 
America. The Centers for Disease control and prevention (CDC) reported over 24,000 cases 
of confirmed Lyme disease patients in 2011, whereas already 17,000 cases where reported 
in 2009 in the Netherlands. 
 
The disease is transmitted by ticks and caused by Borrelia species. Since the original 
description of the disease by Steere and co-workers in 1975 (1) and the discovery of the 
pathogen by Burgdorfer in 1982 (2), our knowledge of the etiology and pathogenesis of 
Lyme disease has increased tremendously. Research into Lyme disease has been triggered by 
the increasing incidence. Although practitioners still have difficulties making the diagnosis, 
signs and symptoms of the infection are nowadays better recognized and this results in early 
antibiotic treatment in many patients. In approximately 10% of the patients symptoms may 
persist, even despite after antibiotic treatment (3). To what extent the prolonged illness is 
due to persistent infection is controversial. More insight into the pathogenesis of Lyme 
disease will help in the management of Lyme disease patients to develop novel treatment 
modalities in the future. This review gives an update on Borrelia recognition by the host 
defense system, the downstream signaling pathways, cytokine production, and effector 
mechanisms. 
 
Borrelia characteristics and early host defense  
Borrelia is a Gram-negative bacterium which can be easily recognizes based on morphology. 
The spirochetal flat-waved body of Borrelia is comparable to Treponema spp., but differs 
from other members of the family of Leptospiraceae (4).  At least three genospecies of the 
Borrelia burgdorferi sensu lato complex cause Lyme disease in humans, respectively Borrelia 
burgdorferi, Borrelia garinii, and Borrelia afzelii. B.burgdorferi is mainly found in ticks from 
the USA, causing predominantly arthritis, whereas B.garinii and B.afzelii cause neurological 
and skin disorders in Eurasia (5).  Borrelia has a typical coiled spiral shape, with lengths 
ranging from 3 to 500 µM, and a diameter ranging from 0.09 to 0.75 µM (6). This variation in 
diameter might be dependent on the environment where the spirochetes were originated, 
but not crucial for their pathogenic behavior. For example, the typical coiled shape Borrelia 
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was not detected in biopsies from kidney or erythema migrans, whereas straightened 
bacteria were found in solid tissues (7). Flagellin-lacking spirochetes could be detected in 
myocardial infection in macaques.  
Borrelia has a complex, but relatively small, genome displaying several circular and linear 
plasmids (8).  Borrelia has 21 plasmids, of which 9 circular and the others linear, thereby 
expressing the most plasmids of all prokrayotes (6). In contrast to other Gram-negative 
bacteria, Lipopolysaccharide (LPS) is not expressed by this bacterium, neither the genes 
encoding for this group of proteins (9).  
When injected into the bloodstream of the host by the tick, Borrelia is unable to protect 
itself from degradation by proteases that are released by the immune system of the human 
host (8, 10, 11). To protect itself, Borrelia spirochetes express a variety of  proteins on its 
outer surface that modulates the defense of the host. One family of proteins expressed by 
Borrelia belongs to the outer surface proteins (OSP) family, of which OspA and OspC are best 
known. OspC is expressed during early stages of infection, and has recently been described 
to bind host plasminogen thereby  preventing degradation of the bacterium when it has 





Figure 1. Borrelia expressed OspC can be recognized through Complement receptor 3. Borrelia 
spirochetes express linear as well as plasmid DNA structures that encode immune evasion genes. 
Borrelia  binds to host plasminogen, subsequently inhibiting the capacity of the host immune system 
to recognize it. After transmission of Borrelia, outer surface protein (Osp) C of the pathogens are 
expressed on the surface of the pathogen, which can be recognized by receptors of the host white 
blood cells (WBC) such as complement receptors (CR). Borrelia-directed immune responses and 
production of cytokines are initiated after activation of complement receptors on host cells. 
 
OspC bound to plasminogen makes it difficult for the host immune system to recognize the 
microorganism. Other surface proteins of Borrelia (such as decorin-binding proteins and 
complement regulator proteins) also contribute to protection of the bacterium against 
degradation by the host defense system.  
 
The immune system of the host is able to react to these incoming bacteria in a short 
timeframe with a wide area of different immune cells. Already in 1984 it was described that 
(parts of) disseminated Borrelia could be recognized and phagocytosed by macrophages, but 
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also neutrophils (13). The role of neutrophils in the early response against Borrelia could be 
further underlined when phagocytosis of Borrelia by human neutrophils could be 
demonstrated using electronmicroscopy (14). Next to phagocytosis, neutrophils are also 
capable of eliminate Borrelia by oxidative burst, and release of hydrolytic enzymes. The 
presence of chemoattractants for polymorphonuclear leukocytes was also detected in 
synovial fluids from Borrelia-infected knee joints (15). 
Recently, Borrelia was shown unable to inhibit the formation of neutrophil extracellular 
traps (NETs). Also the proteins found in the tick saliva, which are known to have immune 
inhibitory capacities, were incapable to influence the formation of NETs (16).  
 
T helper 1 (Th1) cells seem to be among the main players in both the innate and the adaptive 
immune responses against Borrelia. OspC molecules are able to induce a strong Th1-like 
immune response (17), leading to the production of Interferon-γ, and sizable amounts of 
interleukin (IL)-1β, IL-6, and IL-8 (18). This is the rationale why OspC has been proposed as a 
vaccine candidate. Indeed, an experimental recombinant OspC vaccine in mice induced 
protective Th1 responses and a strong anti-OspC IgG2 response (19).  
 
Complement activation and Borrelia killing 
The complement system is part of the innate immune response and able to response within 
hours after infection  is established. The complement system can be activated in three 
different ways; through the classical activation pathway, the lectin activation pathway, and 
the alternative pathway. All three activation pathways can be activated after Borrelia 
infection (20). 
Complement factor C1q binds on the surface of the bacterium and thereafter the 
complement cascade is activated leading to activation of C2 and C4 via the classical 
activation pathway (20). Activation of the lectin pathway is caused by binding of mannose 
binding lectin to the surface of Borrelia, thereby activating C3 convertase, cleaving C3 into 
C3b, and finally causing lysis of cells by the membrane attack complex. The C3 molecule 
binds covalently to proteins expressed by Borrelia, and this results in opsonisation of the 
pathogen. The opsonised Borrelia is recognized by complement receptor (CR)1, CR2, CR3 on 
phagocytic cells. CR1 and CR2 are not the major complement receptors involved in Borrelia 
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recognition, although in mice lacking CR1 and CR2, there was less production of antibodies 
against Borrelia than in wild-type animals (21). Nevertheless, the severity of Borrelia-induced 
arthritis was similar.  
Borrelia induces increased expression of CR3 on polymorphonuclear neutrophils (PMNs) 
(22). Binding of Borrelia to CR3, which also occurs directly through ligation of OspA and 
OspB, induces an oxidative burst and phagocytosis (23, 24) .The opsonisation is dependent 
on CD14 (31). In mice lacking CR3 phagocytosis of Borrelia is diminished , and this leads to 
dissemination of the spirochetes, as exemplified by Borrelia-induced carditis (25). In CR3 
deficient mice with Borrelia infection elevated numbers of infiltrated macrophages and 
increased levels of chemoattractants was found in infected heart tissue. 
The complement system is able to kill several strains of Borrelia (so-called serum-sensitive 
strains). Other Borrelia-family members, including Borrelia burgdorferi B31, are able to 
survive complement killing. Membrane attack complexes cannot be formed by these strains 
(20). Borrelia is able to interfere with complement activation and complement-mediated 
lysis in a number of ways. It binds to complement factor H and factor H-like protein 1 (26). 
Complement regulator acquiring surface proteins (CRASPs) are lipoproteins on the cell 
surface of Borrelia which are able to bind factor H proteins of the complement system, that 
are described to inhibit overactivation of the complement system (27). CRASP-3, -4, and -5 
(3, 28), and OspE (29), found on the surface of Borrelia, are able to interfere with 
complement activation. Borrelia was also found to bind to C4 binding protein, an inhibitor of 
the classical pathway that binds to C4b thereby preventing C2 binding and formation of the 
C3 convertase C4b2a (30). In addition, Borrelia makes use of the complement-regulator 
proteins from the tick (tick salivary protein 8 and 15 (31, 32), to inhibit the complement 
system.  
 
Pattern recognition receptors (PRR) involved in Borrelia detection 
Immune cells have to be activated before cytokines or chemokines can be produced. One of 
the activation mechanisms is induced by the recognition of highly specific microbial ligands 
called pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors 
(PRRs). Several families of PRRs have been described, including Toll-like receptors (TLRs), 
Nod-like receptors (NLRs), C-type lectins (CTLs), and RigI-helicases.  
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Toll like receptors (TLRs) 
The TLR-family comprises 11 human and 13 murine receptors. TLR1, TLR2, TLR4, TLR6, and 
TLR10 are mainly found on the surface of cells whereas TLR3, TLR7, TLR8, and TLR9 are 
located intracellularly. TLR11 is nonfunctional in humans due to an early stopcodon in the 
coding gene (33). Each of the TLRs recognizes a specific set of microbial ligands. TLR1/TLR2 
heterodimers recognize triacetylated bacterial peptides, while TLR2/TLR6 complexes 
recognize mainly diacetylated bacterial peptides (34, 35). TLR3 recognizes double stranded 
RNA as found in viruses, while TLR7 and TLR8  recognize viruses through single stranded 
RNA. TLR9 recognizes bacterial DNA structures with a CpG motif (36), while the ligands for 
TLR10 are not yet known. 
  
Role of TLR1, TLR2, and TLR6 for Borrelia recognition and the pathogenesis of Lyme disease 
By recognizing lipopeptides from Borrelia species (figure 2) (37, 38), TLR2 is a key recognition 
receptor in Lyme disease. TLR2 recognizes the lipoprotein OspA of Borrelia bacteria (39). 
Blockade of TLR2 leads to an abrogated immune responses by Borrelia (40). Furthermore, 
variations in the human TLR2 gene appear to result in different clinical outcomes in Lyme 
disease (41).  
 
Figure 2. Recognition and function of specific pattern recognition receptors. Borrelia spirochetes can 
be recognized by several different PRRs. Each of these PRR will induce different immune responses 
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against Borrelia. In addition, Toll-like receptor family members, C-type lectin and NOD-like receptor 
family members are described to play a role in Borrelia-induced immune responses 
 
TLR2 needs heterodimerization for signaling. This heterodimerization occus with TLR1, TLR6, 
and TLR10. By interacting with a relatively large array of co-receptors, TLR2 is able to 
recognize a broad range of microbial ligands, including peptidoglycans, lipopeptides and 
fungal polysaccharides (42). Until recently, it was unclear whether Borrelia was  recognized 
by either TLR2/6 or TLR1/2 heterodimers. An in vitro study using RNA silencing, showed that 
both TLR1 and TLR2 are important in Borrelia recognition in a human monocytic cell line 
(THP-1) (43). After silencing of either TLR1 or TLR2, reduced amounts of the pro-
inflammatory cytokines IL-6 and TNF-α were observed when THP-1 cells were exposed to live 
Borrelia. We could corroborated these findings by using peripheral blood mononuclear cells 
(PBMCs) bearing single nucleotide polymorphisms (SNPs) leading to dysfunctional TLR 
molecules. Individuals carrying SNPs in the TLR1 gene displayed abrogated cytokine 
responses after Borrelia stimulation, whereas a specific SNP in the TLR6 gene did not affect 
cytokine induction by Borrelia (44). Moreover, in TLR2-transfected human endothelial cells, 
it was demonstrated that additional transfection of TLR6 inhibited the response after OspA 
stimulation (45). TLR6 gene expression was downregulated after stimulation of human 
monocytes with live Borrelia (46). Cells isolated from mice lacking TLR6 displayed the same 
cytokine response to OspA exposure as wild-type animals (34). Taken together, it can be 
concluded that TLR1, rather than TLR6, is involved in the recognition of Borrelia by the host 
defense system.  
 
These data are supported by a study showing that TLR1 and TLR2 are important in a murine 
model of Lyme disease. Wooten et al. demonstrated that higher spirochetal numbers were 
found in joints of TLR2-deficient mice infected with Borrelia (41). Higher amounts of Borrelia 
were also be observed in skin and bladder of TLR1/2 deficient mice (47). In addition, 
Borrelia-induced Lyme arthritis was significantly enhanced in mice missing TLR1 or TLR2, as 
demonstrated by increased cell influx (48, 49). TLR1/2 heterodimers are therefore crucial for 
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TLR3 
TLR3 is a receptor for double stranded viral RNA and induces production of type I interferons 
(50). Although it is currently not known whether Borrelia PAMPs are recognized by TLR3, 
type I interferon transcription and production induced by Borrelia species has been 
described (Figure 2) (46, 50). As will be discussed below, TLRs other than TLR3, such as TLR7 
and TLR8, are able to induce Borrelia-dependent type I interferon production (51). 
 
TLR4 
Borrelia spirochetes lack LPS on their membrane, due to the fact that Borrelia misses the 
DNA sequence for enzymes necessary for synthesis of the polysaccharide tail of LPS (8, 9). 
Hence they miss a major TLR4 ligand and as expected, no differences in cytokine reponse 
could be observed between murine TLR4-deficient cells and normal murine cells exposed to 
Borrelia (40). Still there is one study describing a role for TLR4: suppression of Lyme arthritis 
mice lacking TLR4,developed and macrophages isolated from these mice produced less IL-12 
and TNF-α after Borrelia exposure in vivo (52).The mRNA expression for TLR4 in human 
peripheral blood mononuclear cells is even downregulated by in vitro exposure to Borrelia, 
pointing at a minor role for this PRR in the recognition (53).  
 
The co-receptor for TLR4, CD14, is known to exhibit its own pathogen-recognizing capacity 
by interacting with bacterial cell wall components (54). CD14 on human cells recognizes 
whole Borrelia organisms and more specifically OspA (Figure 2)(55). OspA not only activates 
CD14, but also upregulates the CD14 gene in human primary cells (56, 57). The relevance of 
CD14 activation in host defense against Borrelia is exemplified by experiments with mice 
deficient in CD14. These mice produce more cytokines after Borrelia injection, display more 
severe joint inflammation  and exhibit prolonged duration of disease (58). This is due to the 
fact that activated CD14 is able to upregulate the suppressor of cytokine signaling (SOCS); 
thus in the absence of CD14, this inhibitory loop is not activated leading to exaggerated TNF-
α and IFN-γ production . CD14 is also linked to the influx of neutrophils into infected tissues 
(59), and hence a reduced neutrophil influx is seen in the CD14-deficient mice after infection 




TLR5 recognizes flagellin, the major component of flagellae. Although Borrelia spirochetes 
possess flagella responsible its motility, they are present in a cytoplasmic cylinder, and unlike 
most other flaggelated bacteria not on the outer side of the cell (5). This probably explains 
why TLR5 does not play a major role in the detection of Borrelia by the human defense 
system (43). This became clear in RNA silencing experiments with THP-1 cells: no difference 
in pro-inflammatory cytokine responses between TLR5 silenced cells and control cells (43). 
Still, it had been proposed that degradation of phagocytosed Borrelia bacteria may  unmask 
flagella and expose them for TLR5 sensing or that other components similar to TLR5 may be 
recognized by this PRR (60). However, using a genetically modified Borrelia lacking flagellin it 
was demonstrated that TLR5 is not important for the recognition of this bacterium and 
subsequent cytokine production by human cells (46). In humans bearing a polymorphism in 
the TLR5 gene leading to an altered TLR5 function, no differences between healthy 
individuals and patients upon Borrelia cell stimulation could be detected (61). 
 
TLR7, TLR8, and TLR9 
TLR7, TLR8 and TLR9 are Toll-like receptors that are present intracellularly (Figure 2). TLR7 
was formally known to recognize single stranded viral RNA. However, in 2009, Mancuso et al 
demonstrated that phagocytosed bacteria are also recognized by TLR7, leading to 
production of type I Interferon  (62). RNAse treatment of  Streptococcus pneumoniae or 
Lactococcus lactis almost entirely blocked IFN-β production by human dendritic cells. It is 
now well established that whole bacterial RNA induces a strong type I interferon response 
that is dependent on  TLR7, TLR8, TLR3, and possibly TLR9 (63). Also IL-1β production seems 
to be partially dependent on recognition of bacterial RNA via TLR7 (64).  
 
It was long assumed that only the proteins on the outside of Borrelia cell wall are 
responsible for the induction of inflammatory mediators. Moore et al, however, 
demonstrated that phagocytosis of Borrelia also contributes to production of 
proinflammatory mediators (65). The signaling pathways triggered by phagocytosis of 
complete Borrelia bacteria and encounter with the intracellular TLRs differ from those 
induced by OspA interacting with TLR2 on the cellular surface (46). Exposure of bone 
marrow-derived macrophages to Borrelia resulted in upregulation of interferon-regulating 
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genes, independent of MyD88 and TRIF, the co-stimulatory molecules of surface TLRs (66, 
67). After stimulation of PBMCs with Borrelia spirochetes, 50% of the upregulated genes 
were found to be inducible by the type I interferon family (Figure 2) (53). After blocking TLR7 
with the inhibitor imiquimod, Borrelia induced significantly less production of IFN-α by 
dendritic cells (53). 
 
There is some controversy regarding the role of TLR9 in Borrelia recognition. Although some 
investigators did not find a role for TLR9, others proposed involvement of TLR9 in induction 
of type I interferons after internalization of bacteria (62, 66).  Although the induction of type 
I interferons by Borrelia was not affected in TLR9-deficient murine BMDMs (66), recent 
studies with human white blood cells  show involvement of TLR9 in the type I IFN induction 
by Borrelia (53). Blocking TLR9 with specific inhibitors, almost completely abrogated 
production of IFN-α. Whether TLR7 and TLR9 require cooperation with other PRR for proper 
downstream signaling is unknown. 
 
Cervantes et al. showed recently that cooperation between TLR2 and TLR8 is needed for the 
induction of type I interferons in human mononuclear cells (Figure 2) (51). To this end 
Borrelia-activated TLR2 has  to establish a link with TLR8 intracellularly. TLR2 together with 
TLR8 is responsible for NFκB-dependent cytokines, whereas TLR8 alone is responsible to 
induce type I interferons after Borrelia phagocytosis. From the above it is clear that the type 
I interferons are important mediators in Borrelia infection. It should be noted however that 
they tend to enhance the inflammatory component of the infection, as murine Lyme arthritis 
was found strongly attenuated in mice receiving antibodies against type 1 interferons (66). 
 
NOD like receptors (NLR) 
Nucleotide-binding and leucine-rich repeats family members are a separate class of 
intracellular PRR. The major pattern recognition receptors within this family are the 
Nucleotide Oligomerization Domain (NOD) members 1 and 2, as well as the NLRP receptors 
that are involved inflammasome activation. NOD1 is activated by muramyltripeptide (MTP), 
derived from Gram-negative bacteria while NOD2 is activated by muramyldipeptide (MDP) 
from Gram-positive bacteria. After activation of either NOD1 or NOD2 by these bacterial 
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moieties, activation of the adaptor molecule RICK finally leads to transcription of NFкB and 
production of pro- and anti-inflammatory cytokines.  
 
Although Borrelia is a Gram-negative organism, it has been shown that NOD2 is involved in 
Borrelia-induced cytokine responses of human PBMCs (40). Individuals bearing a genetic 
polymorphism leading to a dysfunctional NOD2 molecule display a decreased cytokine 
production. In mice lacking NOD2, cytokine production after Borrelia stimulation of BMDMs 
is also lower (68), as the production of cytokines by synovial tissue of NOD2 deficient mice 
injected with Borrelia (69). However, then inhibition of cytokine production was not 
complete, indicating that NOD2-independent signaling pathways are present. The NOD2-
deficient BMDMs exposed to Borrelia also exhibit a downregulated type I interferon 
response (68), but as discussed in the paragraphs on TLR7,8 and 9, the type I interferon 
signaling pathways in mice are for a large part independent of NOD2 (67). Despite these 
effects on production of type I interferons and other cytokines, we were unable to 
demonstrate that NOD2 is important for the development of Borrelia-induced arthritis in 
mice (69); the cell influx in the synovial cavity of NOD2-deficient mice was similar to that of 
wild-type animals. This was a discrepancy with the study of Petnicki-Ocwieja showing that 
mice lacking NOD2 develop more severe arthritis than wild-type mice (68). An explanation 
for these divergent findings may be the model. In our experiments we investigated the local 
development of disease after intra-articular injection, whereas Petnicki-Ocwieja et al studied 
dissemination of the infection starting with a local injection of Borrelia.  
The role of the NOD adaptor molecule has also been studied in the context of Lyme 
borreliosis. When RICK was blocked with a specific inhibitor, primary human cells exposed to 
Borrelia resulted in abrogated cytokine responses (40). However, RICK was not found to play 
an important role in our murine model of Lyme arthritis (69). 
 
Inflammasomes 
NLRP3 and ASC are also receptors belonging to the NLR family. These proteins are essential 
elements of the NLRP3 inflammasome. The latter is a complex of homo- and heterodimers of 
proteins that is built up upon an activating signal. The formation of the inflammasome leads 
to activation of caspase-1, the enzyme that cleaves inactive pro-IL-1β and pro IL-18 to 
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generate bioactive IL-1β and IL-18, respectively. Indeed, after exposure to Borrelia in mice, 
caspase-1 is important for the induction of IL-1β and IL-18 (70).  
ASC was found to be of key importance in the formation of Borrelia-induced IL-1β in mice, 
and in the development of murine Lyme arthritis. Unexpectedly, NLRP3, considered as the 
key component of the inflammasome was unable to produce IL-1β upon Borrelia stimulation 
and the severity of Lyme arthritis was not reduced in mice lacking this NLR member (69). 
The activation of ASC and NLRP3 appeared to be dependent on caspase-1 (61).  
 
Next to NLRP3, also AIM2 and IPAF are known to function in inflammasomes thereby 
cleavind caspase-1 as well. AIM2 recognizes dsDNA from Gram-negative intracellular 
bacteria, whereas IPAF can be activated through Gram-negative bacteria expressing type III 
or IV secretion systems (71). To date, no studies about the role of AIM2 nor IPAF 
inflammasomes in the pathogenesis of Borrelia have been performed. A role for AIM2 in 
caspase-1 cleavage after Borrelia recognition might be present, since Borrelia is described to 
express a broad range of plasmids with variable DNA structures (72).  A role for IPAF seems 
unlikely since type III or IV secretion systems in this bacteria are not found (73).   
 
C-type lectin Receptors 
The best known members of the C-type lectin receptors (CLR) family are Dectin-1, Dectin-2, 
Mannose receptor (MR), Mincle, and DC-SIGN. Some of the CLR family members can be 
activated directly through ligand binding, while others require additional signaling adaptor 
molecules (74). These receptors are PRRs that mainly recognize carbohydrates. According to 
a recent study the tick protein Salp15 is also recognized by the C-type lectin receptor DC-
SIGN (75).  
 
Dectin-1 is expressed on a variety of immune cells, including monocytes and macrophages, 
and is upregulated by stimulation with pathogens or specific ligands including β-glucans (76). 
Dectin-1 synergizes with TLR receptors for the production of cytokines and chemokines, 
including IL-1β. After activation of Dectin-1, Syk or Raf-1-proteins are recruited, followed by 
binding to CARD9 and activation of NFκB pathway (77). It is unknown whether Dectin-1 is 
involved in the recognition of Borrelia species. Although Borrelia spirochetes do not express 
beta-glucans, the typical ligands for Dectin-1, they are able to express 4-alpha-
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glucanotransferase, an enzyme that is able to transfer a segment of glucans 
[borreliagenome.org]. Next to that, they possess lectins such as galactopyranosides, which 
might interact with lectin receptors present on immune cells (78, 79).  Individuals carrying 
mutated Dectin-1 or CARD9 proteins display a disturbed cytokine production when 
stimulated with Candida albicans (80, 81). We investigated the cytokine response of PBMCs 
from individuals with either the Dectin-1 or CARD9 mutation to live Borrelia , and found no 
functional changes [Oosting et al., manuscript in preparation]. Dectin-1 also mediates Th17 
responses after Candida recognition (74). Although IL-17 seems to play a role in Lyme 
disease, it is unknown whether dectin-1 is involved here (82, 83).  
 
Dectin-2 was also described to be involved in Th17 responses (84). Dectin-2 contributes to 
the production of pro-inflammatory cytokines, including IL-1β, after Candida exposure. 
Whether there is a role for Dectin-2 in Borrelia-recognition is unknown.  
 
Not much is known about the recognition of bacteria by the Mannose Receptor (MR), but a 
recent study shows that MR binds to the surface of Borrelia (Figure 2) (85).  No data 
available on the role of MR in the immune response against Borrelia. Some DNA sequences 
encoding for mannose structures are present in the Borrelia genome, but whether these 
structures bind to mannose receptor is unknown[borreliagenome.org].  
 
Borrelia antigens, injected into the skin of healthy volunteers, let to increased transcription 
of TLR1 and TLR2, as well as to upregulation of DC-SIGN on dendritic cells, monocytes, and 
macrophages (86). A direct interaction between Borrelia spirochetes and DC-SIGN could 
however not be demonstrated. As mentioned above, a role for DC-SIGN in the interaction 
with tick salivary protein Salp15, and Borrelia, was found (75). Salp15 was shown to inhibit 
the production of pro-inflammatory cytokines induced by Borrelia in human DCs, and it has 
been proposed that the latter mechanism enhances the chance of survival of Borrelia shortly 
after transmission to the host. 
 
RIG-I like receptors 
A third partner in the pattern recognition receptor family is the RIG-I like receptors, 
consisting out of three members, RIG-I, MDA5, and LGP2 (87). These receptors mainly play a 
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role in the recognition of viral particles. Cells without these receptors were described to be 
incapable of type I interferon production upon viral challenge (88). A role for RIG-I like 
receptors in Borrelia is not described so far, but might be present in the production of type I 
interferons after Borrelia infection (see also section TLR7, TLR8, and TLR9). 
 
Signaling pathways induced by Borrelia 
After recognition of Borrelia by immune cells, phagocytosis and intracellular signaling 
pathways are triggered. Which signaling cascades are activated depends on the type of PRR 
engaged. TLR8 together with TLR2 are major PRRs  in the phagocytosis of Borrelia. Next to 
that, the intracellular kinase PI3K is involved in the uptake of Borrelia species, the MAP 
kinases JNK, and ERK, and the components of the JAK/STAT pathway do not seem to be 
involved in phagocytosis (50). PI3K acts as a kinase in the downstream signaling cascade of 
TLR1, TLR2, and TLR6.  
 
MyD88 is the signaling adaptor used by almost all TLR family members, and is crucial for 
induction of cytokine production. MyD88 forms a signaling complex which is called the 
Mydosome, that includes proteins such as mitogen-activated protein kinases (MAPK), IRAK2 
and IRAK4. MyD88 signaling results in activation of NFκB and gene transcription in the 
nucleus will be initiated. MyD88-deficient mice are highly susceptible to the development of 
Lyme arthritis. The spirochetal loads in joints of these mice are 100 times higher than of 
wild-type mice (89, 90). In humans, the role of MyD88 in the development of Lyme disease is 
not established. Individuals with rare deficiencies for MyD88 or IRAK4 are known to suffer 
from severe bacterial infections, indicating that MyD88-mediated pathways are crucial for 
defense against bacteria (91).  
 
SNPs in MyD88 leading to functional defects in the response against pathogens have not 
been described, but SNPs in proteins downstream of MyD88 are known to result in different 
infection rates. For example, a polymorphism in MyD88-adaptor like (Mal/TIRAP) was 
described to decrease the risk to develop complicated infections in HIV patients fourfold 
(92). SNPs in signal adaptor molecules such as MyD88, TRIF, or Mal/TIRAP in relation to the 
severity of Lyme disease have not been investigated. 
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The role of MyD88 in Borrelia-induced activation of immune cells in vitro has been well 
studied (69, 93). Silencing of MyD88 mRNA in THP-1 cells abrogated cytokine production 
after Borrelia exposure (43). In contrast, MyD88-deficient mouse macrophages incubated 
with Borrelia exhibited normal type I interferon production (67), pointing to differences in 
signaling between mice and men. Borrelia is able to activate the MAPK pathways in a way 
dependent on JAK-STAT-  and p38-signaling (94, 95). However, these kinases are not 
required for phagocytosis of Borrelia (60). The role of p38 was also established in vivo; mice 
lacking p38 kinase developed significantly less Borrelia-induced arthritis than wild-type mice 
(94). This effect lasted 8 weeks after onset of arthritis, indicating that p38 is not only 
involved in the early recognition phase of Borrelia, but also in the control of arthritis.  
The development and severity of the Borrelia-induced arthritis might be highly dependent 
on cytokine production. The TLRs family are main receptors for Borrelia, and almost all 
member need MyD88 for signaling. Less cytokine production might cause an outgrowth 
causing arthritis. On the other hand, when p38 is missing, the other signaling pathways 
might take over the induction of NFкB, thereby inducing cytokines which will lead to less 
arthritis. 
 
Other TLR adaptor molecules also contribute to downstream signaling after Borrelia 
recognition by immune cells. MyD88-deficient mouse cells were found to be incapable of 
phagocytosing Borrelia (50). When murine MyD88 deficient cells were pre-treated with poly 
I:C, a ligand for TLR3, phagocytosis of Borrelia by these cells could be restored (50). The 
explanation is that TLR3 is able to transduce signals through the adaptor molecule TRIF, 
independently of MyD88. Likewise, phagocytosis of Borrelia by MyD88-deficient cells could 
be restored by transfecting CR3 (25), underlining that several pathways are activated by 
Borrelia to induce downstream signaling (25). Borrelia also induces interferon regulatory 
factors (IRFs) in a MyD88-independent fashion  (66). Borrelia exposure of human PBMCs 
resulted in a strong upregulation of type I interferon regulating genes (53). Borrelia is 
capable of activating interferon regulating genes thereby inducing interferon regulatory 
factors (IRFs), leading to a type I interferon response in both human and mouse cells. At least 
in the mouse this signaling is MyD88 and TRIF independent (67), but dependent on STAT1 
and IRF3. 
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As mentioned in the caption on TLR7, 8, and 9, the type I interferon response appears to 
enhance disease, since reduced severity of Lyme arthritis was observed in mice after 
blockade of the receptor for type I interferons (IFNAR) (66).  
 
Borrelia-induced cytokines and clinical relevance for Lyme disease  
As has become clear from the foregoing, cytokines are highly relevant in the pathogenesis of 
Lyme disease (figure 3).  
 
 
Figure 3. Borrelia induced cytokines. After recognition of Borrelia by host immune cells, induction of 
early (upper part) as well as late (lower part) cytokines is induced. Each cytokine has different 







after  recognition by attracting other  immune cells  to  the place of  infection. The cytokines 
also  induce T  lymphocyte polarization  leading  to production of  interferon‐γ  (by T helper 1 
lymphocytes) and IL‐17  (by T helper 17 cells). In skin biopsies taken from patients presenting 
with an erythema migrans, high  levels of pro‐inflammatory cytokines  including  IFN‐γ could 
be detected (98).  
Interleukin‐1 beta (IL‐1β)  is one of the cytokines that  is produced  in high concentrations  in 
both murine and human monocytes and macrophages after exposure to Borrelia species (40, 
97, 99, 100).  It was detected  in synovial  fluid of Lyme arthritis patients at early timepoints 
(101). Peptidoglycan from the cell wall of Borrelia is the main inducer of the production of IL‐
1β  (102). Mice  susceptible  for  the  development  of  Lyme  disease  (C3H/HeN  strain) were 
found to respond with high cytokine production when challenged with Borrelia spirochetes 
(103).  The  development  of  murine  Lyme  arthritis  is  critically  dependent  on  IL‐1β  as 
demonstrated  in  IL‐1R deficient mice (Figure 3) (69).  In patients with Lyme arthritis, whose 
arthritis was  reactivated after antibiotic  treatment  it was  shown  that  IL‐1β concentrations 
were higher  in synovial  fluid and tissue than  in patients that recovered from the antibiotic 
treatment (101). Still, the exact role of IL‐1β in the development of persistent Lyme disease 
is not really understood.  It  is  likely that at  least part of the effect of  IL‐1β  is  induction of a 
proper IL‐17/Th17 response against Borrelia spirochetes, with subsequent the production of 





(104).  In  the presence of Borrelia  IL‐10 decreases monocyte migration  through endothelial 
cells  in vitro  (104).  In accordance with this  finding, more spirochetes are  found  in  joints of 
mice deficient in IL‐10, albeit with a lower severity Lyme arthritis score (105). When such IL‐
10  deficient  mice  with  Lyme  arthritis  are  treated  with  antibodies  against  interferon‐γ, 
disease  severity  reduces  significantly,  indicating  that absence of  IL‐10  leads  to a disturbed 
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Th1/Th2 response (106). In addition, several chemokines including IL-8, are downregulated 
in endothelial cells exposed to Borrelia  and IL-10 (104). 
 
The role of IFN-γ, IL-17, IL-22, and IL-23. 
IFN-γ, IL-23, IL-22, and IL-17 are closely linked cytokines. IFN-γ, IL-23, and IL-22 are produced 
after recognition of Borrelia by human peripheral blood mononuclear cells (46, 99). 
Production of IL-22 and IL-17 is under control of IL-1β and IL-23, as was demonstrated in 
experiments with natural IL-1 antagonist IL-1Ra (99), and IL-1β-deficient mice (70). That IL-17 
is important for pathology may be derived from experiments in which IL-17 blockade in 
murine Lyme disease resulted in diminished joint inflammation (107, 108). IFN-γ, and IL-22 
were detected in skin biopsies from individuals with erythema migrans (Figure 3) (109), and 
IL-17 production was found in synovial cells from Lyme disease patients (110). Patients with 
proven late neuroborreliosis exhibited higher IL-17 concentrations than patients with earlier 
stages of neuroborreliosis (82). 
There is minimal evidence that IL-17 is associated with severity of disease in humans. PBMCs 
from Lyme disease patients bearing a SNP in IL-23R exposed to Borrelia show significantly 
decreased IL-17 production. The presence of this SNP was associated with a trend towards a 
lower frequency of chronic clinical Lyme symptoms. 
  
Summary  
In recent years, the knowledge of the Borrelia spirochete and Lyme disease has greatly 
increased and considerable insight into how the encounter between the microorganism and 
the host leads to disease. The inflammatory response is initiated by outer surface proteins of 
Borrelia that activate the complement system. Complement receptor 3 and CD14, both 
independently and in conjunction with members of the TLR family mediate the response of 
the host. TLR2/TLR1 heterodimer recognition of Borrelia leads to a proinflammatory cytokine 
response in Lyme disease. Next to that, TLRs known for the recognition of virus particles, 
TLR3, TLR7, TLR8, and TLR9, do also recognize Borrelia, leading to production of type I 
interferons. Additional recognition of Borrelia by NLRs, in particular NOD2, contributes to 
the type I interferon signature. The role of CLR seems to be limited in the host defense 
against Borrelia, however DC-SIGN might play a role when Borrelia is bound to the tick 
protein SALP-15.  
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Among the various cytokines induced by Borrelia, IL-1β and IL-17 seem to be the most 
important in the pathogenesis of Lyme disease. IL-1β is associated with the acute and 
chronic inflammatory processes seen in Lyme disease, whereas IL-17 seems to be confined 
to the more chronic forms. Since the precise mechanisms leading to chronic Lyme disease 
are still not known, more research is required to unravel the pathogenesis of this 
inflammatory disease. A series of relevant questions emerge from this research, such as 
which molecules derived from Borrelia drive the chronic infection? Are replicating whole 
bacteria needed for the chronic inflammation? Which host factors are responsible for the 
chronic inflammation? Would anti-inflammatory treatment targeting IL-1β or IL-17 be 
beneficial in patients with chronic Lyme disease? Future research should be directed to 
these issues.   
8
220 221 212 
References 
 
(1)  Steere AC, Malawista SE, Snydman 
DR, et al. Lyme arthritis: an epidemic 
of oligoarticular arthritis in children 
and adults in three connecticut 
communities. Arthritis and 
rheumatism 1977; 20:7-17. 
 
(2)  Burgdorfer W, Barbour AG, Hayes SF, 
Benach JL, Grunwaldt E, Davis JP. 
Lyme disease-a tick-borne 
spirochetosis? Science 1982; 
216:1317-9. 
 
(3)  Steere AC, Coburn J, Glickstein L. The 
emergence of Lyme disease. The 
Journal of clinical investigation 2004; 
113:1093-101. 
 
(4)  Charon NW, Cockburn A, Li C, et al. 
The unique paradigm of spirochete 
motility and chemotaxis. Annual 
review of microbiology 2012; 66:349-
70. 
 
(5)  Radolf JD, Caimano MJ, Stevenson B, 
Hu LT. Of ticks, mice and men: 
understanding the dual-host lifestyle 
of Lyme disease spirochaetes. 
NatRevMicrobiol 2012; 10:87-99. 
 
(6)  C.M. Olson EF, Juan Anguita. Clinical 
Immunology. Vol. 4th. 2013. 
 
(7)  Macdonald AB. Borrelia burgdorferi 
tissue morphologies and imaging 
methodologies. European journal of 
clinical microbiology & infectious 
diseases : official publication of the 
European Society of Clinical 
Microbiology 2013. 
 
(8)  Fraser CM, Casjens S, Huang WM, et 
al. Genomic sequence of a Lyme 
disease spirochaete, Borrelia 
burgdorferi. Nature 1997; 390:580-
586. 
 
(9)  Takayama K, Rothenberg RJ, Barbour 
AG. Absence of lipopolysaccharide in 
the Lyme disease spirochete, Borrelia 
burgdorferi. InfectImmun 1987; 
55:2311-2313. 
 
(10) Guyard C, Battisti JM, Raffel SJ, et al. 
Relapsing fever spirochaetes produce 
a serine protease that provides 
resistance to oxidative stress and 
killing by neutrophils. MolMicrobiol 
2006; 60:710-722. 
 
(11)  Kumru OS, Bunikis I, Sorokina I, 
Bergstrom S, Zuckert WR. Specificity 
and role of the Borrelia burgdorferi 
CtpA protease in outer membrane 
protein processing. JBacteriol 2011; 
193:5759-5765. 
 
(12)  Onder O, Humphrey PT, McOmber B, 
et al. OspC is a potent plasminogen-
receptor on the surface of Borrelia 
burgdorferi. JBiolChem 2012. 
 
(13)  Benach JL, Fleit HB, Habicht GS, 
Coleman JL, Bosler EM, Lane BP. 
Interactions of phagocytes with the 
Lyme disease spirochete: role of the Fc 
receptor. The Journal of infectious 
diseases 1984; 150:497-507. 
 
(14)  Peterson PK, Clawson CC, Lee DA, 
Garlich DJ, Quie PG, Johnson RC. 
Human phagocyte interactions with 
the Lyme disease spirochete. Infection 
and immunity 1984; 46:608-11. 
 
(15)  Georgilis K, Noring R, Steere AC, 
Klempner MS. Neutrophil chemotactic 
factors in synovial fluids of patients 
with Lyme disease. Arthritis and 
rheumatism 1991; 34:770-5. 
 
(16)  Menten-Dedoyart C, Faccinetto C, 
Golovchenko M, et al. Neutrophil 
extracellular traps entrap and kill 
Borrelia burgdorferi sensu stricto 
spirochetes and are not affected by 
Ixodes ricinus tick saliva. Journal of 
immunology 2012; 189:5393-401. 
 
 213 
(17)  Strle K, Jones KL, Drouin EE, Li X, 
Steere AC. Borrelia burgdorferi RST1 
(OspC type A) genotype is associated 
with greater inflammation and more 
severe Lyme disease. AmJPathol 2011; 
178:2726-2739. 
 
(18)  Strle K, Drouin EE, Shen S, et al. 
Borrelia burgdorferi stimulates 
macrophages to secrete higher levels 
of cytokines and chemokines than 
Borrelia afzelii or Borrelia garinii. The 
Journal of infectious diseases 2009; 
200:1936-43. 
 
(19)  Krupka M, Masek J, Bartheldyova E, et 
al. Enhancement of immune response 
towards non-lipidized Borrelia 
burgdorferi recombinant OspC antigen 
by binding onto the surface of 
metallochelating nanoliposomes with 
entrapped lipophilic derivatives of 
norAbuMDP. J Control Release 2012; 
160:374-81. 
 
(20)  de Taeye SW, Kreuk L, van Dam AP, 
Hovius JW, Schuijt TJ. Complement 
evasion by Borrelia burgdorferi: it 
takes three to tango. Trends in 
parasitology 2013; 29:119-28. 
 
(21)  Jacobson AC, Ma Y, Zachary JF, Weis 
JJ, Weis JH. Mice lacking CD21 and 
CD35 proteins mount effective 
immune responses against Borrelia 
burgdorferi infection. InfectImmun 
2007; 75:2075-2078. 
 
(22)  Cinco M, Panfili E, Presani G, 
Perticarari S. Interaction with Borrelia 
burgdorferi causes increased 
expression of the CR3 integrin and 
increased binding affinity to 
fibronectin via CR3. J Mol Microbiol 
Biotechnol 2000; 2:575-9. 
 
(23)  Garcia RC, Murgia R, Cinco M. 
Complement receptor 3 binds the 
Borrelia burgdorferi outer surface 
proteins OspA and OspB in an iC3b-
independent manner. Infection and 
immunity 2005; 73:6138-42. 
 
(24)  Suhonen J, Hartiala K, Tuominen-
Gustafsson H, Viljanen MK. Borrelia 
burgdorferi--induced oxidative burst, 
calcium mobilization, and 
phagocytosis of human neutrophils 
are complement dependent. JInfectDis 
2000; 181:195-202. 
 
(25)  Hawley KL, Olson CM, Jr., Iglesias-
Pedraz JM, et al. CD14 cooperates 
with complement receptor 3 to 
mediate MyD88-independent 




(26)  Herzberger P, Siegel C, Skerka C, et al. 
Human pathogenic Borrelia spielmanii 
sp. nov. resists complement-mediated 
killing by direct binding of immune 
regulators factor H and factor H-like 
protein 1. InfectImmun 2007; 
75:4817-4825. 
 
(27)  Kraiczy P, Skerka C, Kirschfink M, Zipfel 
PF, Brade V. Mechanism of 
complement resistance of pathogenic 




(28)  Hammerschmidt C, Hallstrom T, 
Skerka C, et al. Contribution of the 
Infection-Associated Complement 
Regulator-Acquiring Surface Protein 4 
(ErpC) to Complement Resistance of 
Borrelia burgdorferi. ClinDevImmunol 
2012; 2012:349657. 
 
(29)  Kenedy MR, Akins DR. The OspE-
related proteins inhibit complement 
deposition and enhance serum 
resistance of Borrelia burgdorferi, the 
lyme disease spirochete. InfectImmun 
2011; 79:1451-1457. 
 
(30)  Pietikainen J, Meri T, Blom AM, Meri S. 
Binding of the complement inhibitor 
C4b-binding protein to Lyme disease 
Borreliae. MolImmunol 2010; 
47:1299-1305. 
8
222 223 214 
 
(31)  Schuijt TJ, Coumou J, Narasimhan S, et 
al. A tick mannose-binding lectin 
inhibitor interferes with the 
vertebrate complement cascade to 
enhance transmission of the lyme 
disease agent. Cell HostMicrobe 2011; 
10:136-146. 
 
(32)  Schuijt TJ, Hovius JW, van Burgel ND, 
Ramamoorthi N, Fikrig E, van Dam AP. 
The tick salivary protein Salp15 
inhibits the killing of serum-sensitive 
Borrelia burgdorferi sensu lato 
isolates. InfectImmun 2008; 76:2888-
2894. 
 
(33)  Lauw FN, Caffrey DR, Golenbock DT. 
Of mice and man: TLR11 (finally) finds 
profilin. Trends Immunol 2005; 
26:509-511. 
 
(34)  Takeuchi O, Kawai T, Muhlradt PF, et 
al. Discrimination of bacterial 
lipoproteins by Toll-like receptor 6. 
IntImmunol 2001; 13:933-940. 
 
(35)  Takeuchi O, Sato S, Horiuchi T, et al. 
Cutting edge: role of Toll-like receptor 
1 in mediating immune response to 
microbial lipoproteins. JImmunol 
2002; 169:10-14. 
 
(36)  Kawai T, Akira S. The roles of TLRs, 
RLRs and NLRs in pathogen 
recognition. IntImmunol 2009; 21:317-
337. 
 
(37)  Akira S, Takeda K. Toll-like receptor 
signalling. NatRevImmunol 2004; 
4:499-511. 
 
(38)  Lien E, Sellati TJ, Yoshimura A, et al. 
Toll-like receptor 2 functions as a 
pattern recognition receptor for 
diverse bacterial products. JBiolChem 
1999; 274:33419-33425. 
 
(39)  Hirschfeld M, Ma Y, Weis JH, Vogel SN, 
Weis JJ. Cutting edge: repurification of 
lipopolysaccharide eliminates signaling 
through both human and murine toll-
like receptor 2. JImmunol 2000; 
165:618-622. 
(40)  Oosting M, Berende A, Sturm P, et al. 
Recognition of Borrelia burgdorferi by 
NOD2 is central for the induction of an 
inflammatory reaction. JInfectDis 
2010; 201:1849-1858. 
 
(41)  Wooten RM, Ma Y, Yoder RA, et al. 
Toll-like receptor 2 is required for 
innate, but not acquired, host defense 
to Borrelia burgdorferi. JImmunol 
2002; 168:348-355. 
 
(42)  Oliveira-Nascimento L, Massari P, 
Wetzler LM. The Role of TLR2 in 
Infection and Immunity. Frontiers in 
immunology 2012; 3:79. 
 
(43)  Dennis VA, Dixit S, O'Brien SM, Alvarez 
X, Pahar B, Philipp MT. Live Borrelia 
burgdorferi spirochetes elicit 
inflammatory mediators from human 
monocytes via the Toll-like receptor 
signaling pathway. InfectImmun 2009; 
77:1238-1245. 
 
(44)  Oosting M, Ter Hofstede H, Sturm P, 
et al. TLR1/TLR2 heterodimers play an 
important role in the recognition of 
Borrelia spirochetes. PLoSOne 2011; 
6:e25998. 
 
(45)  Bulut Y, Faure E, Thomas L, Equils O, 
Arditi M. Cooperation of Toll-like 
receptor 2 and 6 for cellular activation 
by soluble tuberculosis factor and 
Borrelia burgdorferi outer surface 
protein A lipoprotein: role of Toll-
interacting protein and IL-1 receptor 
signaling molecules in Toll-like 
receptor 2 signaling. JImmunol 2001; 
167:987-994. 
 
(46)  Salazar JC, Duhnam-Ems S, La VC, et al. 
Activation of human monocytes by live 
Borrelia burgdorferi generates TLR2-
dependent and -independent 
responses which include induction of 




(47)  Fikrig E, Narasimhan S, Neelakanta G, 
Pal U, Chen M, Flavell R. Toll-like 
receptors 1 and 2 heterodimers alter 
Borrelia burgdorferi gene expression 
in mice and ticks. JInfectDis 2009; 
200:1331-1340. 
 
(48)  Alexopoulou L, Thomas V, Schnare M, 
et al. Hyporesponsiveness to 
vaccination with Borrelia burgdorferi 
OspA in humans and in. NatMed 2002; 
8:878-884. 
 
(49)  Wang X, Ma Y, Yoder A, et al. T cell 
infiltration is associated with 
increased Lyme arthritis in TLR2-/- 
mice. FEMS ImmunolMedMicrobiol 
2008; 52:124-133. 
 
(50)  Shin OS, Miller LS, Modlin RL, Akira S, 
Uematsu S, Hu LT. Downstream signals 
for MyD88-mediated phagocytosis of 
Borrelia burgdorferi can be initiated 
by TRIF and are dependent on PI3K. 
JImmunol 2009; 183:491-498. 
 
(51)  Cervantes JL, Dunham-Ems SM, La 
Vake CJ, et al. Phagosomal signaling by 
Borrelia burgdorferi in human 
monocytes involves Toll-like receptor 
(TLR) 2 and TLR8 cooperativity and 




(52)  Glickstein LJ, Coburn JL. Short report: 
Association of macrophage 
inflammatory response and cell death 
after in vitro Borrelia burgdorferi 
infection with arthritis resistance. 
AmJTropMedHyg 2006; 75:964-967. 
 
(53)  Petzke MM, Brooks A, Krupna MA, 
Mordue D, Schwartz I. Recognition of 
Borrelia burgdorferi, the Lyme disease 
spirochete, by TLR7 and TLR9 induces 
a type I IFN response by human 
immune cells. JImmunol 2009; 
183:5279-5292. 
 
(54)  Pugin J, Heumann ID, Tomasz A, et al. 
CD14 is a pattern recognition 
receptor. Immunity 1994; 1:509-516. 
(55)  Giambartolomei GH, Dennis VA, 
Lasater BL, Philipp MT. Induction of 
pro- and anti-inflammatory cytokines 
by Borrelia burgdorferi lipoproteins in 
monocytes is mediated by CD14. 
InfectImmun 1999; 67:140-147. 
 
(56)  Cabral ES, Gelderblom H, Hornung RL, 
Munson PJ, Martin R, Marques AR. 
Borrelia burgdorferi lipoprotein-
mediated TLR2 stimulation causes the 
down-regulation of TLR5 in human 
monocytes. JInfectDis 2006; 193:849-
859. 
 
(57)  Sellati TJ, Bouis DA, Kitchens RL, et al. 
Treponema pallidum and Borrelia 
burgdorferi lipoproteins and synthetic 
lipopeptides activate monocytic cells 
via a CD14-dependent pathway 
distinct from that used by 
lipopolysaccharide. JImmunol 1998; 
160:5455-5464. 
 
(58)  Sahay B, Patsey RL, Eggers CH, Salazar 
JC, Radolf JD, Sellati TJ. CD14 signaling 
restrains chronic inflammation 
through induction of p38-MAPK/SOCS-
dependent tolerance. PLoSPathog 
2009; 5:e1000687. 
 
(59)  Sahay B, Singh A, Gnanamani A, Patsey 
RL, Blalock JE, Sellati TJ. CD14 signaling 
reciprocally controls collagen 
deposition and turnover to regulate 
the development of lyme arthritis. 
AmJPathol 2011; 178:724-734. 
 
(60)  Shin OS, Isberg RR, Akira S, Uematsu S, 
Behera AK, Hu LT. Distinct roles for 
MyD88 and Toll-like receptors 2, 5, 
and 9 in phagocytosis of Borrelia 
burgdorferi and cytokine induction. 
InfectImmun 2008; 76:2341-2351. 
 
(61)  Strle K, Shin JJ, Glickstein LJ, Steere AC. 
Association of a Toll-like receptor 1 
polymorphism with heightened Th1 
inflammatory responses and 
8
224 225 216 
antibiotic-refractory Lyme arthritis. 
Arthritis and rheumatism 2012; 
64:1497-507. 
(62)  Mancuso G, Gambuzza M, Midiri A, et 
al. Bacterial recognition by TLR7 in the 
lysosomes of conventional dendritic 
cells. NatImmunol 2009; 10:587-594. 
 
(63)  Kariko K, Buckstein M, Ni H, Weissman 
D. Suppression of RNA recognition by 
Toll-like receptors: the impact of 
nucleoside modification and the 
evolutionary origin of RNA. Immunity 
2005; 23:165-175. 
 
(64)  Eberle F, Sirin M, Binder M, Dalpke 
AH. Bacterial RNA is recognized by 
different sets of immunoreceptors. 
EurJImmunol 2009; 39:2537-2547.
 
(65)  Moore MW, Cruz AR, LaVake CJ, et al. 
Phagocytosis of Borrelia burgdorferi 
and Treponema pallidum potentiates 
innate immune activation and induces 
gamma interferon production. 
InfectImmun 2007; 75:2046-2062. 
 
(66)  Miller JC, Ma Y, Bian J, et al. A critical 
role for type I IFN in arthritis 
development following Borrelia 
burgdorferi infection of mice. 
JImmunol 2008; 181:8492-8503. 
 
(67)  Miller JC, Maylor-Hagen H, Ma Y, Weis 
JH, Weis JJ. The Lyme disease 
spirochete Borrelia burgdorferi utilizes 
multiple ligands, including RNA, for 
interferon regulatory factor 3-
dependent induction of type I 
interferon-responsive genes. 
InfectImmun 2010; 78:3144-3153. 
 
(68)  Petnicki-Ocwieja T, DeFrancesco AS, 
Chung E, et al. Nod2 suppresses 
Borrelia burgdorferi mediated murine 
Lyme arthritis and carditis through the 
induction of tolerance. PLoSOne 2011; 
6:e17414. 
 
(69)  Oosting M, Buffen K, Malireddi SR, et 
al. Murine Borrelia arthritis is highly 
dependent on ASC and caspase-1, but 
independent of NLRP3. Arthritis 
research & therapy 2012; 14:R247. 
 
(70)  Oosting M, van d, V, Kanneganti TD, et 
al. Borrelia species induce 
inflammasome activation and IL-17 
production through a caspase-1-
dependent mechanism. EurJImmunol 
2011; 41:172-181. 
 
(71)  Schroder K, Tschopp J. The 
inflammasomes. Cell 2010; 140:821-
32. 
 
(72)  Stewart PE, Byram R, Grimm D, Tilly K, 
Rosa PA. The plasmids of Borrelia 
burgdorferi: essential genetic 
elements of a pathogen. Plasmid 
2005; 53:1-13. 
 
(73)  Kerr JR. Cell adhesion molecules in the 
pathogenesis of and host defence 
against microbial infection. Molecular 
pathology : MP 1999; 52:220-30. 
 
(74)  Vautier S, Sousa MG, Brown GD. C-
type lectins, fungi and Th17 responses. 
Cytokine Growth Factor Rev 2010; 
21:405-412. 
 
(75)  Hovius JW, de Jong MA, den DJ, et al. 
Salp15 binding to DC-SIGN inhibits 
cytokine expression by impairing both 
nucleosome remodeling and mRNA 
stabilization. PLoSPathog 2008; 4:e31. 
 
(76)  Reid DM, Gow NA, Brown GD. Pattern 
recognition: recent insights from 
Dectin-1. CurrOpinImmunol 2009; 
21:30-37. 
 
(77)  Gringhuis SI, den DJ, Litjens M, et al. 
Dectin-1 directs T helper cell 
differentiation by controlling 
noncanonical NF-kappaB activation 
through Raf-1 and Syk. NatImmunol 
2009; 10:203-213. 
 
(78)  Lee RT, Ichikawa Y, Allen HJ, Lee YC. 
Binding characteristics of galactoside-
binding lectin (galaptin) from human 
 217 
spleen. JBiolChem 1990; 265:7864-
7871. 
 
(79)  Stubs G, Fingerle V, Zahringer U, 
Schumann RR, Rademann J, Schroder 
NW. Acylated cholesteryl galactosides 
are ubiquitous glycolipid antigens 
among Borrelia burgdorferi sensu lato. 
FEMS ImmunolMedMicrobiol 2011; 
63:140-143. 
 
(80)  Rosentul DC, Plantinga TS, Oosting M, 
et al. Genetic variation in the dectin-
1/CARD9 recognition pathway and 
susceptibility to candidemia. JInfectDis 
2011; 204:1138-1145. 
 
(81)  Ferwerda B, Ferwerda G, Plantinga TS, 
et al. Human dectin-1 deficiency and 
mucocutaneous fungal infections. 
NEnglJMed 2009; 361:1760-1767. 
 
(82)  Henningsson AJ, Tjernberg I, Malmvall 
BE, Forsberg P, Ernerudh J. Indications 
of Th1 and Th17 responses in 
cerebrospinal fluid from patients with 
Lyme neuroborreliosis: a large 
retrospective study. 
JNeuroinflammation 2011; 8:36. 
 
(83)  Nardelli DT, Luedtke JO, Munson EL, 
Warner TF, Callister SM, Schell RF. 
Significant differences between the 
Borrelia-infection and Borrelia-
vaccination and -infection models of 




(84)  Robinson MJ, Osorio F, Rosas M, et al. 
Dectin-2 is a Syk-coupled pattern 
recognition receptor crucial for Th17 
responses to fungal infection. 
JExpMed 2009; 206:2037-2051. 
 
(85)  Cinco M, Cini B, Murgia R, Presani G, 
Prodan M, Perticarari S. Evidence of 
involvement of the mannose receptor 
in adhesion of Borrelia burgdorferi to 
monocyte/macrophages. InfectImmun 
2001; 69:2743-2747. 
(86)  Salazar JC, Pope CD, Moore MW, Pope 
J, Kiely TG, Radolf JD. Lipoprotein-
dependent and -independent immune 
responses to spirochetal infection. 
ClinDiagnLab Immunol 2005; 12:949-
958. 
 
(87)  Yoneyama M, Kikuchi M, Matsumoto 
K, et al. Shared and unique functions 
of the DExD/H-box helicases RIG-I, 
MDA5, and LGP2 in antiviral innate 
immunity. Journal of immunology 
2005; 175:2851-8. 
 
(88)  Kato H, Takahasi K, Fujita T. RIG-I-like 
receptors: cytoplasmic sensors for 
non-self RNA. Immunological reviews 
2011; 243:91-8. 
 
(89)  Bolz DD, Sundsbak RS, Ma Y, et al. 
MyD88 plays a unique role in host 
defense but not arthritis development 
in Lyme disease. JImmunol 2004; 
173:2003-2010. 
 
(90)  Liu N, Montgomery RR, Barthold SW, 
Bockenstedt LK. Myeloid 
differentiation antigen 88 deficiency 
impairs pathogen clearance but does 
not alter inflammation in Borrelia 
burgdorferi-infected mice. 
InfectImmun 2004; 72:3195-3203. 
 
(91)  Picard C, Casanova JL, Puel A. 
Infectious diseases in patients with 
IRAK-4, MyD88, NEMO, or 
IkappaBalpha deficiency. Clinical 
microbiology reviews 2011; 24:490-7. 
 
(92)  Papadopoulos AI, Ferwerda B, 
Antoniadou A, et al. Association of 
Mal/TIRAP S180L variant 
polymorphism with decreased 
infection risk in patients with 
advanced HIV-1 infection. Cytokine 
2012. 
 
(93)  Behera AK, Hildebrand E, Bronson RT, 
et al. MyD88 deficiency results in 
tissue-specific changes in cytokine 
induction and inflammation in 
interleukin-18-independent mice 
8
226 227 218 
infected with Borrelia burgdorferi. 
Infection and immunity 2006; 
74:1462-70. 
 
(94)  Anguita J, Barthold SW, Persinski R, et 
al. Murine Lyme arthritis development 
mediated by p38 mitogen-activated 
protein kinase activity. JImmunol 
2002; 168:6352-6357. 
 
(95)  Behera AK, Thorpe CM, Kidder JM, 
Smith W, Hildebrand E, Hu LT. Borrelia 
burgdorferi-induced expression of 
matrix metalloproteinases from 
human chondrocytes requires 
mitogen-activated protein kinase and 
Janus kinase/signal transducer and 
activator of transcription signaling 
pathways. InfectImmun 2004; 
72:2864-2871. 
 
(96)  Miller LC, Isa S, Vannier E, Georgilis K, 
Steere AC, Dinarello CA. Live Borrelia 
burgdorferi preferentially activate 
interleukin-1 beta gene expression 
and protein synthesis over the 
interleukin-1 receptor antagonist. 
JClinInvest 1992; 90:906-912. 
 
(97)  Porat R, Poutsiaka DD, Miller LC, 
Granowitz EV, Dinarello CA. 
Interleukin-1 (IL-1) receptor blockade 
reduces endotoxin and Borrelia 
burgdorferi-stimulated IL-8 synthesis 
in human mononuclear cells. FASEB J 
1992; 6:2482-2486. 
 
(98)  Mullegger RR, Means TK, Shin JJ, et al. 
Chemokine signatures in the skin 
disorders of Lyme borreliosis in 
Europe: predominance of CXCL9 and 
CXCL10 in erythema migrans and 
acrodermatitis and CXCL13 in 
lymphocytoma. InfectImmun 2007; 
75:4621-4628. 
 
(99)  Bachmann M, Horn K, Rudloff I, et al. 
Early production of IL-22 but not IL-17 
by peripheral blood mononuclear cells 
exposed to live Borrelia burgdorferi: 
the role of monocytes and interleukin-
1. PLoSPathog 2010; 6:e1001144. 
(100)  Beck G, Habicht GS, Benach JL, 
Coleman JL, Lysik RM, O'Brien RF. A 
role for interleukin-1 in the 




(101)  Shin JJ, Glickstein LJ, Steere AC. High 
levels of inflammatory chemokines 
and cytokines in joint fluid and 
synovial tissue throughout the course 
of antibiotic-refractory lyme arthritis. 
Arthritis Rheum 2007; 56:1325-1335. 
 
(102)  Beck G, Benach JL, Habicht GS. 
Isolation, preliminary chemical 
characterization, and biological 





(103)  Isogai H, Kimura K, Hayashi S, et al. 
Levels of endogenous interleukin-1, 
interleukin-6, and tumor necrosis 
factor in congenic mice infected with 
Borrelia garinii. MicrobiolImmunol 
1997; 41:427-430. 
 
(104)  Lisinski TJ, Furie MB. Interleukin-10 
inhibits proinflammatory activation of 
endothelium in response to Borrelia 
burgdorferi or lipopolysaccharide but 
not interleukin-1beta or tumor 
necrosis factor alpha. JLeukocBiol 
2002; 72:503-511. 
 
(105)  Brown JP, Zachary JF, Teuscher C, Weis 
JJ, Wooten RM. Dual role of 
interleukin-10 in murine Lyme disease: 
regulation of arthritis severity and 
host defense. InfectImmun 1999; 
67:5142-5150. 
 
(106)  Sonderegger FL, Ma Y, Maylor-Hagan 
H, et al. Localized production of IL-10 
suppresses early inflammatory cell 
infiltration and subsequent 
development of IFN-gamma-mediated 
Lyme arthritis. JImmunol 2012; 
188:1381-1393. 
 219 
(107)  Burchill MA, Nardelli DT, England DM, 
et al. Inhibition of interleukin-17 
prevents the development of arthritis 
in vaccinated mice challenged with 
Borrelia burgdorferi. InfectImmun 
2003; 71:3437-3442. 
 
(108)  Kuo J, Nardelli DT, Warner TF, Callister 
SM, Schell RF. Interleukin-35 enhances 
Lyme arthritis in Borrelia-vaccinated 
and -infected mice. ClinVaccine 
Immunol 2011; 18:1125-1132. 
 
(109)  Jones KL, Muellegger RR, Means TK, et 
al. Higher mRNA levels of chemokines 
and cytokines associated with 
macrophage activation in erythema 
migrans skin lesions in patients from 
the United States than in patients 
from Austria with Lyme borreliosis. 
ClinInfectDis 2008; 46:85-92. 
 
(110)  Codolo G, Amedei A, Steere AC, et al. 
Borrelia burgdorferi NapA-driven Th17 
cell inflammation in lyme arthritis. 






 220  221 
Chapter 9 
 
Summary and general conclusion 
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The knowledge about the Gram-negative spirochete Borrelia  has increased significantly in 
the last two decades. Transmission of this bacterium takes place after attachment of an 
infected tick to the host. During feeding, blood enters the midgut of the tick, and the 
Borrelia bacteria are released from the midgut and salivary glands of the tick and can invade 
the host. After infection, the hosts immune system is able to induce a rapid immune 
response against Borrelia. The different clinical outcomes in Lyme disease can be explained 
by the fact that the innate immune response between individuals varies. Understanding this 
individual variation, both at the genetic and immunological level, is crucial for the progress 
of diagnosis and therapy of Lyme disease. 
 
As an introduction to this thesis, we reviewed the literature regarding the recognition of the 
Borrelia bacteria by the innate immune system of the host (Chapter 1). We describe the 
different clinical signs and phases of Lyme disease, as well as the characteristics of the 
bacterium itself. Thereafter, we assess the mechanisms used by the pathogen to support 
dissemination from the tick to the host without getting eliminated by the immune system of 
the host. In addition, we review the several classes of Pattern  Recognition Receptors (PRRs) 
that are able to recognize specific molecular patterns of the Borrelia to induce an immune 
response. The family of Toll-like receptors (TLRs) consists of 11 mammalian members, which 
can be found both extracellular and intracellular. Next to TLRs, the roles of NOD-like 
receptors (NLRs), C-type lectin receptors (CLRs), and signaling pathways activated by Borrelia 
species are described. 
 
The expression of Toll-Like Receptor (TLR)-2 is found on antigen-presenting cells, epithelial 
and endothelial cells (1). TLR2 has a very broad range of ligands: ranging from peptidoglycan 
from Gram-positive bacteria, to bacterial lipoproteins and mycobacterial cell-wall 
lipoarabinomannan (2). Previous studies showed that TLR2 is required in the induction of the 
innate immune response against Borrelia bacteria (3). In order to recognize specific parts of 
Borrelia, TLR2 needs to form heterodimers with other members of the TLR family (either 
TLR1 or TLR6).  In Chapter 2, we show that TLR1/2 heterodimers play an important role in 
the induction of pro-inflammatory cytokines interleukin-(IL)-1β, and IL-6 after Borrelia 
recognition in human primary cells. Using specific antibodies, we  observed an important 
role for TLR1, and not TLR6, for the induction of Borrelia-induced cytokine response. We also 
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demonstrated the functional consequences of polymorphisms in the TLR1 gene for the 
outcome of cytokine production after Borrelia exposure. It is well known that mutations in 
TLR1 and TLR6 receptors are associated with differential susceptibility to bacterial and fungal 
infections (4, 5). Using peripheral blood mononuclear cells from individuals with 
polymorphisms in TLR1, we demonstrated that expression of a truncated form of the TLR1 
molecule results in significantly reduced cytokine production, whereas persons bearing the 
ancient TLR1 allele produced normal amounts of cytokines after recognition of Borrelia. 
These data reveal a novel mechanism leading to the induction of cytokines by Borrelia 
(figure 1). The recognition through TLR1/TLR2 is necessary not only for induction of a proper 
immune response, but may also contribute to inflammation.  
On chromosome 4 encoding for TLR1, TLR2, and TLR6, the gene of another member of the 
TLR family, TLR10, can be found (6, 7). However, TLR10 differs from other TLRs because it 
lacks the downstream signaling components which are associated with TLR2 family members 
(8). Until recently, TLR10 was the only member of the TLR family without a described 
function or ligand specificity. In Chapter 3 we showed for the first time an inhibitory role for 
TLR10, modulating the function of TLR2 and possibly other TLR family members. Co-
transfection of a cell line with TLR2 and TLR10 resulted in inhibition of the cytokine 
production after Borrelia stimulation. The suppressive function of TLR10 could be 
corroborated using peripheral blood mononuclear cells (PBMCs) in combination with specific 
anti-TLR10 antibodies. Moreover, individuals bearing TLR10 polymorphisms that result in a 
loss of function display an increased capacity to produce cytokines upon stimulation with 
TLR2, but not TLR4, ligands. TLR10 is able to induce IL-1Ra through MAPK pathways 
dependent on PI3k. Whether the produced IL-1Ra is biologically active still needs to be 
demonstrated.  
 
When TLR2 was absent or mutations in this receptor were present, production of Borrelia-
dependent cytokines was not completely abrogated, indicating that also other pathogen 
recognition receptors are involved. The phenomenon of collaborating PRRs was already 
described in the past (9). NOD-like receptor family members are intracellular PPRs which are 
able to recognize bacterial peptidoglycans (10). In Chapter 4 of this thesis we assessed the 
role of intracellular NOD-like receptors NOD1 and NOD2 and their signaling adaptor RICK for 
the recognition of Borrelia. We demonstrated that NOD2-associated RICK adapter molecule 
9
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plays an important role in induction of pro-inflammatory cytokines after Borrelia recognition 
(figure 1). After pharmacologic or genetic inhibition of RICK on murine cells using specific 
inhibitors, we were able to demonstrate a decreased cytokine production. In this chapter we 
also addressed the question what the functional consequences are on cytokine production 
by immune cells, expressing genetic variants in the NOD2 gene. In the NOD2 gene, 
polymorphisms of NOD2 that have been reported to be linked to increased susceptibility to 
Crohn’s disease lead to defective peptidoglycan recognition (11). We demonstrated that 
cytokine production after Borrelia stimulation of PBMCs from individuals bearing the 
polymorphism in NOD2 was significantly decreased. No differences in Borrelia-dependent 
cytokine production could be detected between wild-type cells and cell bearing an insertion 
polymorphism in the NOD1 gene. In conclusion, a crucial role for the pattern recognition 
receptor NOD2 in the recognition of Borrelia was found, while NOD1 is not involved in this 
process (Figure 1). These data make it tempting to speculate whether individuals bearing 
NOD2 polymorphisms may have an increased susceptibility to Lyme disease. 
 
 
Figure 1. Borrelia recognition and signaling 
Borrelia bacteria are recognized through specific Pattern Recognition Receptors, including Toll-like 
receptor 1/2. This signal can be inhibited through TLR10. After activation, NF-κB is transcribed and 
cytokines, such as IL-1β are produced and secreted by immune cells. After internalization of Borrelia, 
intracellular receptor NOD2 is also important in recognition. 
 
 225 
Interleukin-(IL)-1β is one of the most potent pro-inflammatory cytokines which displays a 
wide array of biological functions. This cytokine is produced as an inactive protein (pro-IL-
1β), which needs to be cleaved by the enzyme caspase-1 before the active form of the 
cytokine can be secreted by cells. Before active caspase-1 can be detected in activated cells, 
a protein platform called the inflammasome needs to be assembled inside the cell, formed 
by a PRR of the NLR family and caspase-1. In Chapter 3 of this thesis we could demonstrate 
that Borrelia are potent stimuli for the production of IL-1β, by both murine and human cells. 
Furthermore, IL-1β has been linked to the pathogenesis of Lyme arthritis, which is often seen 
after Borrelia infection. However, the precise signaling pathways that are activated upon 
Borrelia exposure, leading to IL-1β production, were not studied previously. In Chapter 5 we 
thoroughly analyzed the roles of TLR-, NLR- and IL-1 signaling in murine Lyme arthritis using 
several different knockout mice. In this chapter, we were able to observe a strong 
dependency on IL-1 secretion of the inflammation occurring during the development of 
murine Lyme arthritis. When macrophages from mice lacking the IL-1 receptor were 
stimulated with Borrelia spirochetes, abrogated cytokine responses were observed. The 
development of murine Lyme arthritis was found to be highly dependent on IL-1. In this 
chapter we also found that murine Lyme arthritis is dependent on ASC and caspase-1, but 
does not rely on the inflammasome components NLRP3, NOD1, NOD2, and RICK. We also 
report that Borrelia induces inflammasome-mediated caspase-1 activation which is highly 
dependent on TLR2 and the TLR-adaptor molecule MyD88. In light of these findings, we 
propose a critical role for the TLR2-MyD88-NLR-ASC-caspase-1 cascade for the induction of 
IL-1β production in the pathogenesis of Lyme arthritis. The treatment of patients suffering 
from Lyme arthritis is still challenging for clinicians, and treatment for patients with chronic 
Lyme disease is often ineffective. Based on the results in Chapter 5 indicating that IL-1 is one 
of the major mediators in Lyme arthritis, it is rationale to propose that neutralizing IL-1 
activity may also have beneficial effects in chronic Lyme arthritis.  
 
In 70-80% of the patients diagnosed with Lyme disease a typical skin lesion called erythema 
migrans (EM) close to the place of the tick bite is reported. Next to early IL-1β release, also 
Interferon (IFN)-γ was stimulated by Borrelia and detected in EM biopsies. Severe 
destructive arthritis in IFN-γ knockout mice could be prevented providing antibodies against 
IL-17, a late cytokine which is often related to chronic illnesses. Interestingly, IL-1β was 
9
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described to play a role in Th17 development, whereas IFN-γ can lead to Th1 cell 
development and can be induced by IL-18, which was first called IGIF (Interferon gamma 
inducing factor). Both IL-1β and IL-18 can be cleaved into its active form by caspase-1. In 
Chapter 6 the role of caspase-1 in IL-1/IL-18 production by Borrelia was described. Using 
spleen cells from IL-1β-/- or IL-18-/- mice, we could clearly demonstrate that lack of IL-1β 
results in significantly reduced IL-17 production, whereas IFN-γ induction after Borrelia 
exposure is regulated via IL-18. The data presented in Chapter 6 reveal a novel mechanism 
leading to the induction of the Th1 and Th17 response by Borrelia. The essential position 
played by caspase-1 needs further investigation for its role in the Th1 and Th17 response 
during infection or (development of) chronic inflammation, and might lead to the 
development of new immunotherapeutic strategies. Another cytokine that is involved in the 
induction of Th17 cells and subsequent induction of IL-17 is IL-23, which is mainly produced 
by dendritic cells and macrophages. In Chapter 7 we showed a crucial role for IL-23 in the 
production of IL-17 after stimulation of immune cells with Borrelia species. In the IL-23R 
gene, a functional polymorphism was described which was linked to protection against 
several autoimmune diseases, including Crohn’s disease, psoriasis and rheumatoid arthritis, 
due to functional consequences in the IL-23R protein. Using PBMCs from persons with a 
specific polymorphism in the IL-23R gene, we demonstrated that expression of a truncated 
form of the IL-23R molecule results in significantly reduced IL-17 production, whereas 
persons who do not show this polymorphism produce normal amounts of this cytokine after 
recognition of Borrelia. In addition, we have analyzed the functional consequence of the IL-
23R SNP in a cohort of suspected patients with Lyme disease. Interstingly, we found that 
individuals carrying the IL-23R SNP had milder symptoms of chronic Lyme disease. These 
data reveal a novel mechanism leading to the induction of IL-17 by Borrelia. We demonstrate 
that the production of Borrelia-induced IL-17 is dependent on IL-23R signaling. 
 
Our research has delineated new pattern recognition receptors and signaling pathways that 
provide insight into the pathogenesis caused by Borrelia species. We and others have 
performed multiple studies unraveling the complex Lyme disease pathogenesis. In Chapter 
8,  an update of the literature concerning the Borrelia recognition is provided.  
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General conclusion 
In this thesis, I studied several aspects of this complex network, in order to provide novel 
strategies for the treatment of Lyme disease. I have demonstrated that TLR1/TLR2 
heterodimers are crucial for the recognition of Borrelia spirochetes. Thereafter, these 
pattern recognition receptors were also found to play an important role in the induction of 
Borrelia-dependent pro-inflammatory cytokines. In addition, I could demonstrate that NOD2 
is of high importance in Borrelia recognition by the host immune system. This thesis 
demonstrates that interaction of PRRs with specific parts of Borrelia bacteria could lead to 
induction of both innate and adaptive immune responses and likely to Lyme disease. 
Disruption of this interaction by either polymorphisms in PRRs or inhibition of the receptors 
by specific antibodies may lead to differences seen in disease outcome. I have assessed the 
outcomes in Lyme disease development using individuals expressing different genetic 
variants of genes involved in Borrelia-induced signaling.  
 
In conclusion, the immune response induced after recognition of Borrelia spirochetes by the 
host represents a complex signaling structure in which the collaboration between several 
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De afgelopen twee decennia is de kennis over de Gram-negatieve spirocheet Borrelia 
aanzienlijk groter geworden. Besmetting met deze bacterie vindt plaats nadat een 
geïnfecteerde teek in de huid heeft gezeten. Tijdens het voeden komt er bloed van de 
gastheer in het darmstelsel van de teek. Borrelia bacteriën komen op dit moment vrij uit het 
darmweefsel en gaan naar de speekselklieren van de teek waarna ze in de gastheer 
terechtkomen. Na deze infectie induceert het immuunsysteem van de gastheer zeer snel een 
immuunrespons tegen Borrelia. Het verloop van de ziekte van Lyme wisselt sterk tussen 
individuen. De verschillende klinische verschijnselen in de ziekte van Lyme kunnen worden 
verklaard door het feit dat de immuunrespons varieert tussen individuen. Inzicht in deze 
individuele variatie, zowel op genetisch en immunologisch niveau, is van cruciaal belang voor 
de bespoediging van de diagnose en therapie tegen de ziekte van Lyme. 
 
Als inleiding van dit proefschrift hebben we de literatuur omtrent de herkenning van de 
Borrelia bacteriën door het aangeboren immuunsysteem van de gastheer beschreven 
(Hoofdstuk 1). We beschrijven de verschillende klinische uitkomsten en fasen van de ziekte 
van Lyme, alsmede de kenmerken van de bacterie zelf. Daarna beschrijven we de 
mechanismen die door de pathogeen worden gebruikt om zich in de gastheer te kunnen 
verspreiden zonder geëlimineerd te worden door de immuunrespons. Daarnaast geven we 
een overzicht van de verschillende klassen van receptoren die specifieke moleculaire 
patronen van Borrelia kunnen herkennen (Pattern Recognition Receptors; PRRs). De familie 
van Toll-like receptoren (TLR’s) bestaat uit 11 humane leden, die zowel aan de buitenkant en 
binnenkant van een cel kunnen worden gevonden. Naast TLR’s, worden ook de rollen van 
NOD-like receptoren (NLR’s), C-type lectine receptoren (CLR’s), en de signaalroutes 
geïnduceerd door Borrelia hier beschreven. 
 
Toll-like receptor (TLR)-2 kan worden gevonden op antigeen-presenterende cellen, epitheel- 
en endotheelcellen (1). TLR2 heeft een breed spectrum aan liganden: van peptidoglycaan 
gevonden in Gram-positieve bacteriën, tot bacteriële lipoproteinen en mycobacterieel 
lipoarabinomannan (2). Eerdere studies hebben aangetoond dat TLR2 nodig is voor de 
inductie van de vroege immuunrespons tegen Borrelia bacteriën (3). Om specifieke delen 
van de Borrelia te kunnen herkennen, moet TLR2 heterodimeren vormen met andere leden 
van de TLR familie (dit kan TLR1 of TLR6 zijn). In Hoofdstuk 2 hebben we laten zien dat 
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TLR1/2 heterodimeren een belangrijke rol spelen in de inductie van de pro-inflammatoire 
cytokinen interleukine-(IL)-1β en IL-6 na herkenning van Borrelia  in menselijke primaire 
cellen. Met behulp van specifieke antilichamen, hebben we een belangrijke rol voor TLR1, 
maar niet TLR6, kunnen aantonen voor de inductie van de Borrelia-geïnduceerde 
cytokinenrespons. Daarnaast hebben we de functionele consequenties laten zien van 
polymorfismen in het TLR1 gen in de uitkomst van cytokinenproductie na blootstelling van 
cellen aan Borrelia. Het is bekend dat mutaties in de genen die coderen voor TLR1 en TLR6 
receptoren zijn geassocieerd met differentiële gevoeligheid voor bacteriële en 
schimmelinfecties (4, 5). Door gebruik te maken van perifere bloed mononucleaire cellen 
van individuen met polymorfismen in TLR1, hebben we laten zien dat de expressie van een 
afgeknotte vorm van het TLR1 molecuul leidt tot een significante reductie in de productie 
van cytokinen. Daarentegen, individuen met de oorspronkelijke vorm van TLR1 zijn in staat 
een normale hoeveelheid cytokinen te produceren na herkenning van Borrelia. 
Deze gegevens onthullen een nieuw mechanisme dat leidt tot de inductie van cytokinen 
door Borrelia (figuur 1). De herkenning door TLR1/TLR2 is niet alleen nodig voor het 
induceren van een goede immuunrespons, maar kan ook bijdragen aan de onsteking. 
 
Op chromosoom 4 liggen de genen van TLR1, TLR2, en TLR6, maar is ook het gen van een 
ander lid van de TLR-familie gecodeerd, namelijk TLR10 (6, 7). Echter, TLR10 verschilt van de 
andere TLR’s doordat het de onderliggende signaleringscomponenten mist die geassocieerd 
worden met de andere TLR-familieleden (8). Tot voor kort was TLR10 het enige lid van de 
TLR familie zonder een beschreven functie of bekende ligand specificiteit. In Hoofdstuk 3 
laten we voor de eerste keer zien dan TLR10 een remmende rol speelt, waarbij de functie 
van TLR2 en mogelijk andere TLR familie-leden kunnen worden gemoduleerd. Co-transfectie 
van een cellijn met TLR2 en TLR10 resulteerde in remming van de cytokinenproductie na 
Borrelia stimulatie. De onderdrukkende functie van TLR10 werd bevestigd door perifere 
bloed mononucleaire cellen (PBMC’s) in combinatie met specifieke antilichamen tegen 
TLR10 te gebruiken. Individuen met TLR10 polymorfismen die resulteren tot een verlies van 
functie, lieten een verhoogde cytokinenproductie zien na stimulatie met TLR2-, maar niet 
TLR4-, liganden. TLR10 kan IL-1Ra inducerend via de MAPK signaalroute, en is afhankelijk van 
PI3 kinases. Of het geproduceerde IL-1Ra biologisch actief is, moet nog worden aangetoond. 
10
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Wanneer TLR2 afwezig is of als er mutaties in deze receptor aanwezig zijn, was de productie 
van Borrelia-afhankelijke cytokinen niet volledig  geremd, wat aangeeft dat ook andere 
pathogeen herkenningsreceptoren betrokken zijn bij dit proces. Het fenomeen van 
samenwerkende PRR’s was in het verleden al beschreven (9). NOD-like receptor familie-
leden zijn intracellulaire PRR’s die in staat zijn bacteriële peptidoglycanen te herkennen (10). 
In Hoofdstuk 4 van dit proefschrift hebben we de rol van de intracellulaire NOD-like 
receptoren NOD1 en NOD2 en de signaaladaptor RICK voor de herkenning van Borrelia 
bestudeerd. We toonden aan dat NOD2-geassocieerde RICK adaptor moleculen een 
belangrijke rol spelen in de inductie van pro-inflammatoire cytokinen na Borrelia herkenning 
(figuur 1). Na farmacologische of genetische remming van RICK, konden we een verminderde 
cytokinenproductie aantonen in muizencellen. In dit hoofdstuk hebben we ook de vraag aan 
de orde gesteld welke gevolgen verschillende genetische varianten van het NOD2 gen 
hebben op de cytokinenproductie door immuuncellen. In het NOD2 gen, zijn polymorfismen 
gevonden die gekoppeld worden aan verhoogde vatbaarheid voor de ziekte van Crohn door 
een verminderde herkenning van peptidoglucaan door cellen (11).  
We hebben aangetoond dat de cytokinenproductie na Borrelia stimulatie van PBMC’s van 
individuen met polymorfismen in NOD2 aanzienlijk was afgenomen. Er werden geen 
verschillen waargenomen tussen wild-type cellen en cellen met een insertie-polymorfisme in 
NOD1. In conclusie, er werd een cruciale rol voor NOD2 voor de herkenning van Borrelia 
aangetoond, terwijl NOD1 niet betrokken is bij dit proces (figuur 1). Deze gegevens maken 
het verleidelijk te speculeren of personen die polymorfismes hebben in NOD2, een 




Figuur 1. Borrelia herkenning en signalering 
Borrelia bacteriën worden herkend door specifieke patroon herkennings receptoren, waar ook Toll-
like receptor 1/2 bij hoort. Dit signaal kan worden geremd door TLR10. Na activatie wordt NF-кB 
geactiveerd, en cytokinen zoals IL-β worden geproduceerd en uitgescheiden door immuuncellen. Na 
opname van Borrelia is de intracellulaire receptor NOD2 ook belangrijk voor de herkenning. 
 
Interleukine-(IL)-1β is één van de meest krachtige pro-inflammatoire cytokinen die een 
breed scala aan biologische functies heeft. Deze cytokine wordt geproduceerd als een 
inactief eiwit (pro-IL-1β), dat moet worden gesplitst door het enzym caspase-1 voordat de 
actieve vorm van het cytokine kan worden uitgescheiden door cellen. Om caspase-1 te 
activeren moet een eiwit platform (zogenaamd inflammasoom), bestaande uit een PRR van 
de NLR familie en caspase-1, bijeenkomen. In Hoofdstuk 3 van dit proefschrift hebben we al 
aan kunnen tonen dat Borrelia een krachtige stimulus is voor de productie van IL-1β door 
zowel muizelijke als menselijke cellen. Bovendien is IL-1β gekoppeld aan de pathogenese van 
Lyme artritis, een diagnose die vaak gezien wordt na Borrelia infectie. De precieze 
signaalwegen die geactiveerd worden bij blootstelling aan Borrelia die leidt tot IL-1β 
productie, was nog niet eerder bestudeerd. In Hoofdstuk 5 hebben we grondig de rol van 
TLR-, NLR-, en IL-1 signalen bestudeerd in een muis-Lyme artritis model, door gebruik te 
maken van verschillende knock-out muizen. In dit hoofdstuk konden we een sterke 
afhankelijkheid van IL-1 in de ontsteking die tijdens de ontwikkeling van muizen Lyme artritis 
observeren. Wanneer macrofagen van muizen die IL-1 receptor moleculen misten, werden 
10
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gestimuleerd met Borrelia  spirocheten, werd een verlaging van de cytokinenproductie 
waargenomen. De ontwikkeling van muizen Lyme artritis bleek sterk afhankelijk van IL-1. 
In dit hoofdstuk hebben we ook gevonden dat muizen Lyme arthritis afhankelijk is van ASC 
en caspase-1, maar onafhankelijk is van de inflammasoom componenten NLRP3, NOD1, 
NOD2, en RICK. We rapporteerden ook dat Borrelia-inflammasoom-gemedieerde caspase-1 
activering sterk afhankelijk is van TLR2 en TLR-adaptor molecuul MyD88. In het licht van 
deze bevindingen, stellen wij een cruciale rol voor de TLR2-MyD88-NLR-ASC-caspase-1 
cascade voor de inductie van IL-1β productie in de pathogenese van Lyme artritis. De 
behandeling van patiënten die lijden aan Lyme artritis is nog steeds een uitdaging voor 
clinici, en behandeling voor patiënten met chonische ziekte van Lyme is vaak niet effectief. 
Gebaseerd op de resultaten in Hoofdstuk 5 dat aangeeft dat IL-1 één van de belangrijkste 
mediatoren is in Lyme artritis zou het neutraliseren van dit cytokine gunstige effecten 
kunnen hebben in chronische Lyme artritis. 
 
In 70-80% van de patiënten met de ziekte van Lyme wordt een typische lesie, die erythema 
migrans (EM) heet, dichtbij de plaats van de tekenbeet gerapporteerd. Naast vroege 
productie van IL-1β, werd ook Interferon-(IFN)-γ productie geïnduceerd door Borrelia en kon 
ook dit worden aangetoond in EM biopsies. Ernstige destructieve artritis in IFN-γ knock-out 
muizen kan worden voorkomen door antilichamen tegen IL-17 te geven, een late cytokine 
die vaak gerelateerd wordt aan chronische ziekten.  
Interessant was dat IL-1β beschreven is een rol te spelen in de ontwikkeling van Th17 cellen, 
terwijl IFN-γ kan leiden tot Th1 cel ontwikkeling en kan worden geïnduceerd door IL-18 (die 
eerst IGIF; Interferon gamma inducerende factor, werd genoemd). Zowel IL-1β als IL-18 
kunnen worden gesplitst in hun actieve vorm door caspase-1. In Hoofdstuk 6 werd de rol 
van caspase-1 in IL-1/IL-18 productie door Borrelia beschreven. Met miltcellen van IL-1β-/- of 
IL-18-/- muizen, konden we duidelijk laten zien dat een gebrek aan IL-1β resulteerde in 
aanzienlijk minder IL-17 productie, terwijl IFN-γ inductie na blootstelling aan Borrelia 
afhankelijk bleek van IL-18. De gegevens in Hoofdstuk 6 tonen een nieuw mechanisme die 
leidt tot de inductie van Th1 en Th17 responsen door Borrelia.De essentiële positie van 
caspase-1 in de ontwikkeling van de Th1 en Th17 respons tijdens infectie of (ontwikkeling 
van) chronische inflammatie, heeft verder onderzoek nodig, maar kan leiden tot nieuwe 
immunotherapeutische strategieën. Een ander cytokine dat betrokken is bij de inductie van 
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Th17 cellen en daaropvolgende inductie van IL-17 is IL-23, dat voornamelijk wordt 
geproduceerd door dendritische cellen en macrofagen. In Hoofdstuk 7 hebben we een 
cruciale rol voor IL-23 laten zien in de productie van IL-17 na stimulatie van immuuncellen 
met Borrelia soorten. In het IL-23R-gen werd een polymorfisme beschreven met functionele 
consequenties voor het IL-23R eiwit, dat gekoppeld is aan bescherming van verschillende 
auto-immuunziekten, zoals de ziekte van Crohn, psoriasis, en reumatoïde artritis. Met 
PBMC’s van personen met een specifiek polymorfisme in het IL-23R gen hebben we 
aangetoond dat de afgeknotte vorm van het IL-23R molecuul leidt tot aanzienlijk minder IL-
17 productie na Borrelia stimulatie, terwijl personen die dit polymorfisme niet hebben 
normale hoeveelheden van dit cytokine produceren. Bovendien hebben we het functionele 
gevolg van de IL-23R SNP in een cohort van patiënten met vermoedelijke ziekte van Lyme 
onderzocht. Interessant was dat individuen met het functionele polymorfisme mildere 
symptomen van de chronische vorm van de ziekte van Lyme hadden. Deze gegevens 
onhullen een nieuw mechanisme dat leidt tot de inductie van IL-17 door Borrelia. We zien 
dat de productie van Borrelia-geïnduceerde IL-17 afhankelijk is van IL-23R signalering. 
 
Ons onderzoek heeft nieuwe patroon herkenningsreceptoren en signaalwegen aangetoond 
die inzicht geven in de pathogenese die wordt veroorzaakt door Borrelia soorten. Wij en 
anderen hebben meerdere studies uitgevoerd die de complexe ziekte van Lyme ontrafelen. 
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Algemene conclusie 
In dit proefschrift heb ik verschillende aspecten van dit complexe netwerk onderzocht, het 
het oog op nieuwe strategieën voor de behandeling van de ziekte van Lyme. Ik heb 
aangetoond dat TLR1/TLR2 heterodimeren van cruciaal belang zijn voor de herkenning van 
Borrelia spirocheten. Daarna werd ook aangetoond dat deze patroonherkenningsreceptoren 
een belangrijke rol spelen bij de inductie van Borrelia-afhankelijke pro-inflammatoire 
cytokinen. Bovendien heb ik kunnen aantonen dat NOD2 van groot belang is in de 
herkenning van Borrelia door het immuunsysteem van de gastheer. Dit proefschrift toont de 
interactie van PRR’s met specifieke onderdelen van Borrelia bacteriën kan leiden tot inductie 
van zowel aangeboren en late immuunresponsen en waarschijnlijk tot de ziekte van Lyme. 
Verstoring van de functie van PRR’s door polymorfismen of remming van de receptoren door 
specifieke antilichamen kunnen het ziekteverloop beïnvloeden. Ik heb de uitkomsten in de 
ziekte van Lyme tegen het licht gehouden met behulp van individuen met variatie in genen 
die betrokken zijn bij Borrelia-geïnduceerde signalering. 
 
Concluderend, de immuunrespons die wordt geïnduceerd na herkenning van Borrelia 
spirocheten door de gastheer is een complexe signaleringsstructuur waarin de 
samenwerking tussen verschillende klassen van PRR’s en de inductie van cytokinen een 
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